{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-4b-it",
        "variant": "4b",
        "max_new_tokens": 512,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_4b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": true,
        "few_shot": false,
        "answer_first": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-10T18:59:54.880896"
  },
  "experiment": "radiology",
  "model": "google/medgemma-4b-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 50,
    "incorrect": 46,
    "true_positives": 0,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 46,
    "parse_errors": 4,
    "accuracy": 0.5208333333333334,
    "parse_error_rate": 0.04,
    "precision": 0,
    "recall": 0.0,
    "f1": 0
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T19:00:55.882436"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"High-grade medulloblastoma\",\n  \"evidence\": [\n    \"Posterior fossa mass with enhancement and hydrocephalus\",\n    \"Restricted diffusion\",\n    \"High-grade medulloblastoma on histology\"\n  ],\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a cyst or a benign tumor.\",\n    \"The restricted diffusion could be due to a benign process, such as a non-cancerous tumor.\",\n    \"The high-grade medulloblastoma on histology could be a misdiagnosis or an error in the pathology report.\"\n  ],\n  \"conclusion\": \"While the report strongly suggests a high-grade medulloblastoma, it is important to consider the possibility of alternative explanations, such as a benign condition or a misdiagnosis. Further investigation and consultation with a multidisciplinary team (MDT) are recommended to confirm the diagnosis and plan treatment.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"High-grade medulloblastoma\",\n  \"evidence\": [\n    \"Posterior fossa mass with enhancement and hydrocephalus\",\n    \"Restricted diffusion\",\n    \"High-grade medulloblastoma on histology\"\n  ],\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a cyst or a benign tumor.\",\n    \"The restricted diffusion could be due to a benign process, such as a non-cancerous tumor.\",\n    \"The high-grade medulloblastoma on histology could be a misdiagnosis or an error in the pathology report.\"\n  ],\n  \"conclusion\": \"While the report strongly suggests a high-grade medulloblastoma, it is important to consider the possibility of alternative explanations, such as a benign condition or a misdiagnosis. Further investigation and consultation with a multidisciplinary team (MDT) are recommended to confirm the diagnosis and plan treatment.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"High-grade medulloblastoma\",\n  \"evidence\": [\n    \"Posterior fossa mass with enhancement and hydrocephalus\",\n    \"Restricted diffusion\",\n    \"High-grade medulloblastoma on histology\"\n  ],\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a cyst or a benign tumor.\",\n    \"The",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T19:00:55.882469"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection. There are no findings suggestive of malignancy. The lymph node size is decreasing on follow-up, further supporting the benign nature of the findings. Therefore, the findings are reassuring and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy secondary to a viral infection, which is a benign finding. The decreasing node size on follow-up further supports this conclusion. No atypical features are noted, and malignancy is not identified. Therefore, the findings are reassuring and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, which is a benign condition. The findings are described as resolving and not atypical. Malignancy is not identified. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, which is a benign finding. The description of the lymph node size decreasing on follow-up further supports the benign nature of the findings. Malignancy is not identified. Therefore, the findings are reassuring and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, which is a benign finding. No atypical features are mentioned. Malignancy is not identified. The decreasing node size on follow-up further supports the benign nature of the findings. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, which is a benign finding. The findings are described as resolving and not atypical. Malignancy is not identified. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, which is a benign finding. The findings are described as resolving and not atypical. Malignancy is not identified. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymph",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T19:00:55.882483"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report confirms Burkitt lymphoma with abdominal lymphadenopathy and elevated LDH levels. Given the confirmed diagnosis and the patient's age (paediatric oncology assessment), this is a serious finding.\",\n  \"alternative_explanations\": [\n    \"The abdominal lymphadenopathy could be due to a reactive process, although the biopsy confirms Burkitt lymphoma.\",\n    \"Elevated LDH levels can be seen in both benign and malignant conditions, including some inflammatory processes.\"\n  ],\n  \"conclusion\": \"The report indicates Burkitt lymphoma, which is a highly aggressive form of non-Hodgkin lymphoma. Given the confirmed diagnosis and the patient's age, the findings are concerning and warrant immediate further investigation and treatment planning.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes abdominal lymphadenopathy, confirmed as Burkitt lymphoma on biopsy, and elevated LDH levels. Given the confirmed diagnosis and the patient's age (paediatric oncology assessment), this is a serious finding.\",\n  \"alternative_explanations\": [\n    \"The abdominal lymphadenopathy could be due to a reactive process, although the biopsy confirms Burkitt lymphoma.\",\n    \"Elevated LDH levels can be seen in both benign and malignant conditions, including some inflammatory processes.\"\n  ],\n  \"conclusion\": \"The report indicates Burkitt lymphoma, which is a highly aggressive form of non-Hodgkin lymphoma. Given the confirmed diagnosis and the patient's age, the findings are concerning and warrant immediate further investigation and treatment planning.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes abdominal lymphadenopathy, confirmed as Burkitt lymphoma on biopsy, and elevated LDH levels. Given the confirmed diagnosis and the patient's age (paediatric oncology assessment), this is a serious finding.\",\n  \"alternative_explanations\": [\n    \"The abdominal lymphadenopathy could be due to a reactive process, although the biopsy confirms Burkitt lymphoma.\",\n    \"Elevated LDH levels can be seen in both benign and malignant conditions, including some inflammatory processes.\"\n  ],\n  \"conclusion\": \"The report indicates Burkitt lymphoma, which is a highly aggressive form of non-Hodgkin lymphoma. Given the confirmed diagnosis and the patient's age, the findings are concerning and warrant immediate further investigation and treatment planning.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T19:00:55.882502"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n  \"summary\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, consistent with B-cell ALL. CNS involvement is negative. The report recommends MDT discussion and treatment planning. The report does not mention any benign findings.\",\n  \"malignancy_assessment\": \"The report strongly suggests the presence of acute lymphoblastic leukemia (ALL). The high percentage of lymphoblasts (85%) in the bone marrow is a key indicator of malignancy. The immunophenotyping consistent with B-cell ALL further supports this diagnosis.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of ALL, it's important to consider that some rare conditions could present with a similar bone marrow picture. However, given the clinical context (pancytopenia and suspected ALL) and the specific findings (lymphoblasts and B-cell immunophenotyping), these alternative explanations are less likely.\",\n  \"final_judgment\": \"The report indicates a high probability of acute lymphoblastic leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\",\n  \"malignancy_assessment\": \"The report strongly suggests the presence of acute lymphoblastic leukemia (ALL). The high percentage of lymphoblasts (85%) in the bone marrow is a key indicator of malignancy. The immunophenotyping consistent with B-cell ALL further supports this diagnosis.\",\n  \"alternative_explanations\": \"Although the findings are highly suggestive of ALL, it's important to consider that some rare conditions could present with a similar bone marrow picture. However, given the clinical context (pancytopenia and suspected ALL) and the specific findings (lymphoblasts and B-cell immunophenotyping), these alternative explanations are less likely.\",\n  \"final_judgment\": \"The report indicates a high probability of acute lymphoblastic leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\",\n  \"malignancy_assessment\": \"The report strongly suggests the presence of acute",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T19:00:55.882527"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection, and no malignancy is identified. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing, and there are no atypical features. The doctor has provided reassurance. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T19:00:55.882542"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n  \"overall_assessment\": \"The report indicates Stage III Neuroblastoma, with a large heterogeneous suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines. The findings suggest a high likelihood of malignancy, specifically Neuroblastoma.\",\n  \"potential_benign_explanations\": \"While the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"malignancy_assessment\": \"The combination of a large suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines strongly supports a diagnosis of Neuroblastoma. Stage III disease further reinforces this suspicion.\",\n  \"skeptical_arguments_against_malignancy\": \"Although the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"final_conclusion\": \"The report strongly suggests a diagnosis of Stage III Neuroblastoma. Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"overall_assessment\": \"The report indicates Stage III Neuroblastoma, with a large heterogeneous suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines. The findings suggest a high likelihood of malignancy, specifically Neuroblastoma.\",\n  \"potential_benign_explanations\": \"While the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"malignancy_assessment\": \"The combination of a large suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines strongly supports a diagnosis of Neuroblastoma. Stage III disease further reinforces this suspicion.\",\n  \"skeptical_arguments_against_malignancy\": \"Although the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"final_conclusion\": \"The report strongly suggests a diagnosis of Stage III Neuroblastoma. Further investigation and",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T19:00:55.882569"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report states that no malignancy was identified, therefore it is unlikely to be malignant.\",\n  \"alternative_explanations\": \"The report indicates a normal chest radiograph, clear lung fields, no mediastinal mass, and normal heart size. These findings suggest that there is no evidence of malignancy.\",\n  \"conclusion\": \"The report indicates that no malignancy was identified. Therefore, the patient is unlikely to have malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal.\",\n  \"malignancy_assessment\": \"The report indicates no signs of malignancy based on the chest radiograph and other findings.\",\n  \"alternative_explanations\": \"The normal chest radiograph, clear lung fields, absence of mediastinal mass, and normal heart size all support the conclusion that no malignancy is present.\",\n  \"conclusion\": \"Based on the provided report, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified.\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, making it highly unlikely to be malignant.\",\n  \"alternative_explanations\": \"The report provides a normal chest radiograph, clear lung fields, and no mediastinal mass, which further supports the conclusion that no malignancy is present.\",\n  \"conclusion\": \"The report indicates no malignancy, therefore the patient is not likely to have malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal.\",\n  \"malignancy_assessment\": \"The report indicates that the findings are normal, and no malignancy is present.\",\n  \"alternative_explanations\": \"The normal chest radiograph, clear lung fields, absence of mediastinal mass, and normal heart size all support the conclusion that no malignancy is present.\",\n  \"conclusion\": \"The report indicates no malignancy, therefore the patient is not likely to have malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified.\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, making it highly unlikely to",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T19:00:55.882593"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T19:00:55.882601"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor with favorable histology. The key findings are a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. The report recommends MDT discussion and treatment planning. Based on these findings, the report suggests that the patient has a Wilms Tumor, which is a type of kidney cancer that primarily affects children. Given the favorable histology and lack of vascular invasion, the report suggests that the tumor is likely to respond well to treatment. The recommendation for MDT discussion and treatment planning suggests that the patient will likely undergo a multidisciplinary approach to treatment, which may include surgery, chemotherapy, and/or radiation therapy. The report also suggests that the patient is likely to have a good prognosis, as Wilms tumors are often highly curable, especially when diagnosed at an early stage.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor with favorable histology. The key findings are a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. The report recommends MDT discussion and treatment planning. Based on these findings, the report suggests that the patient has a Wilms Tumor, which is a type of kidney cancer that primarily affects children. Given the favorable histology and lack of vascular invasion, the report suggests that the tumor is likely to respond well to treatment. The recommendation for MDT discussion and treatment planning suggests that the patient will likely undergo a multidisciplinary approach to treatment, which may include surgery, chemotherapy, and/or radiation therapy. The report also suggests that the patient is likely to have a good prognosis, as Wilms tumors are often highly curable, especially when diagnosed at an early stage.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor with favorable histology. The key findings are a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. The report recommends MDT discussion and treatment planning. Based on these findings, the report suggests that the patient has a Wilms Tumor, which is a type of kidney cancer that primarily affects children. Given the favorable histology and lack of vascular invasion, the report suggests that the tumor is likely to respond well to treatment. The recommendation for MDT discussion and treatment planning suggests that the patient will likely undergo a multidisciplinary approach to treatment, which may include surgery,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T19:00:55.882623"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass, and PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. This suggests a diagnosis of Hodgkin Lymphoma. While the report states that the findings are consistent with classical Hodgkin, nodular sclerosing type, it's important to note that the presence of FDG-avid nodes indicates the presence of active disease, which can be a sign of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type. The report recommends an MDT discussion and treatment planning, which suggests that the diagnosis is likely confirmed. The report does not explicitly state that the findings are indicative of malignancy, but the presence of FDG-avid nodes and the description of a bulky anterior mediastinal mass raise concerns about the possibility of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type, which is a relatively common subtype of Hodgkin lymphoma and is typically treated with chemotherapy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass, and PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. This suggests a diagnosis of Hodgkin Lymphoma. While the report states that the findings are consistent with classical Hodgkin, nodular sclerosing type, it's important to note that the presence of FDG-avid nodes indicates the presence of active disease, which can be a sign of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type. The report recommends an MDT discussion and treatment planning, which suggests that the diagnosis is likely confirmed. The report does not explicitly state that the findings are indicative of malignancy, but the presence of FDG-avid nodes and the description of a bulky anterior mediastinal mass raise concerns about the possibility of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type, which is a relatively common subtype of Hodgkin lymphoma and is typically treated with chemotherapy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T19:00:55.882800"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": {\n    \"likely_malignant\": true,\n    \"alternative_explanations\": [\n      \"Calcifications could be reactive\",\n      \"MIBG avidity can be seen in benign conditions\",\n      \"Elevated urinary catecholamines can be seen in benign conditions\",\n      \"Stage III disease in pediatric oncology is suggestive of neuroblastoma\"\n    ]\n  },\n  \"conclusion\": \"The report indicates a high likelihood of malignancy, specifically neuroblastoma. However, it's crucial to consider alternative explanations for the abnormal findings, such as reactive processes or benign conditions. Further investigation and discussion with the MDT are necessary to confirm the diagnosis and develop an appropriate treatment plan.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": {\n    \"likely_malignant\": true,\n    \"alternative_explanations\": [\n      \"Calcifications could be reactive\",\n      \"MIBG avidity can be seen in benign conditions\",\n      \"Elevated urinary catecholamines can be seen in benign conditions\",\n      \"Stage III disease in pediatric oncology is suggestive of neuroblastoma\"\n    ]\n  },\n  \"conclusion\": \"The report indicates a high likelihood of malignancy, specifically neuroblastoma. However, it's crucial to consider alternative explanations for the abnormal findings, such as reactive processes or benign conditions. Further investigation and discussion with the MDT are necessary to confirm the diagnosis and develop an appropriate treatment plan.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": {\n    \"likely_malignant\": true,\n    \"alternative_explanations\": [\n      \"Calcifications could be reactive\",\n      \"",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T19:00:55.882824"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous hepatic mass\",\n      \"elevated AFP\",\n      \"Fetal histology subtype\",\n      \"PRETEXT stage II\"\n    ],\n    \"malignancy_assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, suggesting a possible hepatoblastoma. The fetal histology subtype and PRETEXT stage II further support this diagnosis. However, it's important to consider that these findings could also be due to benign conditions, such as a large benign liver tumor or reactive changes related to the underlying cause of the pancytopenia.\",\n    \"skeptical_reasoning\": \"While the findings are concerning, they do not definitively confirm malignancy. A large benign liver tumor could present similarly, and elevated AFP can be seen in various conditions. The PRETEXT staging is based on the findings, but further investigation is needed to confirm the diagnosis and rule out other possibilities.\",\n    \"conclusion\": \"The report suggests a possible hepatoblastoma, but further investigation is needed to confirm the diagnosis and rule out benign conditions. A multidisciplinary team (MDT) discussion and treatment planning are recommended.\"\n  }\n}\n```\n```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous hepatic mass\",\n      \"elevated AFP\",\n      \"Fetal histology subtype\",\n      \"PRETEXT stage II\"\n    ],\n    \"malignancy_assessment\": \"The report describes a large, heterogeneous hepatic mass with elevated AFP, and classifies it as a Fetal histology subtype with PRETEXT stage II. This presentation is highly suggestive of hepatoblastoma, a malignant tumor of the liver, particularly in children.\",\n    \"skeptical_reasoning\": \"While the findings are concerning and consistent with hepatoblastoma, it's crucial to consider that other conditions can mimic these findings. For instance, a large benign liver tumor, such as a hemangioma or a focal nodular hyperplasia (FNH), could present with a similar mass and elevated AFP levels. It's also possible that the elevated AFP is due to a non-hepatic malignancy or a reactive process. The PRETEXT staging, while providing some information about the tumor's extent, doesn't definitively rule out other possibilities.\",\n    \"conclusion\": \"The report strongly suggests hepatoblastoma, but further investigation is necessary to confirm the diagnosis and exclude",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T19:00:55.882851"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n  \"summary\": \"The report describes multiple lytic skull lesions with soft tissue component, positive for CD1a and Langerin, suggestive of Langerhans Cell Histiocytosis (LCH). The report recommends MDT discussion and treatment planning.\",\n  \"assessment\": \"The report clearly indicates multiple lytic skull lesions with soft tissue component and positive immunohistochemical staining for CD1a and Langerin, which are characteristic of Langerhans Cell Histiocytosis. The report also recommends MDT discussion and treatment planning, suggesting a higher level of concern regarding the findings. The report is from a Paediatric Oncologist and the reason for request is suspected Langerhans Cell Histiocytosis. The findings are from a CT scan.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of LCH, other less likely possibilities could include metastatic disease, although the presence of CD1a and Langerin positivity makes this less probable. It is also important to consider if the patient has a history of previous radiation or chemotherapy, which could potentially cause lytic bone lesions. It is also important to consider if the patient has an underlying immune deficiency, which could potentially predispose them to LCH.\",\n  \"conclusion\": \"The findings are most likely Langerhans Cell Histiocytosis, but other possibilities should be considered. Further investigation and MDT discussion are recommended.\"\n}\n```\n```json\n{\n  \"summary\": \"The report describes multiple lytic skull lesions with soft tissue component, positive for CD1a and Langerin, suggestive of Langerhans Cell Histiocytosis (LCH). The report recommends MDT discussion and treatment planning.\",\n  \"assessment\": \"The report clearly indicates multiple lytic skull lesions with soft tissue component and positive immunohistochemical staining for CD1a and Langerin, which are characteristic of Langerhans Cell Histiocytosis. The report also recommends MDT discussion and treatment planning, suggesting a higher level of concern regarding the findings. The report is from a Paediatric Oncologist and the reason for request is suspected Langerhans Cell Histiocytosis. The findings are from a CT scan.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of LCH, other less likely possibilities could include metastatic disease, although the presence of CD1a and Langerin positivity makes this less probable. It is also important to consider if the patient has a history of previous radiation or chemotherapy, which could potentially cause lytic bone lesions. It is also important",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T19:00:55.882903"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive Monospot and EBV serology. No malignancy is identified. The report provides reassurance.\",\n  \"malignancy_likelihood\": \"Low\",\n  \"justification\": \"The report explicitly states that no malignancy is identified. The findings are consistent with a post-viral condition, specifically mononucleosis, which is a benign self-limiting infection. The resolution of atypical lymphocytes further supports this diagnosis. The report also provides reassurance, which is typical of a benign finding.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging is recommended.\",\n  \"malignancy_likelihood\": \"Moderate\",\n  \"justification\": \"The report mentions a small nodule in the liver. While the report states no malignancy is identified, the presence of a nodule warrants further investigation to rule out malignancy. The nodule could be a benign lesion, but it could also be a sign of cancer. Further imaging is needed to determine the nature of the nodule.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging is recommended.\",\n  \"malignancy_likelihood\": \"Moderate\",\n  \"justification\": \"The report mentions a small nodule in the liver. While the report states no malignancy is identified, the presence of a nodule warrants further investigation to rule out malignancy. The nodule could be a benign lesion, but it could also be a sign of cancer. Further imaging is needed to determine the nature of the nodule.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging is recommended.\",\n  \"malignancy_likelihood\": \"Moderate\",\n  \"justification\": \"The report mentions a small nodule in the liver. While the report states no malignancy is identified, the presence of a nodule warrants further investigation to rule out malignancy. The nodule could be a benign lesion, but it could also be a sign of cancer. Further imaging is needed to determine the nature of the nodule.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T19:00:55.882919"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"Myeloblasts accounting for 70% of marrow cellularity, t(8;21) translocation, and favorable risk category are all consistent with Acute Myeloid Leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report indicates a high percentage of myeloblasts (70%) in the bone marrow, which is a hallmark of Acute Myeloid Leukemia. The presence of the t(8;21) translocation is also strongly suggestive of this diagnosis. The report further categorizes the risk as favorable, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report explicitly states that myeloblasts account for 70% of the bone marrow cellularity, a key diagnostic criterion for Acute Myeloid Leukemia. The presence of the t(8;21) translocation, a specific chromosomal abnormality, further supports this diagnosis. The report also indicates a favorable risk category, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning are in line with the findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report indicates a high percentage of myeloblasts in the bone marrow, which is a hallmark of Acute Myeloid Leukemia. The presence of the t(8;21) translocation is also strongly suggestive of this diagnosis. The report further categorizes the risk as favorable, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report indicates a high percentage of myeloblasts (70%) in the bone marrow, which is a hallmark of Acute Myeloid Leukemia. The presence of the t(8;21) translocation is also strongly suggestive of this diagnosis. The report further categorizes the risk as favorable, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning support the diagnosis.\"\n",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T19:00:55.882927"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a type of cancer. The findings suggest a parameningeal mass with intracranial extension. The report also mentions a PAX-FOXO1 fusion negative result. Given the presence of a mass and the diagnosis of rhabdomyosarcoma, there is a significant possibility of malignancy. However, it is important to consider that the report is a biopsy and may not fully represent the extent of the disease. Further investigations and treatment planning are recommended. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a type of cancer. The findings suggest a parameningeal mass with intracranial extension. The report also mentions a PAX-FOXO1 fusion negative result. Given the presence of a mass and the diagnosis of rhabdomyosarcoma, there is a significant possibility of malignancy. However, it is important to consider that the report is a biopsy and may not fully represent the extent of the disease. Further investigations and treatment planning are recommended. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T19:00:55.883031"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T19:00:55.883046"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and a high-grade medulloblastoma. This is highly suggestive of malignancy, specifically medulloblastoma, a common childhood brain tumor. The recommendation for MDT discussion and treatment planning further supports this conclusion. The report also mentions a history of brain tumor, and the patient is a child.\",\n  \"potential_benign_explanations\": \"Although the report strongly suggests malignancy, it is crucial to consider potential benign explanations. For example, while less likely, a rare benign tumor could present with similar imaging characteristics. The report does not explicitly mention any benign possibilities. The patient is a child, and the report mentions a history of brain tumor, which could be a source of confusion. It is important to rule out any other potential causes of the findings.\",\n  \"overall_conclusion\": \"Based on the available information, the report is highly suggestive of a high-grade medulloblastoma. Further investigation and MDT discussion are warranted to confirm the diagnosis and initiate appropriate treatment. The history of brain tumor and the patient's age are relevant factors to consider.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and a high-grade medulloblastoma. This is highly suggestive of malignancy, specifically medulloblastoma, a common childhood brain tumor. The recommendation for MDT discussion and treatment planning further supports this conclusion. The report also mentions a history of brain tumor, and the patient is a child.\",\n  \"potential_benign_explanations\": \"Although the report strongly suggests malignancy, it is crucial to consider potential benign explanations. For example, while less likely, a rare benign tumor could present with similar imaging characteristics. The report does not explicitly mention any benign possibilities. The patient is a child, and the report mentions a history of brain tumor, which could be a source of confusion. It is important to rule out any other potential causes of the findings.\",\n  \"overall_conclusion\": \"Based on the available information, the report is highly suggestive of a high-grade medulloblastoma. Further investigation and MDT discussion are warranted to confirm the diagnosis and initiate appropriate treatment. The history of brain tumor and the patient's age are relevant factors to consider.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T19:00:55.883072"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Neuroblastoma\",\n  \"reasoning\": \"The report indicates the presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. These findings, along with the stage III diagnosis, strongly suggest Neuroblastoma. The recommendation for MDT discussion and treatment planning further supports this conclusion. A pediatric oncology assessment was also performed, which is consistent with the diagnosis of Neuroblastoma.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Neuroblastoma, it's important to consider that other conditions could potentially present with similar imaging characteristics. For example, a rare type of renal cell carcinoma or a metastatic lesion from another primary site could, in theory, exhibit some of these features. However, the combination of findings, particularly the MIBG avidity and elevated catecholamines, makes Neuroblastoma the most likely diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report mentions calcifications and MIBG avidity, which are not necessarily indicative of malignancy. Calcifications can occur in benign lesions, and MIBG avidity can be seen in some benign conditions. The elevated urinary catecholamines could be related to a benign condition such as a pheochromocytoma or a benign tumor producing catecholamines. The stage III diagnosis is also not directly indicative of malignancy, as staging systems can be complex and influenced by factors other than the presence of cancer cells. The recommendation for MDT discussion and treatment planning suggests that the clinicians are still considering the possibility of malignancy, but it doesn't definitively rule it out.\",\n  \"alternative_explanations\": \"It is possible that the mass is a benign condition that is mimicking Neuroblastoma on imaging. For example, a benign tumor or a reactive process could present with similar features. The elevated urinary catecholamines could be due to a benign cause, such as a pheochromocytoma or a benign tumor producing catecholamines. The stage III diagnosis is not directly indicative of malignancy, and it is possible that the patient has a stage III benign condition. Further investigation is needed to determine the exact cause of the findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Neuroblastoma\",\n  \"reasoning\": \"The report clearly states that the patient has Neuroblastoma, with a stage III diagnosis. The presence of a suprarenal mass with calcifications, MIBG avidity,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T19:00:55.883094"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor, which is a childhood kidney cancer. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. Given the absence of vascular invasion and favorable histology, it is highly unlikely that this is a malignant tumor. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a large heterogeneous left renal mass with a pseudocapsule. It also states that there is no vascular invasion and favorable histology on biopsy. This information suggests that the mass is likely benign, rather than malignant. The report also indicates that the stage is II, which is a relatively early stage of the disease. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy. This information suggests that the mass is likely benign, rather than malignant. The report also recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T19:00:55.883107"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n  \"summary\": \"The report indicates a normal brain MRI with no mass lesions or abnormal enhancement. The patient reports migraines, which are attributed to this condition. No malignancy is identified.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no evidence of malignancy. The patient's headaches are likely due to migraines, and the normal brain MRI supports this conclusion.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates normal findings in the brain. The patient's headaches are attributed to migraines.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no evidence of malignancy. The patient's headaches are likely due to migraines, and the normal brain MRI supports this conclusion.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates normal findings in the brain. The patient's headaches are attributed to migraines.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no evidence of malignancy. The patient's headaches are likely due to migraines, and the normal brain MRI supports this conclusion.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates normal findings in the brain. The patient's headaches are attributed to migraines.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T19:00:55.883123"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": \"large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II.\",\n    \"malignancy_assessment\": \"The report describes a large heterogeneous left renal mass with a pseudocapsule. The absence of vascular invasion and favorable histology on biopsy are positive findings. The stage is II. The report concludes that the findings are consistent with a Wilms tumor.\",\n    \"skeptical_assessment\": \"While the report suggests a Wilms tumor, the presence of a pseudocapsule and the description of the mass as heterogeneous raise questions. The absence of vascular invasion is a positive finding, but it is not definitive proof of benignity. The favorable histology on biopsy is also reassuring, but it does not rule out the possibility of a low-grade or partially differentiated Wilms tumor. The stage II classification indicates a relatively early-stage tumor, but it does not exclude the possibility of metastasis. The report does not provide enough information to definitively rule out the possibility of a benign mass. Further investigation, such as imaging studies or a repeat biopsy, may be necessary to confirm the diagnosis and exclude the possibility of a benign mass.\",\n    \"alternative_explanations\": [\n      \"The mass could be a benign renal tumor, such as a renal cell carcinoma or a angiomyolipoma.\",\n      \"The mass could be a metastatic lesion from another primary tumor.\"\n    ],\n    \"final_judgment\": \"The report suggests a Wilms tumor, but further investigation is needed to confirm the diagnosis and exclude the possibility of a benign mass. The absence of vascular invasion and favorable histology on biopsy are positive findings, but they do not rule out the possibility of a low-grade or partially differentiated Wilms tumor. The stage II classification indicates a relatively early-stage tumor, but it does not exclude the possibility of metastasis. The report does not provide enough information to definitively rule out the possibility of a benign mass. Further investigation, such as imaging studies or a repeat biopsy, may be necessary to confirm the diagnosis and exclude the possibility of a benign mass.\"\n  }\n}\n```\n```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": \"large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II.\",\n    \"malignancy_assessment\": \"The report describes a large heterogeneous left renal mass with a",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T19:00:55.883165"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report indicates a benign presentation with no prior oncology history. The brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report indicates a benign presentation with no prior oncology history. The brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T19:00:55.883174"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that the routine surveillance PET-CT was normal. No malignancy was identified. The brain MRI also showed no mass lesion or abnormal enhancement. The patient reports migraines, which are attributed to this condition.\",\n  \"abnormal_findings\": [],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, and the brain MRI shows no mass lesion or abnormal enhancement. Therefore, there is no evidence of malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to migraine, which is a benign condition.\",\n    \"The PET-CT scan may have been performed at the correct time, and the patient may have been in remission.\",\n    \"The scan may have been performed at the wrong time, and the patient may have developed a new malignancy.\"\n  ],\n  \"final_judgment\": \"The report suggests that the patient is currently in remission and does not have any evidence of malignancy. Further surveillance may be necessary to monitor for any new developments.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the routine surveillance PET-CT was normal. No malignancy was identified, and the brain MRI also showed no mass lesion or abnormal enhancement. The patient reports migraines, which are attributed to this condition.\",\n  \"abnormal_findings\": [],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, and the brain MRI shows no mass lesion or abnormal enhancement. Therefore, there is no evidence of malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to migraine, which is a benign condition.\",\n    \"The PET-CT scan may have been performed at the correct time, and the patient may have been in remission.\",\n    \"The scan may have been performed at the wrong time, and the patient may have developed a new malignancy.\"\n  ],\n  \"final_judgment\": \"The report suggests that the patient is currently in remission and does not have any evidence of malignancy. Further surveillance may be necessary to monitor for any new developments.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the routine surveillance PET-CT was normal. No malignancy was identified, and the brain MRI also showed no mass lesion or abnormal enhancement. The patient reports migraines, which are attributed to this condition.\",\n  ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T19:00:55.883197"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n  \"final_diagnosis\": \"Ewing Sarcoma\",\n  \"reasoning\": \"The report describes permeative bone destruction in the left femoral diaphysis with a large soft tissue mass and onion-skin periosteal reaction. It also mentions an EWSR1 fusion, which is a common genetic marker in Ewing Sarcoma. Given the patient's history of unexplained fever and weight loss, the findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin perioste",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T19:00:55.883210"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T19:00:55.883219"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T19:00:55.883225"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T19:00:55.883231"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n  \"clinical_impression\": \"Stage III Neuroblastoma\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous suprarenal mass with calcifications\",\n      \"MIBG avidity\",\n      \"elevated urinary catecholamines\",\n      \"Stage III disease\"\n    ],\n    \"malignancy_assessment\": {\n      \"potential_malignancy\": true,\n      \"alternative_explanations\": [\n        \"Calcifications could be due to benign processes, although less likely in this context.\",\n        \"MIBG avidity is highly suggestive of Neuroblastoma, but could be present in other rare conditions.\",\n        \"Elevated urinary catecholamines are a classic finding in Neuroblastoma, but could be elevated in other conditions.\",\n        \"Stage III disease is a serious finding, but could be a misdiagnosis or a misinterpretation of the imaging.\"\n      ],\n      \"conclusion\": \"While the findings are highly suggestive of Neuroblastoma, it is important to consider the possibility of alternative explanations. Further investigation is warranted to confirm the diagnosis.\"\n    }\n  }\n}\n```\n```json\n{\n  \"clinical_impression\": \"Stage III Neuroblastoma\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous suprarenal mass with calcifications\",\n      \"MIBG avidity\",\n      \"elevated urinary catecholamines\",\n      \"Stage III disease\"\n    ],\n    \"malignancy_assessment\": {\n      \"potential_malignancy\": true,\n      \"alternative_explanations\": [\n        \"Calcifications could be due to benign processes, although less likely in this context.\",\n        \"MIBG avidity is highly suggestive of Neuroblastoma, but could be present in other rare conditions.\",\n        \"Elevated urinary catecholamines are a classic finding in Neuroblastoma, but could be elevated in other conditions.\",\n        \"Stage III disease is a serious finding, but could be a misdiagnosis or a misinterpretation of the imaging.\"\n      ],\n      \"conclusion\": \"The findings are highly suggestive of Neuroblastoma, but further investigation is needed to confirm the diagnosis.\"\n    }\n  }\n}\n```\n```json\n{\n  \"clinical_impression\": \"Stage III Neuroblastoma\",\n  \"skeptical_assessment\": {\n    \"abnormal_",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T19:00:55.883256"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a high-grade medulloblastoma in the posterior fossa, along with hydrocephalus. This strongly suggests malignancy. The restricted diffusion and enhancement on ultrasound are also consistent with a malignant process. The recommendation for MDT discussion and treatment planning further supports the diagnosis of a brain tumor.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion. These findings are suggestive of a malignant process, specifically a high-grade medulloblastoma. The recommendation for MDT discussion and treatment planning reinforces the suspicion of malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a posterior fossa mass with enhancement and hydrocephalus. The presence of restricted diffusion on ultrasound is a concerning finding that is often associated with malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor. The recommendation for MDT discussion and treatment planning further supports the diagnosis of a brain tumor. Given these findings, it is likely that the mass is malignant.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a posterior fossa mass with enhancement and hydrocephalus. The presence of restricted diffusion on ultrasound is a concerning finding that is often associated with malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor. The recommendation for MDT discussion and treatment planning further supports the diagnosis of a brain tumor. Given these findings, it is likely that the mass is malignant.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion. These findings are suggestive of a malignant process, specifically a high-grade medulloblastoma. The recommendation for MDT discussion and treatment planning reinforces the suspicion of malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor. Given these findings, it is likely that the mass is malignant.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion. These findings are suggestive of a malignant process, specifically a high",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T19:00:55.883267"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a normal chest radiograph with no evidence of malignancy.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T19:00:55.883279"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"sacrococcygeal mass with mixed solid and cystic components, Elevated AFP and beta-hCG, Yolk sac tumor elements present\",\n  \"malignancy_assessment\": \"The findings suggest a possible germ cell tumor, specifically a yolk sac tumor, given the elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. However, it's important to consider that these findings could be reactive or benign, particularly in the context of a known germ cell tumor.\",\n  \"skeptical_reasoning\": \"While the report points towards a germ cell tumor, it's crucial to consider alternative explanations for the elevated AFP and beta-hCG. These could be due to reactive processes, other malignancies, or even medication side effects. The presence of yolk sac tumor elements is highly suggestive, but it's essential to rule out any possibility of a benign cause. The sacrococcygeal mass itself could be a reactive response to the elevated tumor markers, or it could be a benign lesion. Further investigation and a multidisciplinary team (MDT) discussion are warranted to confirm the diagnosis and treatment plan.\",\n  \"conclusion\": \"Based on the report, the findings are suggestive of a germ cell tumor, specifically a yolk sac tumor, but further investigation and MDT discussion are necessary to confirm the diagnosis and rule out alternative explanations.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated AFP and beta-hCG\",\n  \"malignancy_assessment\": \"Elevated AFP and beta-hCG can be indicative of germ cell tumors, but they can also be elevated in benign conditions such as pregnancy, liver disease, or certain infections.\",\n  \"skeptical_reasoning\": \"While elevated AFP and beta-hCG raise suspicion for germ cell tumors, it's important to consider other potential causes. These could include pregnancy, liver disease, or certain infections. The clinical context and further investigations are crucial to differentiate between malignancy and benign causes.\",\n  \"conclusion\": \"Elevated AFP and beta-hCG warrant further investigation to rule out non-malignant causes.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Yolk sac tumor elements present\",\n  \"malignancy_assessment\": \"The presence of yolk sac tumor elements is highly suggestive of a germ cell tumor, particularly a yolk sac tumor. However, it",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T19:00:55.883306"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report describes a mediastinal mass with FDG-avid nodes, consistent with classical Hodgkin lymphoma. While the findings are suggestive of malignancy, it is important to consider alternative explanations, such as reactive lymphadenopathy, although the PET-CT findings make this less likely. Further investigation, including MDT discussion and treatment planning, is warranted.\",\n  \"abnormal_findings\": [\n    \"mediastinal lymphadenopathy\",\n    \"bulky anterior mediastinal mass\",\n    \"FDG-avid nodes\"\n  ],\n  \"malignancy_assessment\": \"The report indicates FDG-avid nodes, which are highly suggestive of malignancy. The description of the mass as 'bulky' also raises concern. However, reactive lymphadenopathy can also show FDG uptake, and the 'bulky' nature of the mass could be due to reactive inflammation.\",\n  \"alternative_explanations\": [\n    \"reactive lymphadenopathy\",\n    \"reactive inflammation\"\n  ],\n  \"benign_findings\": [\n    \"None explicitly mentioned\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a mediastinal mass with FDG-avid nodes, which is highly suggestive of malignancy. While the report mentions that the findings could be due to reactive lymphadenopathy, the presence of FDG-avid nodes makes this less likely. Further investigation, including MDT discussion and treatment planning, is warranted.\",\n  \"abnormal_findings\": [\n    \"mediastinal lymphadenopathy\",\n    \"bulky anterior mediastinal mass\",\n    \"FDG-avid nodes\"\n  ],\n  \"malignancy_assessment\": \"The report indicates FDG-avid nodes, which are highly suggestive of malignancy. The description of the mass as 'bulky' also raises concern. However, reactive lymphadenopathy can also show FDG uptake, and the 'bulky' nature of the mass could be due to reactive inflammation.\",\n  \"alternative_explanations\": [\n    \"reactive lymphadenopathy\",\n    \"reactive inflammation\"\n  ],\n  \"benign_findings\": [\n    \"None explicitly mentioned\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a mediast",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T19:00:55.883330"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates that the bone marrow biopsy was normal, with no blast cells and no evidence of malignancy. The CBC results are within normal limits. The patient received reassurance. Therefore, there is no evidence of malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient is a young child with a normal bone marrow. Blast cells are not always present in malignant conditions.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report shows a normal CBC and no blast cells, ruling out acute leukemia. While the report mentions a bone marrow biopsy, the description of the findings is reassuring and does not suggest malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient's age might be a factor in the bone marrow composition, and normal values are expected.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal bone marrow biopsy with no evidence of malignancy. The CBC results are within normal limits, further supporting the absence of malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient may be undergoing routine surveillance, and the bone marrow biopsy was performed to rule out any potential issues.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the bone marrow biopsy was normal, with no blast cells and no evidence of malignancy. The CBC results are within normal limits. The patient received reassurance. Therefore, there is no evidence of malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient is a young child with a normal bone marrow. Blast cells are not always present in malignant conditions.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal bone",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T19:00:55.883344"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T19:00:55.883352"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"No malignancy identified.\",\n  \"malignancy_assessment\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass. The heart size is normal. Therefore, based on the provided information, there is no evidence of malignancy.\",\n  \"alternative_explanations\": \"The findings are consistent with a normal bone marrow and overall health. The screening was performed as a precaution, and the normal results provide reassurance.\",\n  \"conclusion\": \"The report indicates no evidence of malignancy. The findings are consistent with a normal bone marrow and overall health.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass. The heart size is normal.\",\n  \"malignancy_assessment\": \"The report indicates no malignancy. The chest radiograph is normal, showing clear lung fields and no mediastinal mass. The heart size is normal. Therefore, the report does not suggest malignancy.\",\n  \"alternative_explanations\": \"The report is a screening result. Normal findings do not necessarily rule out the possibility of future malignancy, but they do not indicate any current malignancy.\",\n  \"conclusion\": \"The report indicates no evidence of malignancy. The findings are consistent with a normal bone marrow and overall health.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass. The heart size is normal.\",\n  \"malignancy_assessment\": \"The report indicates no malignancy. The chest radiograph is normal, showing clear lung fields and no mediastinal mass. The heart size is normal. Therefore, the report does not suggest malignancy.\",\n  \"alternative_explanations\": \"The report is a screening result. Normal findings do not necessarily rule out the possibility of future malignancy, but they do not indicate any current malignancy.\",\n  \"conclusion\": \"The report indicates no evidence of malignancy. The findings are consistent with a normal bone marrow and overall health.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T19:00:55.883368"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T19:00:55.883381"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. Elevated alkaline phosphatase is also noted. These findings are highly suggestive of osteosarcoma, a primary bone cancer. The recommendation for MDT discussion and treatment planning further supports this suspicion. However, it's important to consider that other conditions, such as aggressive infections or rare bone tumors, could potentially mimic these findings. Further investigation, including biopsy, is necessary to confirm the diagnosis and rule out alternative possibilities.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": [\n    \"Aggressive infection (e.g., osteomyelitis)\",\n    \"Rare bone tumor (e.g., giant cell tumor, chondrosarcoma)\",\n    \"Benign bone lesion with aggressive features\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, along with elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma. The recommendation for MDT discussion and treatment planning further supports this suspicion. However, it's important to consider that other conditions, such as aggressive infections or rare bone tumors, could potentially mimic these findings. Further investigation, including biopsy, is necessary to confirm the diagnosis and rule out alternative possibilities.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": [\n    \"Aggressive infection (e.g., osteomyelitis)\",\n    \"Rare bone tumor (e.g., giant cell tumor, chondrosarcoma)\",\n    \"Benign bone lesion with aggressive features\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. Elevated alkaline phosphatase is also noted. These findings are highly suggestive of osteosarcoma, a primary bone cancer. The recommendation for MDT discussion and treatment planning further supports this suspicion. However, it's important to consider that other conditions, such as aggressive infections or rare bone tumors, could potentially mimic these findings. Further investigation, including biopsy, is necessary to confirm the diagnosis and rule out alternative possibilities.\",\n  \"malignancy_",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T19:00:55.883402"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_reasoning\": \"The report explicitly states that no malignancy was identified and provides reassurance. The findings are consistent with a post-viral infection, specifically mononucleosis, confirmed by EBV serology. Therefore, the presence of atypical lymphocytes resolving is a normal reaction to the viral infection, and not a sign of malignancy.\",\n  \"final_conclusion\": \"No malignancy\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated PSA. Possible prostate cancer. Further investigation required.\",\n  \"malignancy_assessment\": \"Possible prostate cancer. Further investigation required.\",\n  \"skeptical_reasoning\": \"Elevated PSA can be caused by a variety of factors, including benign prostatic hyperplasia (BPH), prostatitis, urinary tract infections, and even recent ejaculation. While prostate cancer is a possibility, it is not the only explanation. The report recommends further investigation, which is a prudent approach to rule out other potential causes.\",\n  \"final_conclusion\": \"Further investigation required\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Microscopic hematuria. Possible renal cell carcinoma. Further investigation required.\",\n  \"malignancy_assessment\": \"Possible renal cell carcinoma. Further investigation required.\",\n  \"skeptical_reasoning\": \"Microscopic hematuria can be caused by a variety of benign conditions, such as benign prostatic hyperplasia, kidney stones, or urinary tract infections. While renal cell carcinoma is a possibility, it is not the only explanation. The report recommends further investigation to determine the cause of the hematuria.\",\n  \"final_conclusion\": \"Further investigation required\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated CEA. Possible colorectal cancer. Further investigation required.\",\n  \"malignancy_assessment\": \"Possible colorectal cancer. Further investigation required.\",\n  \"skeptical_reasoning\": \"Elevated CEA can be caused by a variety of factors, including benign conditions such as inflammatory bowel disease, smoking, and certain medications. While colorectal cancer is a possibility, it is not the only explanation. The report recommends further investigation to determine the cause of the elevated",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T19:00:55.883417"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"no vascular invasion\",\n    \"favorable histology on biopsy\",\n    \"stage II\"\n  ],\n  \"malignancy_assessment\": \"The report describes a left renal mass with favorable histology and no vascular invasion. The stage is II. While this indicates malignancy, the favorable histology suggests a less aggressive type of Wilms tumor. The absence of vascular invasion is also a positive finding.\",\n  \"alternative_explanations\": [\n    \"The large renal mass could be a benign tumor, such as a simple cyst or angiomyolipoma, although the description suggests it is a Wilms tumor.\",\n    \"The stage II designation could be misleading, and the tumor might be less aggressive than initially suspected.\",\n    \"The report might be an error, and the patient actually has a benign condition.\"\n  ],\n  \"conclusion\": \"While the report suggests a stage II Wilms tumor with favorable histology, the presence of a large renal mass warrants further investigation to rule out benign possibilities. The report should be reviewed to confirm the diagnosis and stage.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"pancytopenia\"\n  ],\n  \"malignancy_assessment\": \"Pancytopenia can be caused by various conditions, including bone marrow disorders, infections, medications, and autoimmune diseases. It is not specific to malignancy.\",\n  \"alternative_explanations\": [\n    \"The pancytopenia could be due to a medication side effect.\",\n    \"The pancytopenia could be caused by an underlying autoimmune disorder.\",\n    \"The pancytopenia could be due to a viral infection.\"\n  ],\n  \"conclusion\": \"Pancytopenia requires further investigation to determine the underlying cause. It is not sufficient to conclude that the patient has a malignancy based solely on pancytopenia.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"no vascular invasion\",\n    \"favorable histology on biopsy\",\n    \"stage II\"\n  ],\n  \"malignancy_assessment\": \"The report describes a left renal mass with favorable histology and no vascular invasion. The stage is II. While this indicates malignancy, the favorable histology suggests a less aggressive type of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T19:00:55.883441"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n  \"malignancy_assessment\": \"The report indicates mediastinal lymphadenopathy with a bulky anterior mediastinal mass, FDG-avid nodes, and a diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type). These findings are highly suggestive of malignancy. The report also recommends MDT discussion and treatment planning, further supporting the suspicion of malignancy.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Hodgkin Lymphoma, it's important to consider alternative explanations, such as: 1) Reactive lymphadenopathy: Inflammatory conditions can mimic malignant lymphadenopathy. 2) Other malignancies: Although less likely given the specific description of Classical Hodgkin Lymphoma, other lymphomas or metastatic cancers could present with similar findings. 3) Benign conditions: Certain benign conditions can cause mediastinal masses and lymph node enlargement. However, the presence of FDG-avid nodes strongly suggests malignancy.\",\n  \"final_conclusion\": \"Based on the report, the findings are highly suggestive of Classical Hodgkin Lymphoma. Further investigation, including MDT discussion and treatment planning, is recommended. However, it's crucial to consider alternative explanations, such as reactive lymphadenopathy or other malignancies, before definitively concluding that the patient has Hodgkin Lymphoma.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass and FDG-avid nodes. These findings are suggestive of malignancy.\",\n  \"alternative_explanations\": \"1) Reactive lymphadenopathy: Inflammatory processes can cause similar findings. 2) Metastatic disease: Cancer from another site can spread to the mediastinum. 3) Lymphoma: Other types of lymphoma can present with similar findings. 4) Benign conditions: Certain benign conditions can cause mediastinal masses.\",\n  \"final_conclusion\": \"The findings are suggestive of malignancy. Further investigation is warranted to determine the underlying cause.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass and FDG-avid nodes. These findings are suggestive of malignancy.\",\n  \"alternative_explanations\": \"1) Reactive lymphadenopathy: Inflammatory processes can cause similar findings. 2) Metastatic disease: Cancer from another site can spread to the mediastinum. 3) Lymphoma: Other types of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T19:00:55.883468"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that no malignancy was identified. It also describes post-viral lymphocytosis and atypical lymphocytes resolving, with a positive Monospot and EBV serology confirming the diagnosis. Therefore, the report provides reassurance that there is no malignancy present.\",\n  \"alternative_explanations\": \"The findings could be due to a viral infection, such as mononucleosis (Epstein-Barr virus). The atypical lymphocytes and positive Monospot/EBV serology support this diagnosis. Other less common viral infections could also present with similar findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report states that no malignancy was identified. The findings suggest post-viral lymphocytosis, with atypical lymphocytes resolving and a positive Monospot and EBV serology. This confirms the diagnosis of a viral infection, such as mononucleosis, which is not malignant. Therefore, the report provides reassurance that there is no malignancy present.\",\n  \"alternative_explanations\": \"The findings could be due to a viral infection, such as mononucleosis (Epstein-Barr virus). The atypical lymphocytes and positive Monospot/EBV serology support this diagnosis. Other less common viral infections could also present with similar findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report clearly states that no malignancy was found. The presence of post-viral lymphocytosis, resolving atypical lymphocytes, and positive Monospot/EBV serology confirms a viral infection, specifically mononucleosis. This is not a malignancy. Therefore, the report provides reassurance.\",\n  \"alternative_explanations\": \"The findings could be due to a viral infection, such as mononucleosis (Epstein-Barr virus). The atypical lymphocytes and positive Monospot/EBV serology support this diagnosis. Other less common viral infections could also present with similar findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that no malignancy was identified. The presence of post-viral lymphocytosis, resolving atypical lymphocytes, and positive Monospot/EBV serology confirms a viral infection, specifically mon",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T19:00:55.883483"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T19:00:55.883491"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report describes a case of Ewing Sarcoma. Based on the findings of permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and EWSR1 fusion positivity, the report strongly suggests the presence of Ewing Sarcoma. The clinical context of suspected Ewing Sarcoma further supports this conclusion. The report recommends MDT discussion and treatment planning, indicating the need for further investigation and management.\",\n  \"alternative_explanations\": \"While the report strongly suggests Ewing Sarcoma, it's important to consider alternative explanations for the observed findings. For example, other bone tumors, such as osteosarcoma or chondrosarcoma, could present with similar features. Additionally, metastatic disease from another primary site could potentially cause bone destruction and soft tissue masses. However, the EWSR1 fusion positivity is highly suggestive of Ewing Sarcoma and makes these alternative diagnoses less likely.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a case of Ewing Sarcoma. Based on the findings of permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and EWSR1 fusion positivity, the report strongly suggests the presence of Ewing Sarcoma. The clinical context of suspected Ewing Sarcoma further supports this conclusion. The report recommends MDT discussion and treatment planning, indicating the need for further investigation and management.\",\n  \"alternative_explanations\": \"While the report strongly suggests Ewing Sarcoma, it's important to consider alternative explanations for the observed findings. For example, other bone tumors, such as osteosarcoma or chondrosarcoma, could present with similar features. Additionally, metastatic disease from another primary site could potentially cause bone destruction and soft tissue masses. However, the EWSR1 fusion positivity is highly suggestive of Ewing Sarcoma and makes these alternative diagnoses less likely.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a case of Ewing Sarcoma. Based on the findings of permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and EWSR1 fusion positivity, the report strongly suggests the presence of Ewing Sarcoma. The clinical context of suspected Ewing Sarcoma further supports this conclusion. The report recommends MDT discussion and treatment planning, indicating the need for further investigation and management.\",\n  \"alternative_explanations\": \"While the report strongly suggests Ewing Sarcoma, it's important to consider alternative",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T19:00:55.883511"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n  \"analysis\": \"The report indicates that the MRI of the brain was normal for the patient's age. No mass lesions or abnormal enhancement were observed. Headaches are attributed to migraine, and no malignancy was identified. The report provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report mentions follow-up post-treatment. No previous oncology history is stated. The MRI shows normal brain findings, including no mass lesions or abnormal enhancement. Headaches are attributed to migraine. The report concludes that no malignancy was identified and provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report describes a follow-up MRI of the brain post-treatment. No previous oncology history is mentioned. The MRI findings are normal, with no mass lesions or abnormal enhancement. The report attributes headaches to migraine and states that no malignancy was identified. It provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report indicates a follow-up MRI of the brain after treatment. No prior oncology history is stated. The MRI shows normal brain structures, with no mass lesions or abnormal enhancement. Headaches are attributed to migraine, and no malignancy is identified. The report provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report describes a follow-up MRI of the brain after treatment. No prior oncology history is mentioned. The MRI shows normal brain findings, including no mass lesions or abnormal enhancement. The report attributes headaches to migraine and states that no malignancy was identified. It provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report mentions a follow-up MRI of the brain post-treatment. No previous oncology history is stated. The MRI shows normal brain structures, with no mass lesions or abnormal enhancement. Headaches are attributed to migraine, and no malignancy is identified. The report provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report describes a follow-up MRI of the brain after treatment. No prior oncology history is mentioned. The MRI findings are normal, with no mass lesions or abnormal enhancement. The report attributes headaches",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T19:00:55.883521"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Physiological splenomegaly\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Physiological splenomegaly for age.\",\n  \"conclusion\": \"The report indicates physiological splenomegaly, which is a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Normal echo texture.\",\n  \"conclusion\": \"The report indicates no focal lesions and normal echo texture. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T19:00:55.883530"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy secondary to a viral infection. There are no atypical features and no malignancy identified. The node size is decreasing on follow-up. The report provides reassurance. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report states that there is no malignancy identified and that the findings are reactive lymphadenopathy secondary to a viral infection. The report also mentions that the node size is decreasing on follow-up. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a non-malignant condition. The report further states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up, which is a positive sign. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes reactive lymphadenopathy, which is a benign condition. The report also states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a non-malignant condition. The report further states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up, which is a positive sign. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a benign condition. The report also states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a non-malignant condition. The report further states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up, which is a positive sign. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a benign condition.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T19:00:55.883539"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, along with elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer. Further investigation and discussion with the MDT (Multi-Disciplinary Team) are recommended to determine the appropriate treatment plan.\",\n  \"reasoning\": \"The report explicitly mentions osteosarcoma, a malignant bone tumor, as the suspected diagnosis. The findings of a destructive lesion, soft tissue component, and sunburst periosteal reaction are all characteristic of osteosarcoma. Elevated alkaline phosphatase is also a common finding in bone tumors. The recommendation for MDT discussion and treatment planning further supports the suspicion of malignancy. However, it is important to note that the report is based on a preliminary assessment, and further investigations, such as biopsy and imaging studies, are needed to confirm the diagnosis and stage the cancer. While osteosarcoma is a malignant condition, it is possible that the findings could be due to a benign process. The report does not provide enough information to rule out other possibilities, such as infection or inflammatory conditions. Therefore, a definitive diagnosis requires further evaluation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report suggests osteosarcoma, but the findings could potentially be explained by a benign process. Further investigation is needed to confirm the diagnosis.\",\n  \"reasoning\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. These findings are highly suggestive of osteosarcoma, a malignant bone tumor. The elevated alkaline phosphatase is also consistent with bone tumors. However, it is important to consider that some benign conditions can also cause similar findings. For example, infection or inflammatory conditions can lead to bone destruction and periosteal reaction. Therefore, it is essential to rule out these possibilities before concluding that the findings represent osteosarcoma. A biopsy is needed to confirm the diagnosis and determine the nature of the lesion.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, along with elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer. Further investigation and discussion with the MDT (Multi-Disciplinary Team) are recommended to determine the appropriate treatment plan.\",\n  \"reasoning\": \"The report explicitly mentions oste",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T19:00:55.883565"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T19:00:55.883570"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T19:00:55.883580"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. There is no mention of any malignant cells or suspicious features. The report also provides reassurance that no intervention is required.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report indicates that a benign soft tissue mass, specifically a lipoma, was identified. The mass is described as well-circumscribed and not enhancing, which are characteristics associated with benign lesions. The report also states that no malignancy was identified. Therefore, the findings are consistent with a benign process.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report clearly states that a benign soft tissue mass (lipoma) was found. The description of the mass as well-circumscribed and non-enhancing further supports the benign nature of the findings. The report also explicitly mentions that no malignancy was identified, which is a key indicator of a benign diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report indicates the presence of a benign soft tissue mass, identified as a lipoma. The mass is described as well-circumscribed and not enhancing, which are typical characteristics of benign lipomas. Furthermore, the report explicitly states that no malignancy was identified. Therefore, the findings are consistent with a benign diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report clearly states that a benign soft tissue mass, specifically a lipoma, was identified. The mass is described as well-circumscribed and not enhancing, which are characteristics associated with benign lesions. The report also provides reassurance that no intervention is required. Therefore, the findings are consistent with a benign process.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report indicates that a benign soft tissue mass, a lipoma, was found. The description of the mass as well-circumscribed and non-enhancing supports the benign nature of the findings. The report explicitly states that no malignancy was identified. Therefore, the findings are consistent with a benign diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T19:00:55.883588"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n  \"clinical_impression\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II. Recommend MDT discussion and treatment planning.\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II.\",\n    \"malignancy_assessment\": \"The report indicates a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. Stage II. The presence of a mass and the stage are concerning for malignancy. However, the report also mentions favorable histology, which suggests a more benign or less aggressive tumor. The absence of vascular invasion is also a positive finding. The report recommends MDT discussion and treatment planning. This suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"clinical_impression\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II. Recommend MDT discussion and treatment planning.\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II.\",\n    \"malignancy_assessment\": \"The report indicates a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. Stage II. The presence of a mass and the stage are concerning for malignancy. However, the report also mentions favorable histology, which suggests a more benign or less aggressive tumor. The absence of vascular invasion is also a positive finding. The report recommends MDT discussion and treatment planning. This suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T19:00:55.883688"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to a viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T19:00:55.883698"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report describes a large heterogeneous hepatic mass with elevated AFP in a patient with a history of hepatoblastoma. The staging is PRETEXT stage II, and the recommendation is for MDT discussion and treatment planning. The report does not explicitly state whether the mass is malignant or benign. The presence of a hepatic mass with elevated AFP in a patient with a history of hepatoblastoma raises concern for malignancy. However, it is important to consider that the mass could be a recurrence of the original hepatoblastoma, or it could be a different type of liver cancer. Further investigation, such as a biopsy, is needed to determine the nature of the mass. The PRETEXT stage II suggests that the disease is locally advanced, but it does not necessarily mean that the disease is metastatic. Therefore, the report does not provide enough information to definitively conclude whether the mass is malignant or benign. It is important to consider all possible explanations before making a final diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP in a patient with a history of hepatoblastoma, staged as PRETEXT stage II. While the presence of a mass and elevated AFP are concerning, the report does not definitively state that the mass is malignant. The patient's history of hepatoblastoma suggests the possibility of recurrence, but other etiologies for the mass and elevated AFP should be considered. Further investigation, such as a biopsy, is necessary to determine the nature of the mass. The PRETEXT staging indicates that the disease is locally advanced, but it does not necessarily mean that the disease is metastatic. Therefore, the report does not provide enough information to definitively conclude whether the mass is malignant or benign. It is important to consider all possible explanations before making a final diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a large heterogeneous hepatic mass with elevated AFP in a patient with a history of hepatoblastoma, staged as PRETEXT stage II. While the presence of a mass and elevated AFP are concerning, the report does not definitively state that the mass is malignant. The patient's history of hepatoblastoma suggests the possibility of recurrence, but other etiologies for the mass and elevated AFP should be considered. Further investigation, such as a biopsy, is necessary to determine the nature of the mass. The PRETEXT staging indicates that the disease is locally advanced, but it does not necessarily mean that the disease is metastatic. Therefore",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T19:00:55.883720"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T19:00:55.883732"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T19:00:55.883741"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Germ Cell Tumor\",\n  \"suspicion\": \"Yolk sac tumor\",\n  \"alternative_explanations\": [\n    \"Benign cystic mass\",\n    \"Inflammatory process\",\n    \"Other non-cancerous conditions\"\n  ],\n  \"justification\": \"The report mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. While these findings are suggestive of a Germ Cell Tumor, particularly a Yolk Sac Tumor, it's crucial to consider that these markers can be elevated in benign conditions. The report also notes that the mass is in the sacrococcygeal region, which is a common location for benign cysts and masses. Furthermore, the report indicates the patient is a child, which could point towards a benign etiology. The report does not explicitly rule out benign explanations, so it's essential to consider them before concluding that the findings are indicative of malignancy. The report also recommends an MDT discussion and treatment planning, which suggests that the possibility of malignancy is being taken seriously, but it doesn't automatically confirm it. Therefore, while the findings are concerning, it's important to consider alternative explanations before reaching a definitive conclusion. It is important to note that the presence of yolk sac tumor elements is highly suggestive of malignancy. However, the report does not provide sufficient information to rule out the possibility of a benign condition.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Germ Cell Tumor\",\n  \"suspicion\": \"Yolk sac tumor\",\n  \"alternative_explanations\": [\n    \"Benign cystic mass\",\n    \"Inflammatory process\",\n    \"Other non-cancerous conditions\"\n  ],\n  \"justification\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. While these findings are suggestive of a Germ Cell Tumor, particularly a Yolk Sac Tumor, it's crucial to consider that these markers can be elevated in benign conditions. The report also notes that the mass is in the sacrococcygeal region, which is a common location for benign cysts and masses. Furthermore, the report indicates the patient is a child, which could point towards a benign etiology. The report does not explicitly rule out benign explanations,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T19:00:55.883770"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n  \"malignancy_assessment\": \"The report suggests a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, specifically a Yolk Sac Tumor. Given the patient's history of suspected Germ Cell Tumor and the presence of these specific tumor markers, the suspicion of malignancy is high.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of malignancy, it is important to consider the possibility of a reactive process or a benign condition that mimics a germ cell tumor. For example, a benign cystic mass could be mistaken for a yolk sac tumor, or elevated tumor markers could be due to an inflammatory process. However, the presence of yolk sac tumor elements and the clinical context of a suspected germ cell tumor make these alternative explanations less likely.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report indicates a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. This constellation of findings strongly suggests a germ cell tumor, specifically a yolk sac tumor. The elevated tumor markers further support this diagnosis. Therefore, the suspicion of malignancy is high.\",\n  \"alternative_explanations\": \"Although the findings are highly suggestive of malignancy, it's crucial to consider that a reactive process or a benign condition could mimic a germ cell tumor. For example, a benign cystic mass could be misdiagnosed as a yolk sac tumor, or elevated tumor markers could be due to an inflammatory response. However, the presence of yolk sac tumor elements and the clinical context of a suspected germ cell tumor make these alternative explanations less probable.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor. The elevated tumor markers further support this diagnosis. Therefore, the suspicion of malignancy is high.\",\n  \"alternative_explanations\": \"While the findings strongly suggest malignancy, it is important to consider that a reactive process or a benign condition could potentially mimic a germ cell tumor. For instance, a benign cystic mass could be misdiagnosed as a yolk sac tumor",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T19:00:55.883790"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"severity\": \"Malignant\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'. The clinical history also indicates 'Rhabdomyosarcoma'. The presence of a 'parameningeal mass with intracranial extension' further supports the diagnosis of a malignant tumor. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy.\",\n  \"alternative_explanations\": \"While the report strongly suggests malignancy, it's important to consider that the clinical context (paediatric oncology assessment) and the presence of a mass with intracranial extension are highly suggestive. However, it's crucial to rule out any other potential causes for the findings, such as a rare benign tumor or a reactive process. Further investigation and specialist consultation are warranted to confirm the diagnosis and rule out alternative possibilities.\",\n  \"further_investigation\": \"Further investigations may include imaging studies (MRI, CT scan) to assess the extent of the tumor and to rule out other potential causes. A multidisciplinary team (MDT) discussion is recommended to determine the best course of treatment.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"severity\": \"Benign\",\n  \"justification\": \"The report indicates that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy. However, the report also states that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy. However, the report also states that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy. However, the report also states that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T19:00:55.883815"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. The brain MRI was normal, and no mass lesions or abnormal enhancement were found. Headaches are attributed to migraine, which is not a malignancy. Therefore, there is no evidence to suggest malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to other causes unrelated to malignancy.\",\n    \"The absence of a mass lesion on the brain MRI does not definitively rule out malignancy, as some cancers may not present as mass lesions.\"\n  ],\n  \"conclusion\": \"No malignancy identified. The patient is reassured.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. The brain MRI was normal, and no mass lesions or abnormal enhancement were found. Headaches are attributed to migraine, which is not a malignancy. Therefore, there is no evidence to suggest malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to other causes unrelated to malignancy.\",\n    \"The absence of a mass lesion on the brain MRI does not definitively rule out malignancy, as some cancers may not present as mass lesions.\"\n  ],\n  \"conclusion\": \"No malignancy identified. The patient is reassured.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. The brain MRI was normal, and no mass lesions or abnormal enhancement were found. Headaches are attributed to migraine, which is not a malignancy. Therefore, there is no evidence to suggest malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to other causes unrelated to malignancy.\",\n    \"The absence of a mass lesion on the brain MRI does not definitively rule out malignancy, as some cancers may not present as mass lesions.\"\n  ],\n  \"conclusion\": \"No malignancy identified. The patient is reassured.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T19:00:55.883832"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report describes post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T19:00:55.883841"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T19:00:55.883850"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T19:00:55.883876"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection. No malignancy is identified. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that reactive lymphadenopathy is present, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T19:00:55.883884"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes a patient with a history of retinoblastoma, confirmed by imaging and genetic testing. The presence of an intraocular mass with calcifications and bilateral disease, along with a positive family history and a detected RB1 germline mutation, strongly suggests retinoblastoma. While the report does not explicitly state the stage or extent of the disease, the description of the mass and bilateral involvement indicates a significant and potentially aggressive form of the disease. Given the patient's age (paediatric oncology assessment) and the presence of a germline mutation, the diagnosis is highly likely. The report also recommends MDT discussion and treatment planning, further supporting the diagnosis of retinoblastoma. While benign explanations are possible, the combination of findings makes malignancy the most probable diagnosis.\",\n  \"malignancy_likelihood\": \"High\",\n  \"benign_explanation_possible\": \"No\",\n  \"alternative_diagnosis_possible\": \"No\",\n  \"stage_and_extent\": \"Unknown\",\n  \"conclusion\": \"The report strongly suggests retinoblastoma, likely a significant and aggressive form given the patient's age, bilateral involvement, and presence of a germline mutation. Further evaluation and treatment planning are warranted.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a patient with a history of retinoblastoma, confirmed by imaging and genetic testing. The presence of an intraocular mass with calcifications and bilateral disease, along with a positive family history and a detected RB1 germline mutation, strongly suggests retinoblastoma. While the report does not explicitly state the stage or extent of the disease, the description of the mass and bilateral involvement indicates a significant and potentially aggressive form of the disease. Given the patient's age (paediatric oncology assessment) and the presence of a germline mutation, the diagnosis is highly likely. The report also recommends MDT discussion and treatment planning, further supporting the diagnosis of retinoblastoma. While benign explanations are possible, the combination of findings makes malignancy the most probable diagnosis.\",\n  \"malignancy_likelihood\": \"High\",\n  \"benign_explanation_possible\": \"No\",\n  \"alternative_diagnosis_possible\": \"No\",\n  \"stage_and_extent\": \"Unknown\",\n  \"conclusion\": \"The report strongly suggests retinoblastoma, likely a significant and aggressive form given the patient's age, bilateral involvement, and presence of a germline mutation",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T19:00:55.883910"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": \"The report suggests Stage III Neuroblastoma, which is a malignant tumor. The presence of a heterogeneous mass, calcifications, MIBG avidity, and elevated urinary catecholamines are all concerning for malignancy. The report recommends MDT discussion and treatment planning, further supporting the diagnosis of malignancy.\",\n  \"alternative_explanations\": [\n    \"The heterogeneous mass could be a benign tumor with calcifications. While calcifications are more common in malignant tumors, they can also occur in benign ones.\",\n    \"MIBG avidity is a marker for neuroendocrine tumors, which can be both benign and malignant. It is not specific to neuroblastoma.\",\n    \"Elevated urinary catecholamines can be caused by various factors, including benign conditions such as pheochromocytoma. While neuroblastoma is a common cause, other causes should be considered.\",\n    \"Stage III disease is a serious finding, but it can be associated with both benign and malignant conditions. The staging criteria may not be fully understood.\"\n  ],\n  \"final_judgement\": \"The report strongly suggests malignancy, specifically Stage III Neuroblastoma, due to the combination of the heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. However, further investigation is needed to confirm the diagnosis and rule out alternative explanations. The alternative explanations should be considered before making a final judgement.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": \"The report suggests Stage III Neuroblastoma, which is a malignant tumor. The presence of a heterogeneous mass, calcifications, MIBG avidity, and elevated urinary catecholamines are all concerning for malignancy. The report recommends MDT discussion and treatment planning, further supporting the diagnosis of malignancy.\",\n  \"alternative_explanations\": [\n    \"The heterogeneous mass could be a benign tumor with calcifications. While calcifications are more common in malignant tumors, they can also occur in benign ones.\",\n",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T19:00:55.883944"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T19:00:55.883952"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, a type of cancer, in the bone marrow. The presence of a parameningeal mass with intracranial extension is also mentioned. However, the report also states that the PAX-FOXO1 fusion is negative, which is important information. The clinical context suggests a possible rhabdomyosarcoma, and the biopsy confirms the diagnosis. The recommendation for MDT discussion and treatment planning is also important. The report mentions the bone pain and the suspicion of rhabdomyosarcoma, which are relevant clinical factors. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, a type of cancer, in the bone marrow. The presence of a parameningeal mass with intracranial extension is also mentioned. However, the report also states that the PAX-FOXO1 fusion is negative, which is important information. The clinical context suggests a possible rhabdomyosarcoma, and the biopsy confirms the diagnosis. The recommendation for MDT discussion and treatment planning is also important. The report mentions the bone pain and the suspicion of rhabdomyosarcoma, which are relevant clinical factors. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T19:00:55.884047"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates that a bone marrow biopsy was performed to rule out malignancy. However, the findings are normal, and no malignancy is identified. The chest radiograph is also clear, and there is no evidence of a mediastinal mass. The heart size is normal. Therefore, the report provides reassurance that no malignancy is present. The patient has no previous oncology history.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"The bone marrow biopsy was performed due to a concern about malignancy, but the biopsy itself was normal.\",\n    \"The patient's symptoms, if any, are not related to malignancy.\"\n  ],\n  \"final_conclusion\": \"No malignancy is identified in the bone marrow biopsy or chest radiograph. The patient is reassured.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that a bone marrow biopsy was performed to rule out malignancy. The findings are normal, and no malignancy is identified. The chest radiograph is also clear, and there is no evidence of a mediastinal mass. The heart size is normal. Therefore, the report provides reassurance that no malignancy is present. The patient has no previous oncology history.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"The bone marrow biopsy was performed due to a concern about malignancy, but the biopsy itself was normal.\",\n    \"The patient's symptoms, if any, are not related to malignancy.\"\n  ],\n  \"final_conclusion\": \"No malignancy is identified in the bone marrow biopsy or chest radiograph. The patient is reassured.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that a bone marrow biopsy was performed to rule out malignancy. The findings are normal, and no malignancy is identified. The chest radiograph is also clear, and there is no evidence of a mediastinal mass. The heart size is normal. Therefore, the report provides reassurance that no malignancy is present. The patient has no previous oncology history.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"The bone marrow biopsy was performed due to a concern about malignancy, but the biopsy itself was normal.\",\n    \"The patient's symptoms, if any, are not related to malignancy.\"\n  ],\n  \"final_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T19:00:55.884065"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"intraocular mass with calcifications\",\n    \"bilateral disease\",\n    \"family history positive\",\n    \"RB1 germline mutation detected\"\n  ],\n  \"malignancy_assessment\": \"The report indicates a possible retinoblastoma, which is a type of eye cancer. The presence of an intraocular mass with calcifications, bilateral disease, positive family history, and an RB1 germline mutation are all concerning findings that support a diagnosis of retinoblastoma. The recommendation for MDT discussion and treatment planning further reinforces the suspicion of malignancy.\",\n  \"skeptical_reasoning\": \"While the findings are concerning, it is important to consider alternative explanations. The intraocular mass could be a benign tumor, such as a hamartoma or a tumor of non-malignant origin. Bilateral disease could be due to a non-malignant condition affecting both eyes. A positive family history does not automatically indicate malignancy, as it could be due to a genetic predisposition to a non-malignant condition. The RB1 germline mutation is associated with retinoblastoma, but it could also be associated with other conditions. It is important to gather more information about the patient's symptoms and perform further investigations to confirm the diagnosis of retinoblastoma and rule out other possibilities.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"intraocular mass with calcifications\",\n    \"bilateral disease\",\n    \"family history positive\",\n    \"RB1 germline mutation detected\"\n  ],\n  \"malignancy_assessment\": \"The report indicates a possible retinoblastoma, which is a type of eye cancer. The presence of an intraocular mass with calcifications, bilateral disease, positive family history, and an RB1 germline mutation are all concerning findings that support a diagnosis of retinoblastoma. The recommendation for MDT discussion and treatment planning further reinforces the suspicion of malignancy.\",\n  \"skeptical_reasoning\": \"The report suggests a possible retinoblastoma. However, it is important to consider whether the findings are truly indicative of malignancy. The intraocular mass could be a benign tumor, such as a hamartoma. Bilateral disease could be due to a non-malignant condition affecting both eyes. A positive family history does not automatically indicate malignancy, as it could be due to a genetic predisposition to a non-malignant condition. The",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T19:00:55.884092"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report suggests a diagnosis of Classical Hodgkin Lymphoma. However, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T19:00:55.884106"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T19:00:55.884119"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T19:00:55.884131"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive.\",\n  \"malignancy_assessment\": \"The report explicitly mentions 'Ewing Sarcoma' and 'EWSR1 fusion positive'. These findings strongly suggest malignancy. The presence of 'permeative bone destruction' and 'onion-skin periosteal reaction' are also indicative of a malignant process.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Ewing Sarcoma, it is important to consider that other rare bone tumors or metastatic disease could present with similar features. However, the combination of findings and the patient's history (Ewing Sarcoma) makes this less likely.\",\n  \"final_judgment\": \"The report strongly suggests the presence of Ewing Sarcoma. Further investigation and confirmation are necessary, but the current evidence is highly concerning for malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive.\",\n  \"malignancy_assessment\": \"The report explicitly mentions 'Ewing Sarcoma' and 'EWSR1 fusion positive'. These findings strongly suggest malignancy. The presence of 'permeative bone destruction' and 'onion-skin periosteal reaction' are also indicative of a malignant process.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Ewing Sarcoma, it is important to consider that other rare bone tumors or metastatic disease could present with similar features. However, the combination of findings and the patient's history (Ewing Sarcoma) makes this less likely.\",\n  \"final_judgment\": \"The report strongly suggests the presence of Ewing Sarcoma. Further investigation and confirmation are necessary, but the current evidence is highly concerning for malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive.\",\n  \"malignancy_assessment\": \"The report explicitly mentions 'Ewing Sarcoma' and 'EWSR1 fusion positive'. These findings strongly suggest malignancy. The presence of 'permeative bone destruction' and 'onion-skin periosteal reaction' are also indicative",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T19:00:55.884151"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection, with no evidence of malignancy. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that reactive lymphadenopathy secondary to a viral infection was found. No atypical features were noted, and no malignancy was identified. The node size is decreasing on follow-up. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, likely due to a viral infection, with no evidence of malignancy. The node size is decreasing, and there are no atypical features. The report provides reassurance. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that reactive lymphadenopathy is present, which is a common finding and not necessarily indicative of malignancy. No atypical features are mentioned, and the node size is decreasing. The report provides reassurance. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the presence of reactive lymphadenopathy, which is a benign condition. No atypical features are observed, and the node size is decreasing. The report provides reassurance, and the findings do not suggest malignancy. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, likely caused by a viral infection. No atypical features are identified, and the node size is decreasing on follow-up. The report provides reassurance, and the findings do not suggest malignancy. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that reactive lymphadenopathy is present, which is a common finding and does not necessarily indicate malignancy. No atypical features are mentioned, and the node size is decreasing on follow-up. The report provides reassurance. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the presence of reactive lymphadenopathy, which is a benign condition. No atypical features are observed, and the node",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T19:00:55.884160"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n  \"patient_history\": \"Benign presentation. No previous oncology history.\",\n  \"lab_results\": {\n    \"cbc\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits.\",\n    \"malignancy\": \"No malignancy identified.\"\n  },\n  \"imaging_findings\": \"No malignancy identified.\",\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_assessment\": {\n    \"is_malignancy_likely\": false,\n    \"reason\": \"The report explicitly states that no malignancy is identified. The CBC is normal, and there are no blast cells. Therefore, it is highly unlikely that the patient has cancer.\"\n  }\n}\n```\n```json\n{\n  \"patient_history\": \"Benign presentation. No previous oncology history.\",\n  \"lab_results\": {\n    \"cbc\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits.\",\n    \"malignancy\": \"No malignancy identified.\"\n  },\n  \"imaging_findings\": \"No malignancy identified.\",\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_assessment\": {\n    \"is_malignancy_likely\": false,\n    \"reason\": \"The report explicitly states that no malignancy is identified. The CBC is normal, and there are no blast cells. Therefore, it is highly unlikely that the patient has cancer.\"\n  }\n}\n```\n```json\n{\n  \"patient_history\": \"Benign presentation. No previous oncology history.\",\n  \"lab_results\": {\n    \"cbc\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits.\",\n    \"malignancy\": \"No malignancy identified.\"\n  },\n  \"imaging_findings\": \"No malignancy identified.\",\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_assessment\": {\n    \"is_malignancy_likely\": false,\n    \"reason\": \"The report explicitly states that no malignancy is identified. The CBC is normal, and there are no blast cells. Therefore, it is highly unlikely that the patient has cancer.\"\n  }\n}\n```\n```json\n{\n  \"patient_history\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T19:00:55.884177"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified. The report explicitly states that there are no pathological features and no malignancy was identified. The healing fracture is described as a normal process.\",\n  \"alternative_explanations\": [\n    \"The fracture is healing normally, and there are no pathological features that indicate malignancy.\",\n    \"The bone density is normal, and there is no evidence of metastatic disease.\"\n  ],\n  \"final_conclusion\": \"The report indicates that the healing fracture is normal and there is no evidence of malignancy. The bone density is normal. Therefore, malignancy is ruled out.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"no pathological features\",\n  \"malignancy_assessment\": \"The report states that there are no pathological features, which is a key indicator that malignancy is not present.\",\n  \"alternative_explanations\": [\n    \"The absence of pathological features could be due to the healing process of the fracture.\",\n    \"The bone density is normal, and there is no evidence of metastatic disease.\"\n  ],\n  \"final_conclusion\": \"Given that the report explicitly states there are no pathological features and no malignancy is identified, the conclusion is that malignancy is ruled out.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"no malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important piece of information.\",\n  \"alternative_explanations\": [\n    \"The absence of malignancy could be due to the healing process of the fracture.\",\n    \"The bone density is normal, and there is no evidence of metastatic disease.\"\n  ],\n  \"final_conclusion\": \"The report indicates that no malignancy was identified. Therefore, the conclusion is that malignancy is ruled out.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"bone density normal\",\n  \"malignancy_assessment\": \"A normal bone density makes the presence of malignancy less likely.\",\n  \"alternative_explanations\": [\n    \"The normal bone density could be due to the healing process of the fracture.\",\n    \"The absence of malignancy could be due to the healing process of the fracture.\"\n  ],\n  \"final_conclusion\": \"The normal bone density makes malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T19:00:55.884193"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n  \"malignancy_assessment\": \"The report describes bone marrow infiltration with lymphoblasts, consistent with Acute Lymphoblastic Leukemia (ALL). The immunophenotyping is also consistent with B-cell ALL. CNS involvement is negative.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a reactive process, although this is less likely given the high percentage of lymphoblasts.\",\n    \"The bone marrow infiltration could be due to a different hematologic malignancy, although ALL is the most likely diagnosis based on the information provided.\",\n    \"The CNS involvement could be negative due to early stage disease or the presence of a treatment that has effectively suppressed the disease in the CNS.\"\n  ],\n  \"conclusion\": \"Based on the report, the findings are highly suggestive of Acute Lymphoblastic Leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a reactive process, although this is less likely given the high percentage of lymphoblasts.\",\n    \"The bone marrow infiltration could be due to a different hematologic malignancy, although ALL is the most likely diagnosis based on the information provided.\",\n    \"The CNS involvement could be negative due to early stage disease or the presence of a treatment that has effectively suppressed the disease in the CNS.\"\n  ],\n  \"conclusion\": \"Based on the report, the findings are highly suggestive of Acute Lymphoblastic Leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a reactive process, although this is less likely given the high percentage of lymphoblasts.\",\n    \"The bone marrow infiltration could be due to a different hematologic malignancy, although ALL is the most likely diagnosis based on the information provided.\",\n    \"The CNS involvement could be negative due to early stage disease or the",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T19:00:55.884213"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T19:00:55.884221"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"Physiological splenomegaly for age\",\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"Physiological splenomegaly for age\",\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T19:00:55.884232"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Lipoma\",\n  \"justification\": \"The report explicitly states that a benign soft tissue mass, confirmed as a lipoma, was found. The lipoma is well-circumscribed, shows no enhancement, and no intervention is required. Malignancy is explicitly ruled out.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report indicates a benign soft tissue mass, specifically a lipoma. The description of the lipoma (well-circumscribed, no enhancement) further supports a benign diagnosis. The report explicitly states that no malignancy was identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report explicitly states that a benign soft tissue mass, confirmed as a lipoma, was found. The lipoma is well-circumscribed, shows no enhancement, and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report describes a benign soft tissue mass, confirmed as a lipoma. The lipoma is well-circumscribed and shows no enhancement. The report explicitly states that no malignancy was identified. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report states that a benign soft tissue mass, confirmed as a lipoma, was found. The lipoma is described as well-circumscribed and showing no enhancement. The report explicitly states that no malignancy was identified. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report indicates a benign soft tissue mass, confirmed as a lipoma. The description of the lipoma (well-circumscribed, no enhancement) further supports a benign diagnosis. The report explicitly states that no malignancy was identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report describes a benign soft tissue mass, confirmed as a lipoma. The lipoma is well-circumscribed and shows no enhancement. The report explicitly states that no malignancy was identified. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T19:00:55.884241"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"No vascular invasion\",\n    \"Favorable histology on biopsy\",\n    \"Stage II\"\n  ],\n  \"malignancy_assessment\": \"The report indicates a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology. The stage is II. The report recommends MDT discussion and treatment planning.  The presence of a mass and the recommendation for treatment planning suggest a potential malignancy, but the 'favorable histology' and 'no vascular invasion' are reassuring. The stage II is also important.  Given the 'favorable histology', it is less likely to be a high-grade malignancy. The absence of vascular invasion is a positive prognostic factor.  The stage II suggests a localized disease, which is also a positive prognostic factor.\",\n  \"skeptical_reasoning\": \"While the report describes a renal mass with features suggestive of malignancy, the 'favorable histology' and 'no vascular invasion' are crucial pieces of information. These findings suggest a less aggressive tumor. The stage II also suggests a localized disease, which is a positive prognostic factor. Further investigation, such as immunohistochemistry, might be needed to confirm the diagnosis and grade of the tumor.  It is important to consider the patient's clinical context and other imaging findings to fully assess the risk. The recommendation for MDT discussion and treatment planning is standard practice in this scenario, but it does not automatically confirm malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"No vascular invasion\",\n    \"Favorable histology on biopsy\",\n    \"Stage II\"\n  ],\n  \"malignancy_assessment\": \"The report describes a large, heterogeneous left renal mass with a pseudocapsule. The absence of vascular invasion and favorable histology on biopsy are important findings. The stage is II. The report recommends MDT discussion and treatment planning.  The presence of a mass and the recommendation for treatment planning suggest a potential malignancy, but the 'favorable histology' and 'no vascular invasion' are reassuring. The stage II is also important.  Given the 'favorable histology', it is less likely to be a high-grade malignancy. The absence of vascular invasion is a positive prognostic factor. The stage II suggests a localized disease, which is also a",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T19:00:55.884272"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Osteosarcoma\",\n  \"justification\": \"The report mentions a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are characteristic findings of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to other bone tumors, such as Ewing sarcoma or chondrosarcoma, although these are less likely given the presence of sunburst periosteal reaction.\",\n    \"The findings could be due to a benign condition, such as a bone infection or a reactive process.\",\n    \"The findings could be due to a metastatic lesion from another primary cancer.\"\n  ],\n  \"conclusion\": \"While the findings are suggestive of osteosarcoma, further investigation is needed to confirm the diagnosis. An MDT discussion and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Osteosarcoma\",\n  \"justification\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are classic features of osteosarcoma. The elevated alkaline phosphatase also points towards bone turnover, consistent with tumor activity.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign process, such as a reactive bone lesion or a non-neoplastic inflammatory condition. However, the presence of a soft tissue component and sunburst periosteal reaction makes this less likely.\",\n    \"It is possible that the findings represent a metastatic lesion from another primary cancer, but this is less likely given the location in the distal femur.\"\n  ],\n  \"conclusion\": \"The findings are highly suggestive of osteosarcoma. Further investigation, including imaging studies and potentially a biopsy, is necessary to confirm the diagnosis and rule out other possibilities.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Osteosarcoma\",\n  \"justification\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. Elevated alkaline phosphatase is also noted. These findings are highly suggestive of osteosarcoma.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a reactive bone lesion or a non-neoplastic inflammatory process. However, the presence of a soft tissue component and sunburst periosteal reaction makes",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T19:00:55.884291"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report explicitly states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report explicitly states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T19:00:55.884301"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T19:00:55.884306"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, consistent with a fetal histology subtype of hepatoblastoma. The stage is II, and the report recommends MDT discussion and treatment planning. The findings are suggestive of malignancy.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": \"While the findings are suggestive of hepatoblastoma, it's important to consider alternative explanations. Elevated AFP can be seen in other conditions, and the heterogeneous appearance could be due to other liver diseases. The stage II classification suggests a localized disease, but metastasis cannot be completely ruled out without further investigation.\",\n  \"final_judgement\": \"The report is highly suggestive of hepatoblastoma. Further investigation, including biopsy and MDT discussion, is recommended to confirm the diagnosis and plan treatment. However, the possibility of alternative explanations should be considered.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, consistent with a fetal histology subtype of hepatoblastoma. The stage is II, and the report recommends MDT discussion and treatment planning. The findings are suggestive of malignancy.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": \"While the findings are suggestive of hepatoblastoma, it's important to consider alternative explanations. Elevated AFP can be seen in other conditions, and the heterogeneous appearance could be due to other liver diseases. The stage II classification suggests a localized disease, but metastasis cannot be completely ruled out without further investigation.\",\n  \"final_judgement\": \"The report is highly suggestive of hepatoblastoma. Further investigation, including biopsy and MDT discussion, is recommended to confirm the diagnosis and plan treatment. However, the possibility of alternative explanations should be considered.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, consistent with a fetal histology subtype of hepatoblastoma. The stage is II, and the report recommends MDT discussion and treatment planning. The findings are suggestive of malignancy.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": \"While the findings are suggestive of hepatoblastoma, it's important to consider alternative explanations. Elevated AFP can be seen in other conditions, and the heterogeneous appearance could be due to other liver diseases. The stage II classification suggests a localized disease, but metastasis",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T19:00:55.884327"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates the presence of myeloblasts, a cytogenetic translocation t(8;21), and a favorable risk category. These findings are suggestive of Acute Myeloid Leukemia (AML). However, the report also mentions that the myeloblasts account for 70% of marrow cellularity and the patient is a child. While the presence of myeloblasts and a translocation are concerning, the relatively low percentage of myeloblasts and the favorable risk category suggest that the disease might be indolent or potentially curable with appropriate treatment. Further investigation and discussion with the Multidisciplinary Team (MDT) are warranted to confirm the diagnosis and determine the optimal treatment plan. It's crucial to consider that the report is a preliminary assessment, and a definitive diagnosis requires further investigations and analysis. Therefore, while the findings are concerning, they do not automatically confirm malignancy. A more detailed evaluation is needed to rule out any possibility of benign explanations for the abnormal findings.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates the presence of myeloblasts, a cytogenetic translocation t(8;21), and a favorable risk category. These findings are suggestive of Acute Myeloid Leukemia (AML). However, the report also mentions that the myeloblasts account for 70% of marrow cellularity and the patient is a child. While the presence of myeloblasts and a translocation are concerning, the relatively low percentage of myeloblasts and the favorable risk category suggest that the disease might be indolent or potentially curable with appropriate treatment. Further investigation and discussion with the Multidisciplinary Team (MDT) are warranted to confirm the diagnosis and determine the optimal treatment plan. It's crucial to consider that the report is a preliminary assessment, and a definitive diagnosis requires further investigations and analysis. Therefore, while the findings are concerning, they do not automatically confirm malignancy. A more detailed evaluation is needed to rule out any possibility of benign explanations for the abnormal findings.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates the presence of myeloblasts, a cytogenetic translocation t(8;21), and a favorable risk category. These findings are suggestive of Acute Myeloid Leukemia (AML). However, the report also mentions that the myeloblasts account for 70% of marrow cellularity and the patient is a child. While the presence of myeloblasts and a translocation are concerning, the relatively low percentage of myeloblasts and the favorable risk category",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T19:00:55.884349"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a left renal mass with favorable histology and Stage II. While the report mentions Wilms Tumor, the biopsy shows favorable histology and no vascular invasion. Given the favorable histology and the absence of vascular invasion, it's likely that the patient is responding well to treatment. Therefore, the report does not provide enough evidence to suggest malignancy. The report recommends MDT discussion and treatment planning, which is a standard approach for Wilms Tumor.\",\n  \"conclusion\": \"The report suggests a favorable response to treatment and does not provide enough evidence to indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report mentions pancytopenia and a suspected Wilms Tumor. The bone marrow biopsy reveals a large heterogeneous left renal mass with pseudocapsule, but no vascular invasion. The histology is described as favorable. Given the favorable histology and the absence of vascular invasion, it is less likely that the renal mass is malignant. Pancytopenia could be related to the tumor itself or to treatment.\",\n  \"conclusion\": \"The renal mass is likely not malignant, based on the favorable histology and absence of vascular invasion. Pancytopenia may be related to the tumor or treatment.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a large heterogeneous left renal mass with pseudocapsule. The biopsy shows favorable histology and no vascular invasion. The report mentions pancytopenia, which could be related to the tumor or treatment. The report concludes that the patient should be discussed in MDT and treatment planning should be done. The report suggests a favorable response to treatment and does not provide enough evidence to indicate malignancy.\",\n  \"conclusion\": \"The renal mass is likely not malignant, based on the favorable histology and absence of vascular invasion. Pancytopenia may be related to the tumor or treatment.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a left renal mass with favorable histology and no vascular invasion. The report mentions pancytopenia, which could be related to the tumor or treatment. The report concludes that the patient should be discussed in MDT and treatment planning should be done. The report suggests a favorable response to treatment and does not provide enough evidence to indicate malignancy.\",\n  \"conclusion\": \"The renal mass is likely not malignant, based on the favorable histology and absence of vascular invasion. Pancytopenia may be related to the tumor or treatment.\"\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T19:00:55.884364"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy shows infiltration with lymphoblasts comprising 85% of nucleated cells, which is consistent with Acute Lymphoblastic Leukemia (ALL). The immunophenotyping is also consistent with B-cell ALL. CNS involvement is negative. The report recommends MDT discussion and treatment planning.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy reveals a high percentage of lymphoblasts (85%), which is a hallmark of Acute Lymphoblastic Leukemia (ALL). The immunophenotyping further confirms this diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy shows infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping is consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy shows infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping is consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T19:00:55.884374"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report describes an intraocular mass with calcifications in both eyes, a positive family history for retinoblastoma, and the presence of an RB1 germline mutation. These findings are highly suggestive of retinoblastoma. However, it's important to consider the possibility of a benign explanation for the mass, such as a tumor other than retinoblastoma. Further evaluation is needed to confirm the diagnosis and rule out other possibilities.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T19:00:55.884387"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified. The report explicitly states that no pathological features or malignancy were found. The healing fracture is considered a normal process.\",\n  \"alternative_explanations\": \"Healing fracture. Trauma history consistent.\",\n  \"conclusion\": \"The report indicates a healing fracture with no pathological features or malignancy. The trauma history is consistent with the findings. Therefore, the report does not suggest malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated PSA\",\n  \"malignancy_assessment\": \"The report mentions an elevated PSA, but it does not provide sufficient information to definitively conclude malignancy. Further investigation, such as a repeat PSA, free PSA, and/or prostate biopsy, is needed to determine the cause of the elevated PSA.\",\n  \"alternative_explanations\": \"Benign prostatic hyperplasia (BPH), prostatitis, or other non-cancerous conditions can cause elevated PSA levels.\",\n  \"conclusion\": \"While the elevated PSA raises suspicion, it is not conclusive evidence of malignancy. Further investigation is required to determine the cause of the elevated PSA.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Presence of cancer cells\",\n  \"malignancy_assessment\": \"The presence of cancer cells is a significant finding that suggests malignancy. However, it is important to consider the context of the findings. The report should provide information about the type of cancer cells, their location, and their stage. Further investigation is needed to determine the extent of the disease.\",\n  \"alternative_explanations\": \"The cancer cells could be a result of a benign condition or a misdiagnosis. Further investigation is needed to determine the cause of the cancer cells.\",\n  \"conclusion\": \"The presence of cancer cells is a concerning finding that suggests malignancy. However, further investigation is needed to determine the extent of the disease and to rule out other possible explanations.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated LDH\",\n  \"malignancy_assessment\": \"An elevated LDH level can be associated with various conditions, including malignancy. However, it is not a specific marker for cancer. Other causes of elevated LDH include hemolysis, liver disease, and certain infections. Further investigation is needed to determine the cause of the elevated LDH.\",\n  \"alternative_explanations\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T19:00:55.884400"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features, normal bone density, and no recurrence on imaging. Malignancy is not identified. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the diagnosis of malignancy.\",\n  \"benign_findings_ignored\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the diagnosis of malignancy.\",\n  \"benign_findings_ignored\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the diagnosis of malignancy.\",\n  \"benign_findings_ignored\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T19:00:55.884415"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Healing fracture - normal process.\"\n  ],\n  \"final_judgment\": \"The report indicates a healing fracture with no pathological features. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Abnormal lymph nodes\",\n  \"malignancy_assessment\": \"Abnormal lymph nodes are noted. Further investigation is warranted to determine the cause.\",\n  \"alternative_explanations\": [\n    \"The abnormal lymph nodes could be reactive to a recent infection or inflammation.\",\n    \"The abnormal lymph nodes could be due to a benign condition such as lymphoma or metastatic disease.\"\n  ],\n  \"final_judgment\": \"The abnormal lymph nodes warrant further investigation to determine the underlying cause. While malignancy is a possibility, benign explanations should be considered first. The report suggests that further investigation is warranted.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated PSA\",\n  \"malignancy_assessment\": \"The patient's PSA level is elevated. This could be due to prostate cancer, but it could also be due to a benign condition such as prostatitis or benign prostatic hyperplasia.\",\n  \"alternative_explanations\": [\n    \"Prostatitis\",\n    \"Benign prostatic hyperplasia (BPH)\",\n    \"Other benign causes of elevated PSA\"\n  ],\n  \"final_judgment\": \"The elevated PSA level warrants further investigation to determine the underlying cause. While prostate cancer is a concern, benign conditions such as prostatitis or BPH are also possible. Further evaluation is needed to differentiate between these possibilities.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Abnormal liver function tests\",\n  \"malignancy_assessment\": \"Abnormal liver function tests are noted. This could be due to a variety of causes, including liver cancer, but it could also be due to a benign condition such as hepatitis or cirrhosis.\",\n  \"alternative_explanations\": [\n    \"Hepatitis\",\n    \"Cirrhosis\",\n    \"Medications\",\n    \"Other benign causes of abnormal liver function tests\"\n  ],\n  \"final_judgment\": \"Abnormal liver function tests warrant further investigation to determine the underlying",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T19:00:55.884425"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report confirms the absence of malignancy. The MRI is normal, and no mass lesions or abnormal enhancement are present. The patient's headaches are attributed to migraines. Therefore, there is no evidence to suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the brain MRI is normal, and no mass lesions or abnormal enhancement were found. The patient's headaches are attributed to migraines, and no malignancy is identified. Therefore, the report suggests the absence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The patient's headaches are attributed to migraines, and no malignancy is identified. This suggests that there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the absence of malignancy. The brain MRI is normal, and no mass lesions or abnormal enhancement are present. The patient's headaches are attributed to migraines. Therefore, there is no evidence to suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the brain MRI is normal, and no mass lesions or abnormal enhancement were found. The patient's headaches are attributed to migraines, and no malignancy is identified. Therefore, the report suggests the absence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The patient's headaches are attributed to migraines, and no malignancy is identified. This suggests that there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the absence of malignancy. The brain MRI is normal, and no mass lesions or abnormal enhancement are present. The patient's headaches are attributed to migraines. Therefore, there is no evidence to suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the brain MRI is normal, and no mass lesions or abnormal enhancement were found. The patient's headaches are attributed to migraines, and no malignancy is identified. Therefore, the report suggests the absence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T19:00:55.884434"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Healing fracture - normal process\",\n    \"No pathological features\",\n    \"Bone density normal\",\n    \"Trauma history consistent\"\n  ],\n  \"conclusion\": \"The report indicates a healing fracture with no pathological features, normal bone density, and a consistent trauma history. Therefore, malignancy is not identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"a few small nodules in the right lung\",\n  \"malignancy_assessment\": \"The report mentions a few small nodules in the right lung, but it does not explicitly state that these are malignant. It only mentions that the findings are being followed up.\",\n  \"alternative_explanations\": [\n    \"The nodules could be benign, such as granulomas or hamartomas.\",\n    \"The nodules could be due to a benign process, such as inflammation or infection.\",\n    \"The nodules could be related to a prior infection or exposure.\"\n  ],\n  \"conclusion\": \"The report suggests the presence of nodules in the lung, but without further information, it is difficult to determine whether they are malignant. Further investigation is needed to rule out malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"a few small nodules in the right lung\",\n  \"malignancy_assessment\": \"The report mentions a few small nodules in the right lung, but it does not explicitly state that these are malignant. It only mentions that the findings are being followed up.\",\n  \"alternative_explanations\": [\n    \"The nodules could be benign, such as granulomas or hamartomas.\",\n    \"The nodules could be due to a benign process, such as inflammation or infection.\",\n    \"The nodules could be related to a prior infection or exposure.\"\n  ],\n  \"conclusion\": \"The report suggests the presence of nodules in the lung, but without further information, it is difficult to determine whether they are malignant. Further investigation is needed to rule out malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"a few small nodules in the right lung\",\n  \"malignancy_assessment\": \"The report mentions a few small nodules in the right lung, but it does not explicitly",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T19:00:55.884446"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n  \"patient_history\": \"Hodgkin Lymphoma\",\n  \"imaging_findings\": \"Mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type.\",\n  \"differential_diagnosis\": \"Hodgkin Lymphoma\",\n  \"conclusion\": \"The report indicates a diagnosis of Hodgkin Lymphoma with mediastinal involvement and FDG-avid nodes on PET-CT. The imaging characteristics are consistent with the nodular sclerosing type. Further investigation and treatment planning are recommended. While the report strongly suggests Hodgkin Lymphoma, it's important to consider that other conditions can mimic this presentation, such as lymphoma variants or reactive lymphadenopathy. However, the report's description of the PET-CT findings and the clinical context of Hodgkin Lymphoma make this diagnosis the most likely.\"\n}\n```\n```json\n{\n  \"patient_history\": \"Hodgkin Lymphoma\",\n  \"imaging_findings\": \"Mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type.\",\n  \"differential_diagnosis\": \"Hodgkin Lymphoma\",\n  \"conclusion\": \"The report suggests a diagnosis of Hodgkin Lymphoma, with mediastinal involvement and FDG-avid nodes on PET-CT. The imaging characteristics are consistent with the nodular sclerosing type. Further investigation and treatment planning are recommended. While the report strongly suggests Hodgkin Lymphoma, it's important to consider that other conditions can mimic this presentation, such as lymphoma variants or reactive lymphadenopathy. However, the report's description of the PET-CT findings and the clinical context of Hodgkin Lymphoma make this diagnosis the most likely.\"\n}\n```\n```json\n{\n  \"patient_history\": \"Hodgkin Lymphoma\",\n  \"imaging_findings\": \"Mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type.\",\n  \"differential_diagnosis\": \"Hodgkin Lymphoma\",\n  \"conclusion\": \"The report indicates a diagnosis of Hodgkin Lymphoma with mediastinal involvement and FDG-avid nodes on PET-CT. The imaging characteristics are consistent with the nodular sclerosing type. Recommend MDT discussion and treatment planning. While the report strongly suggests Hod",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T19:00:55.884464"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report confirms a diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. This is a type of brain tumor. Given the patient is a child, the grade II classification is relevant. The report also recommends MDT discussion and treatment planning. The findings indicate a mass with mass effect, which is consistent with a brain tumor. The biopsy confirms the diagnosis. While a Grade II astrocytoma is not typically considered a high-grade malignancy, it is still a tumor and requires treatment. The MDT discussion and treatment planning are important steps in managing the patient's condition.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. The presence of a mass with mass effect suggests a tumor. The biopsy confirms the diagnosis. While a Grade II astrocytoma is not considered a high-grade malignancy, it is still a tumor and requires treatment. The recommendation for MDT discussion and treatment planning is standard practice for brain tumors. The patient's age is relevant to the overall management plan. The report does not explicitly state that the tumor is cancerous, but it is a confirmed diagnosis of a brain tumor. Further investigation may be needed to determine the extent of the tumor and the patient's prognosis.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report confirms a diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. The presence of a mass with mass effect is consistent with a brain tumor. The biopsy confirms the diagnosis. While a Grade II astrocytoma is not a high-grade malignancy, it is still a tumor and requires treatment. The recommendation for MDT discussion and treatment planning is standard practice. The report does not provide any information about the tumor's aggressiveness or potential for metastasis. Further investigation may be needed to assess the tumor's extent and the patient's prognosis. The patient's age is relevant to the overall management plan. The report does not explicitly state that the tumor is cancerous, but it is a confirmed diagnosis of a brain tumor. The recommendation for MDT discussion and treatment planning is important to determine the appropriate treatment strategy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report confirms the diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. The presence of a mass with mass",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T19:00:55.884478"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T19:00:55.884487"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report suggests the presence of mediastinal lymphadenopathy with a bulky anterior mediastinal mass, confirmed by PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. The report recommends MDT discussion and treatment planning. Based on the description, it is highly likely that the findings represent a malignancy, specifically Hodgkin Lymphoma. The patient is a child, which is a common age for Hodgkin Lymphoma. The presence of FDG-avid nodes on PET-CT is a strong indicator of malignancy. Therefore, the report is consistent with a diagnosis of Hodgkin Lymphoma.\",\n  \"supporting_evidence\": [\n    \"Mediastinal lymphadenopathy\",\n    \"Bulky anterior mediastinal mass\",\n    \"FDG-avid nodes on PET-CT\",\n    \"Nodular sclerosing type Hodgkin Lymphoma\",\n    \"Paediatric oncology assessment\"\n  ],\n  \"alternative_explanations\": [\n    \"The mediastinal lymphadenopathy could be due to a reactive process, although this is less likely given the presence of FDG-avid nodes.\",\n    \"The PET-CT findings could be due to a non-Hodgkin lymphoma, although the nodular sclerosing type is less common.\"\n  ],\n  \"uncertainties\": [\n    \"The exact extent of the disease is not fully defined, and further imaging may be required.\",\n    \"The specific subtype of Hodgkin Lymphoma is not fully characterized.\",\n    \"The patient's response to treatment is unknown.\"\n  ]\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass, confirmed by PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. The report recommends MDT discussion and treatment planning. Based on the description, it is highly likely that the findings represent a malignancy, specifically Hodgkin Lymphoma. The patient is a child, which is a common age for Hodgkin Lymphoma. The presence of FDG-avid nodes on PET-CT is a strong indicator of malignancy. Therefore, the report is consistent with a diagnosis of Hodgkin Lymphoma.\",\n  \"supporting_evidence\": [\n    \"Mediastinal lymphadenopathy\",\n    \"Bulky anterior mediastinal mass\",\n    \"FDG-avid nodes",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T19:00:55.884515"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted.\",\n  \"conclusion\": \"The report indicates that the patient has resolved a febrile illness, their blood counts have normalized, there is no organomegaly, and clinical improvement has been noted. No malignancy is identified. The report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T19:00:55.882436"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"High-grade medulloblastoma\",\n  \"evidence\": [\n    \"Posterior fossa mass with enhancement and hydrocephalus\",\n    \"Restricted diffusion\",\n    \"High-grade medulloblastoma on histology\"\n  ],\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a cyst or a benign tumor.\",\n    \"The restricted diffusion could be due to a benign process, such as a non-cancerous tumor.\",\n    \"The high-grade medulloblastoma on histology could be a misdiagnosis or an error in the pathology report.\"\n  ],\n  \"conclusion\": \"While the report strongly suggests a high-grade medulloblastoma, it is important to consider the possibility of alternative explanations, such as a benign condition or a misdiagnosis. Further investigation and consultation with a multidisciplinary team (MDT) are recommended to confirm the diagnosis and plan treatment.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"High-grade medulloblastoma\",\n  \"evidence\": [\n    \"Posterior fossa mass with enhancement and hydrocephalus\",\n    \"Restricted diffusion\",\n    \"High-grade medulloblastoma on histology\"\n  ],\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a cyst or a benign tumor.\",\n    \"The restricted diffusion could be due to a benign process, such as a non-cancerous tumor.\",\n    \"The high-grade medulloblastoma on histology could be a misdiagnosis or an error in the pathology report.\"\n  ],\n  \"conclusion\": \"While the report strongly suggests a high-grade medulloblastoma, it is important to consider the possibility of alternative explanations, such as a benign condition or a misdiagnosis. Further investigation and consultation with a multidisciplinary team (MDT) are recommended to confirm the diagnosis and plan treatment.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"High-grade medulloblastoma\",\n  \"evidence\": [\n    \"Posterior fossa mass with enhancement and hydrocephalus\",\n    \"Restricted diffusion\",\n    \"High-grade medulloblastoma on histology\"\n  ],\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a cyst or a benign tumor.\",\n    \"The",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T19:00:55.882469"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection. There are no findings suggestive of malignancy. The lymph node size is decreasing on follow-up, further supporting the benign nature of the findings. Therefore, the findings are reassuring and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy secondary to a viral infection, which is a benign finding. The decreasing node size on follow-up further supports this conclusion. No atypical features are noted, and malignancy is not identified. Therefore, the findings are reassuring and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, which is a benign condition. The findings are described as resolving and not atypical. Malignancy is not identified. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, which is a benign finding. The description of the lymph node size decreasing on follow-up further supports the benign nature of the findings. Malignancy is not identified. Therefore, the findings are reassuring and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, which is a benign finding. No atypical features are mentioned. Malignancy is not identified. The decreasing node size on follow-up further supports the benign nature of the findings. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, which is a benign finding. The findings are described as resolving and not atypical. Malignancy is not identified. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, which is a benign finding. The findings are described as resolving and not atypical. Malignancy is not identified. Therefore, the report suggests that the lymphadenopathy is likely due to a benign cause and does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymph",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T19:00:55.882483"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report confirms Burkitt lymphoma with abdominal lymphadenopathy and elevated LDH levels. Given the confirmed diagnosis and the patient's age (paediatric oncology assessment), this is a serious finding.\",\n  \"alternative_explanations\": [\n    \"The abdominal lymphadenopathy could be due to a reactive process, although the biopsy confirms Burkitt lymphoma.\",\n    \"Elevated LDH levels can be seen in both benign and malignant conditions, including some inflammatory processes.\"\n  ],\n  \"conclusion\": \"The report indicates Burkitt lymphoma, which is a highly aggressive form of non-Hodgkin lymphoma. Given the confirmed diagnosis and the patient's age, the findings are concerning and warrant immediate further investigation and treatment planning.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes abdominal lymphadenopathy, confirmed as Burkitt lymphoma on biopsy, and elevated LDH levels. Given the confirmed diagnosis and the patient's age (paediatric oncology assessment), this is a serious finding.\",\n  \"alternative_explanations\": [\n    \"The abdominal lymphadenopathy could be due to a reactive process, although the biopsy confirms Burkitt lymphoma.\",\n    \"Elevated LDH levels can be seen in both benign and malignant conditions, including some inflammatory processes.\"\n  ],\n  \"conclusion\": \"The report indicates Burkitt lymphoma, which is a highly aggressive form of non-Hodgkin lymphoma. Given the confirmed diagnosis and the patient's age, the findings are concerning and warrant immediate further investigation and treatment planning.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes abdominal lymphadenopathy, confirmed as Burkitt lymphoma on biopsy, and elevated LDH levels. Given the confirmed diagnosis and the patient's age (paediatric oncology assessment), this is a serious finding.\",\n  \"alternative_explanations\": [\n    \"The abdominal lymphadenopathy could be due to a reactive process, although the biopsy confirms Burkitt lymphoma.\",\n    \"Elevated LDH levels can be seen in both benign and malignant conditions, including some inflammatory processes.\"\n  ],\n  \"conclusion\": \"The report indicates Burkitt lymphoma, which is a highly aggressive form of non-Hodgkin lymphoma. Given the confirmed diagnosis and the patient's age, the findings are concerning and warrant immediate further investigation and treatment planning.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T19:00:55.882502"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n  \"summary\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, consistent with B-cell ALL. CNS involvement is negative. The report recommends MDT discussion and treatment planning. The report does not mention any benign findings.\",\n  \"malignancy_assessment\": \"The report strongly suggests the presence of acute lymphoblastic leukemia (ALL). The high percentage of lymphoblasts (85%) in the bone marrow is a key indicator of malignancy. The immunophenotyping consistent with B-cell ALL further supports this diagnosis.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of ALL, it's important to consider that some rare conditions could present with a similar bone marrow picture. However, given the clinical context (pancytopenia and suspected ALL) and the specific findings (lymphoblasts and B-cell immunophenotyping), these alternative explanations are less likely.\",\n  \"final_judgment\": \"The report indicates a high probability of acute lymphoblastic leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\",\n  \"malignancy_assessment\": \"The report strongly suggests the presence of acute lymphoblastic leukemia (ALL). The high percentage of lymphoblasts (85%) in the bone marrow is a key indicator of malignancy. The immunophenotyping consistent with B-cell ALL further supports this diagnosis.\",\n  \"alternative_explanations\": \"Although the findings are highly suggestive of ALL, it's important to consider that some rare conditions could present with a similar bone marrow picture. However, given the clinical context (pancytopenia and suspected ALL) and the specific findings (lymphoblasts and B-cell immunophenotyping), these alternative explanations are less likely.\",\n  \"final_judgment\": \"The report indicates a high probability of acute lymphoblastic leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\",\n  \"malignancy_assessment\": \"The report strongly suggests the presence of acute",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T19:00:55.882527"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection, and no malignancy is identified. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing, and there are no atypical features. The doctor has provided reassurance. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary to a viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are not suggestive of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to viral infection. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the lymphadenopathy is reactive and secondary",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T19:00:55.882542"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n  \"overall_assessment\": \"The report indicates Stage III Neuroblastoma, with a large heterogeneous suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines. The findings suggest a high likelihood of malignancy, specifically Neuroblastoma.\",\n  \"potential_benign_explanations\": \"While the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"malignancy_assessment\": \"The combination of a large suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines strongly supports a diagnosis of Neuroblastoma. Stage III disease further reinforces this suspicion.\",\n  \"skeptical_arguments_against_malignancy\": \"Although the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"final_conclusion\": \"The report strongly suggests a diagnosis of Stage III Neuroblastoma. Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"overall_assessment\": \"The report indicates Stage III Neuroblastoma, with a large heterogeneous suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines. The findings suggest a high likelihood of malignancy, specifically Neuroblastoma.\",\n  \"potential_benign_explanations\": \"While the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"malignancy_assessment\": \"The combination of a large suprarenal mass, calcifications, MIBG avidity, and elevated urinary catecholamines strongly supports a diagnosis of Neuroblastoma. Stage III disease further reinforces this suspicion.\",\n  \"skeptical_arguments_against_malignancy\": \"Although the findings are highly suggestive of Neuroblastoma, it's important to consider the possibility of a benign etiology. Some benign conditions can mimic Neuroblastoma, although they are less common. Further investigation may be needed to rule out these possibilities.\",\n  \"final_conclusion\": \"The report strongly suggests a diagnosis of Stage III Neuroblastoma. Further investigation and",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T19:00:55.882569"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report states that no malignancy was identified, therefore it is unlikely to be malignant.\",\n  \"alternative_explanations\": \"The report indicates a normal chest radiograph, clear lung fields, no mediastinal mass, and normal heart size. These findings suggest that there is no evidence of malignancy.\",\n  \"conclusion\": \"The report indicates that no malignancy was identified. Therefore, the patient is unlikely to have malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal.\",\n  \"malignancy_assessment\": \"The report indicates no signs of malignancy based on the chest radiograph and other findings.\",\n  \"alternative_explanations\": \"The normal chest radiograph, clear lung fields, absence of mediastinal mass, and normal heart size all support the conclusion that no malignancy is present.\",\n  \"conclusion\": \"Based on the provided report, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified.\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, making it highly unlikely to be malignant.\",\n  \"alternative_explanations\": \"The report provides a normal chest radiograph, clear lung fields, and no mediastinal mass, which further supports the conclusion that no malignancy is present.\",\n  \"conclusion\": \"The report indicates no malignancy, therefore the patient is not likely to have malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal.\",\n  \"malignancy_assessment\": \"The report indicates that the findings are normal, and no malignancy is present.\",\n  \"alternative_explanations\": \"The normal chest radiograph, clear lung fields, absence of mediastinal mass, and normal heart size all support the conclusion that no malignancy is present.\",\n  \"conclusion\": \"The report indicates no malignancy, therefore the patient is not likely to have malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified.\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, making it highly unlikely to",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T19:00:55.882593"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T19:00:55.882601"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor with favorable histology. The key findings are a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. The report recommends MDT discussion and treatment planning. Based on these findings, the report suggests that the patient has a Wilms Tumor, which is a type of kidney cancer that primarily affects children. Given the favorable histology and lack of vascular invasion, the report suggests that the tumor is likely to respond well to treatment. The recommendation for MDT discussion and treatment planning suggests that the patient will likely undergo a multidisciplinary approach to treatment, which may include surgery, chemotherapy, and/or radiation therapy. The report also suggests that the patient is likely to have a good prognosis, as Wilms tumors are often highly curable, especially when diagnosed at an early stage.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor with favorable histology. The key findings are a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. The report recommends MDT discussion and treatment planning. Based on these findings, the report suggests that the patient has a Wilms Tumor, which is a type of kidney cancer that primarily affects children. Given the favorable histology and lack of vascular invasion, the report suggests that the tumor is likely to respond well to treatment. The recommendation for MDT discussion and treatment planning suggests that the patient will likely undergo a multidisciplinary approach to treatment, which may include surgery, chemotherapy, and/or radiation therapy. The report also suggests that the patient is likely to have a good prognosis, as Wilms tumors are often highly curable, especially when diagnosed at an early stage.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor with favorable histology. The key findings are a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. The report recommends MDT discussion and treatment planning. Based on these findings, the report suggests that the patient has a Wilms Tumor, which is a type of kidney cancer that primarily affects children. Given the favorable histology and lack of vascular invasion, the report suggests that the tumor is likely to respond well to treatment. The recommendation for MDT discussion and treatment planning suggests that the patient will likely undergo a multidisciplinary approach to treatment, which may include surgery,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T19:00:55.882623"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass, and PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. This suggests a diagnosis of Hodgkin Lymphoma. While the report states that the findings are consistent with classical Hodgkin, nodular sclerosing type, it's important to note that the presence of FDG-avid nodes indicates the presence of active disease, which can be a sign of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type. The report recommends an MDT discussion and treatment planning, which suggests that the diagnosis is likely confirmed. The report does not explicitly state that the findings are indicative of malignancy, but the presence of FDG-avid nodes and the description of a bulky anterior mediastinal mass raise concerns about the possibility of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type, which is a relatively common subtype of Hodgkin lymphoma and is typically treated with chemotherapy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass, and PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. This suggests a diagnosis of Hodgkin Lymphoma. While the report states that the findings are consistent with classical Hodgkin, nodular sclerosing type, it's important to note that the presence of FDG-avid nodes indicates the presence of active disease, which can be a sign of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type. The report recommends an MDT discussion and treatment planning, which suggests that the diagnosis is likely confirmed. The report does not explicitly state that the findings are indicative of malignancy, but the presence of FDG-avid nodes and the description of a bulky anterior mediastinal mass raise concerns about the possibility of malignancy. However, the report also mentions that the findings are consistent with classical Hodgkin, nodular sclerosing type, which is a relatively common subtype of Hodgkin lymphoma and is typically treated with chemotherapy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it is likely that the findings are indicative of Hodgkin lymphoma. However, it is important to note that the report does not explicitly state that the findings are indicative of malignancy. The report does not mention any other findings that would suggest a benign cause for the lymphadenopathy. Therefore, based on the information provided, it",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T19:00:55.882800"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": {\n    \"likely_malignant\": true,\n    \"alternative_explanations\": [\n      \"Calcifications could be reactive\",\n      \"MIBG avidity can be seen in benign conditions\",\n      \"Elevated urinary catecholamines can be seen in benign conditions\",\n      \"Stage III disease in pediatric oncology is suggestive of neuroblastoma\"\n    ]\n  },\n  \"conclusion\": \"The report indicates a high likelihood of malignancy, specifically neuroblastoma. However, it's crucial to consider alternative explanations for the abnormal findings, such as reactive processes or benign conditions. Further investigation and discussion with the MDT are necessary to confirm the diagnosis and develop an appropriate treatment plan.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": {\n    \"likely_malignant\": true,\n    \"alternative_explanations\": [\n      \"Calcifications could be reactive\",\n      \"MIBG avidity can be seen in benign conditions\",\n      \"Elevated urinary catecholamines can be seen in benign conditions\",\n      \"Stage III disease in pediatric oncology is suggestive of neuroblastoma\"\n    ]\n  },\n  \"conclusion\": \"The report indicates a high likelihood of malignancy, specifically neuroblastoma. However, it's crucial to consider alternative explanations for the abnormal findings, such as reactive processes or benign conditions. Further investigation and discussion with the MDT are necessary to confirm the diagnosis and develop an appropriate treatment plan.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": {\n    \"likely_malignant\": true,\n    \"alternative_explanations\": [\n      \"Calcifications could be reactive\",\n      \"",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T19:00:55.882824"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous hepatic mass\",\n      \"elevated AFP\",\n      \"Fetal histology subtype\",\n      \"PRETEXT stage II\"\n    ],\n    \"malignancy_assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, suggesting a possible hepatoblastoma. The fetal histology subtype and PRETEXT stage II further support this diagnosis. However, it's important to consider that these findings could also be due to benign conditions, such as a large benign liver tumor or reactive changes related to the underlying cause of the pancytopenia.\",\n    \"skeptical_reasoning\": \"While the findings are concerning, they do not definitively confirm malignancy. A large benign liver tumor could present similarly, and elevated AFP can be seen in various conditions. The PRETEXT staging is based on the findings, but further investigation is needed to confirm the diagnosis and rule out other possibilities.\",\n    \"conclusion\": \"The report suggests a possible hepatoblastoma, but further investigation is needed to confirm the diagnosis and rule out benign conditions. A multidisciplinary team (MDT) discussion and treatment planning are recommended.\"\n  }\n}\n```\n```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous hepatic mass\",\n      \"elevated AFP\",\n      \"Fetal histology subtype\",\n      \"PRETEXT stage II\"\n    ],\n    \"malignancy_assessment\": \"The report describes a large, heterogeneous hepatic mass with elevated AFP, and classifies it as a Fetal histology subtype with PRETEXT stage II. This presentation is highly suggestive of hepatoblastoma, a malignant tumor of the liver, particularly in children.\",\n    \"skeptical_reasoning\": \"While the findings are concerning and consistent with hepatoblastoma, it's crucial to consider that other conditions can mimic these findings. For instance, a large benign liver tumor, such as a hemangioma or a focal nodular hyperplasia (FNH), could present with a similar mass and elevated AFP levels. It's also possible that the elevated AFP is due to a non-hepatic malignancy or a reactive process. The PRETEXT staging, while providing some information about the tumor's extent, doesn't definitively rule out other possibilities.\",\n    \"conclusion\": \"The report strongly suggests hepatoblastoma, but further investigation is necessary to confirm the diagnosis and exclude",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T19:00:55.882851"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n  \"summary\": \"The report describes multiple lytic skull lesions with soft tissue component, positive for CD1a and Langerin, suggestive of Langerhans Cell Histiocytosis (LCH). The report recommends MDT discussion and treatment planning.\",\n  \"assessment\": \"The report clearly indicates multiple lytic skull lesions with soft tissue component and positive immunohistochemical staining for CD1a and Langerin, which are characteristic of Langerhans Cell Histiocytosis. The report also recommends MDT discussion and treatment planning, suggesting a higher level of concern regarding the findings. The report is from a Paediatric Oncologist and the reason for request is suspected Langerhans Cell Histiocytosis. The findings are from a CT scan.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of LCH, other less likely possibilities could include metastatic disease, although the presence of CD1a and Langerin positivity makes this less probable. It is also important to consider if the patient has a history of previous radiation or chemotherapy, which could potentially cause lytic bone lesions. It is also important to consider if the patient has an underlying immune deficiency, which could potentially predispose them to LCH.\",\n  \"conclusion\": \"The findings are most likely Langerhans Cell Histiocytosis, but other possibilities should be considered. Further investigation and MDT discussion are recommended.\"\n}\n```\n```json\n{\n  \"summary\": \"The report describes multiple lytic skull lesions with soft tissue component, positive for CD1a and Langerin, suggestive of Langerhans Cell Histiocytosis (LCH). The report recommends MDT discussion and treatment planning.\",\n  \"assessment\": \"The report clearly indicates multiple lytic skull lesions with soft tissue component and positive immunohistochemical staining for CD1a and Langerin, which are characteristic of Langerhans Cell Histiocytosis. The report also recommends MDT discussion and treatment planning, suggesting a higher level of concern regarding the findings. The report is from a Paediatric Oncologist and the reason for request is suspected Langerhans Cell Histiocytosis. The findings are from a CT scan.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of LCH, other less likely possibilities could include metastatic disease, although the presence of CD1a and Langerin positivity makes this less probable. It is also important to consider if the patient has a history of previous radiation or chemotherapy, which could potentially cause lytic bone lesions. It is also important",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T19:00:55.882903"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive Monospot and EBV serology. No malignancy is identified. The report provides reassurance.\",\n  \"malignancy_likelihood\": \"Low\",\n  \"justification\": \"The report explicitly states that no malignancy is identified. The findings are consistent with a post-viral condition, specifically mononucleosis, which is a benign self-limiting infection. The resolution of atypical lymphocytes further supports this diagnosis. The report also provides reassurance, which is typical of a benign finding.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging is recommended.\",\n  \"malignancy_likelihood\": \"Moderate\",\n  \"justification\": \"The report mentions a small nodule in the liver. While the report states no malignancy is identified, the presence of a nodule warrants further investigation to rule out malignancy. The nodule could be a benign lesion, but it could also be a sign of cancer. Further imaging is needed to determine the nature of the nodule.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging is recommended.\",\n  \"malignancy_likelihood\": \"Moderate\",\n  \"justification\": \"The report mentions a small nodule in the liver. While the report states no malignancy is identified, the presence of a nodule warrants further investigation to rule out malignancy. The nodule could be a benign lesion, but it could also be a sign of cancer. Further imaging is needed to determine the nature of the nodule.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging is recommended.\",\n  \"malignancy_likelihood\": \"Moderate\",\n  \"justification\": \"The report mentions a small nodule in the liver. While the report states no malignancy is identified, the presence of a nodule warrants further investigation to rule out malignancy. The nodule could be a benign lesion, but it could also be a sign of cancer. Further imaging is needed to determine the nature of the nodule.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a small nodule in the right lobe of the liver. Further imaging",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T19:00:55.882919"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"Myeloblasts accounting for 70% of marrow cellularity, t(8;21) translocation, and favorable risk category are all consistent with Acute Myeloid Leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report indicates a high percentage of myeloblasts (70%) in the bone marrow, which is a hallmark of Acute Myeloid Leukemia. The presence of the t(8;21) translocation is also strongly suggestive of this diagnosis. The report further categorizes the risk as favorable, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report explicitly states that myeloblasts account for 70% of the bone marrow cellularity, a key diagnostic criterion for Acute Myeloid Leukemia. The presence of the t(8;21) translocation, a specific chromosomal abnormality, further supports this diagnosis. The report also indicates a favorable risk category, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning are in line with the findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report indicates a high percentage of myeloblasts in the bone marrow, which is a hallmark of Acute Myeloid Leukemia. The presence of the t(8;21) translocation is also strongly suggestive of this diagnosis. The report further categorizes the risk as favorable, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Myeloid Leukemia\",\n  \"justification\": \"The report indicates a high percentage of myeloblasts (70%) in the bone marrow, which is a hallmark of Acute Myeloid Leukemia. The presence of the t(8;21) translocation is also strongly suggestive of this diagnosis. The report further categorizes the risk as favorable, which is consistent with the diagnosis. The doctor's assessment and recommendation for MDT discussion and treatment planning support the diagnosis.\"\n",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T19:00:55.882927"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a type of cancer. The findings suggest a parameningeal mass with intracranial extension. The report also mentions a PAX-FOXO1 fusion negative result. Given the presence of a mass and the diagnosis of rhabdomyosarcoma, there is a significant possibility of malignancy. However, it is important to consider that the report is a biopsy and may not fully represent the extent of the disease. Further investigations and treatment planning are recommended. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a type of cancer. The findings suggest a parameningeal mass with intracranial extension. The report also mentions a PAX-FOXO1 fusion negative result. Given the presence of a mass and the diagnosis of rhabdomyosarcoma, there is a significant possibility of malignancy. However, it is important to consider that the report is a biopsy and may not fully represent the extent of the disease. Further investigations and treatment planning are recommended. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT discussion and treatment planning is a standard procedure for this type of cancer and is necessary to determine the appropriate course of action. The fact that the patient is a child with a suspected diagnosis of rhabdomyosarcoma is a significant factor that needs to be considered. Rhabdomyosarcoma is a relatively rare cancer, and the presence of a mass with intracranial extension is concerning. The absence of a PAX-FOXO1 fusion does not rule out the diagnosis of rhabdomyosarcoma, as other genetic alterations can be present. The presence of a mass with intracranial extension raises concerns for potential metastasis, which would indicate a more advanced stage of the disease. While the report does not explicitly state metastasis, it is a possibility that needs to be considered. The recommendation for MDT",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T19:00:55.883031"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important finding.\",\n  \"alternative_explanations\": \"The report mentions a normal chest radiograph and clear lung fields, which would be expected in a healthy individual. The heart size is normal.\",\n  \"conclusion\": \"The report indicates no malignancy, and the supporting evidence (normal chest radiograph, clear lung fields, normal heart size) makes this conclusion highly likely.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No malignancy identified\",\n  \"malignancy_assessment",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T19:00:55.883046"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and a high-grade medulloblastoma. This is highly suggestive of malignancy, specifically medulloblastoma, a common childhood brain tumor. The recommendation for MDT discussion and treatment planning further supports this conclusion. The report also mentions a history of brain tumor, and the patient is a child.\",\n  \"potential_benign_explanations\": \"Although the report strongly suggests malignancy, it is crucial to consider potential benign explanations. For example, while less likely, a rare benign tumor could present with similar imaging characteristics. The report does not explicitly mention any benign possibilities. The patient is a child, and the report mentions a history of brain tumor, which could be a source of confusion. It is important to rule out any other potential causes of the findings.\",\n  \"overall_conclusion\": \"Based on the available information, the report is highly suggestive of a high-grade medulloblastoma. Further investigation and MDT discussion are warranted to confirm the diagnosis and initiate appropriate treatment. The history of brain tumor and the patient's age are relevant factors to consider.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and a high-grade medulloblastoma. This is highly suggestive of malignancy, specifically medulloblastoma, a common childhood brain tumor. The recommendation for MDT discussion and treatment planning further supports this conclusion. The report also mentions a history of brain tumor, and the patient is a child.\",\n  \"potential_benign_explanations\": \"Although the report strongly suggests malignancy, it is crucial to consider potential benign explanations. For example, while less likely, a rare benign tumor could present with similar imaging characteristics. The report does not explicitly mention any benign possibilities. The patient is a child, and the report mentions a history of brain tumor, which could be a source of confusion. It is important to rule out any other potential causes of the findings.\",\n  \"overall_conclusion\": \"Based on the available information, the report is highly suggestive of a high-grade medulloblastoma. Further investigation and MDT discussion are warranted to confirm the diagnosis and initiate appropriate treatment. The history of brain tumor and the patient's age are relevant factors to consider.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T19:00:55.883072"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Neuroblastoma\",\n  \"reasoning\": \"The report indicates the presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. These findings, along with the stage III diagnosis, strongly suggest Neuroblastoma. The recommendation for MDT discussion and treatment planning further supports this conclusion. A pediatric oncology assessment was also performed, which is consistent with the diagnosis of Neuroblastoma.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Neuroblastoma, it's important to consider that other conditions could potentially present with similar imaging characteristics. For example, a rare type of renal cell carcinoma or a metastatic lesion from another primary site could, in theory, exhibit some of these features. However, the combination of findings, particularly the MIBG avidity and elevated catecholamines, makes Neuroblastoma the most likely diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report mentions calcifications and MIBG avidity, which are not necessarily indicative of malignancy. Calcifications can occur in benign lesions, and MIBG avidity can be seen in some benign conditions. The elevated urinary catecholamines could be related to a benign condition such as a pheochromocytoma or a benign tumor producing catecholamines. The stage III diagnosis is also not directly indicative of malignancy, as staging systems can be complex and influenced by factors other than the presence of cancer cells. The recommendation for MDT discussion and treatment planning suggests that the clinicians are still considering the possibility of malignancy, but it doesn't definitively rule it out.\",\n  \"alternative_explanations\": \"It is possible that the mass is a benign condition that is mimicking Neuroblastoma on imaging. For example, a benign tumor or a reactive process could present with similar features. The elevated urinary catecholamines could be due to a benign cause, such as a pheochromocytoma or a benign tumor producing catecholamines. The stage III diagnosis is not directly indicative of malignancy, and it is possible that the patient has a stage III benign condition. Further investigation is needed to determine the exact cause of the findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Neuroblastoma\",\n  \"reasoning\": \"The report clearly states that the patient has Neuroblastoma, with a stage III diagnosis. The presence of a suprarenal mass with calcifications, MIBG avidity,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T19:00:55.883094"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor, which is a childhood kidney cancer. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. Given the absence of vascular invasion and favorable histology, it is highly unlikely that this is a malignant tumor. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a large heterogeneous left renal mass with a pseudocapsule. It also states that there is no vascular invasion and favorable histology on biopsy. This information suggests that the mass is likely benign, rather than malignant. The report also indicates that the stage is II, which is a relatively early stage of the disease. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy. This information suggests that the mass is likely benign, rather than malignant. The report also recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a Stage II Wilms Tumor. The report explicitly states that there is no vascular invasion and favorable histology on biopsy, suggesting a relatively benign presentation. The report recommends MDT discussion and treatment planning, which is standard for this type of cancer. Therefore, the report does not indicate malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T19:00:55.883107"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n  \"summary\": \"The report indicates a normal brain MRI with no mass lesions or abnormal enhancement. The patient reports migraines, which are attributed to this condition. No malignancy is identified.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no evidence of malignancy. The patient's headaches are likely due to migraines, and the normal brain MRI supports this conclusion.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates normal findings in the brain. The patient's headaches are attributed to migraines.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no evidence of malignancy. The patient's headaches are likely due to migraines, and the normal brain MRI supports this conclusion.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates normal findings in the brain. The patient's headaches are attributed to migraines.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no evidence of malignancy. The patient's headaches are likely due to migraines, and the normal brain MRI supports this conclusion.\"\n}\n```\n```json\n{\n  \"summary\": \"The report indicates normal findings in the brain. The patient's headaches are attributed to migraines.\",\n  \"malignancy_assessment\": \"No malignancy is identified.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches are due to migraines and not a sign of malignancy.\",\n    \"The normal brain MRI excludes the possibility of brain tumors or other intracranial malignancies.\"\n  ],\n  \"conclusion\": \"The report suggests no",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T19:00:55.883123"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": \"large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II.\",\n    \"malignancy_assessment\": \"The report describes a large heterogeneous left renal mass with a pseudocapsule. The absence of vascular invasion and favorable histology on biopsy are positive findings. The stage is II. The report concludes that the findings are consistent with a Wilms tumor.\",\n    \"skeptical_assessment\": \"While the report suggests a Wilms tumor, the presence of a pseudocapsule and the description of the mass as heterogeneous raise questions. The absence of vascular invasion is a positive finding, but it is not definitive proof of benignity. The favorable histology on biopsy is also reassuring, but it does not rule out the possibility of a low-grade or partially differentiated Wilms tumor. The stage II classification indicates a relatively early-stage tumor, but it does not exclude the possibility of metastasis. The report does not provide enough information to definitively rule out the possibility of a benign mass. Further investigation, such as imaging studies or a repeat biopsy, may be necessary to confirm the diagnosis and exclude the possibility of a benign mass.\",\n    \"alternative_explanations\": [\n      \"The mass could be a benign renal tumor, such as a renal cell carcinoma or a angiomyolipoma.\",\n      \"The mass could be a metastatic lesion from another primary tumor.\"\n    ],\n    \"final_judgment\": \"The report suggests a Wilms tumor, but further investigation is needed to confirm the diagnosis and exclude the possibility of a benign mass. The absence of vascular invasion and favorable histology on biopsy are positive findings, but they do not rule out the possibility of a low-grade or partially differentiated Wilms tumor. The stage II classification indicates a relatively early-stage tumor, but it does not exclude the possibility of metastasis. The report does not provide enough information to definitively rule out the possibility of a benign mass. Further investigation, such as imaging studies or a repeat biopsy, may be necessary to confirm the diagnosis and exclude the possibility of a benign mass.\"\n  }\n}\n```\n```json\n{\n  \"analysis\": {\n    \"abnormal_findings\": \"large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II.\",\n    \"malignancy_assessment\": \"The report describes a large heterogeneous left renal mass with a",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T19:00:55.883165"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report indicates a benign presentation with no prior oncology history. The brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report indicates a benign presentation with no prior oncology history. The brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"reasoning\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T19:00:55.883174"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that the routine surveillance PET-CT was normal. No malignancy was identified. The brain MRI also showed no mass lesion or abnormal enhancement. The patient reports migraines, which are attributed to this condition.\",\n  \"abnormal_findings\": [],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, and the brain MRI shows no mass lesion or abnormal enhancement. Therefore, there is no evidence of malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to migraine, which is a benign condition.\",\n    \"The PET-CT scan may have been performed at the correct time, and the patient may have been in remission.\",\n    \"The scan may have been performed at the wrong time, and the patient may have developed a new malignancy.\"\n  ],\n  \"final_judgment\": \"The report suggests that the patient is currently in remission and does not have any evidence of malignancy. Further surveillance may be necessary to monitor for any new developments.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the routine surveillance PET-CT was normal. No malignancy was identified, and the brain MRI also showed no mass lesion or abnormal enhancement. The patient reports migraines, which are attributed to this condition.\",\n  \"abnormal_findings\": [],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified, and the brain MRI shows no mass lesion or abnormal enhancement. Therefore, there is no evidence of malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to migraine, which is a benign condition.\",\n    \"The PET-CT scan may have been performed at the correct time, and the patient may have been in remission.\",\n    \"The scan may have been performed at the wrong time, and the patient may have developed a new malignancy.\"\n  ],\n  \"final_judgment\": \"The report suggests that the patient is currently in remission and does not have any evidence of malignancy. Further surveillance may be necessary to monitor for any new developments.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the routine surveillance PET-CT was normal. No malignancy was identified, and the brain MRI also showed no mass lesion or abnormal enhancement. The patient reports migraines, which are attributed to this condition.\",\n  ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T19:00:55.883197"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n  \"final_diagnosis\": \"Ewing Sarcoma\",\n  \"reasoning\": \"The report describes permeative bone destruction in the left femoral diaphysis with a large soft tissue mass and onion-skin periosteal reaction. It also mentions an EWSR1 fusion, which is a common genetic marker in Ewing Sarcoma. Given the patient's history of unexplained fever and weight loss, the findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin periosteal reaction and an EWSR1 fusion. These findings are highly suggestive of Ewing Sarcoma, a type of bone cancer. The MDT discussion and treatment planning recommendation further support this conclusion.\"\n}\n```\n```json\n{\n  \"final_diagnosis\": \"Benign\",\n  \"reasoning\": \"The report describes bone destruction and a soft tissue mass. However, it also mentions an onion-skin perioste",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T19:00:55.883210"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high LDH levels are all consistent with Burkitt lymphoma.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Burkitt lymphoma\",\n  \"justification\": \"The report explicitly states that Burkitt lymphoma was confirmed on biopsy. The presence of abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and high",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T19:00:55.883219"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified.\"\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T19:00:55.883225"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T19:00:55.883231"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n  \"clinical_impression\": \"Stage III Neuroblastoma\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous suprarenal mass with calcifications\",\n      \"MIBG avidity\",\n      \"elevated urinary catecholamines\",\n      \"Stage III disease\"\n    ],\n    \"malignancy_assessment\": {\n      \"potential_malignancy\": true,\n      \"alternative_explanations\": [\n        \"Calcifications could be due to benign processes, although less likely in this context.\",\n        \"MIBG avidity is highly suggestive of Neuroblastoma, but could be present in other rare conditions.\",\n        \"Elevated urinary catecholamines are a classic finding in Neuroblastoma, but could be elevated in other conditions.\",\n        \"Stage III disease is a serious finding, but could be a misdiagnosis or a misinterpretation of the imaging.\"\n      ],\n      \"conclusion\": \"While the findings are highly suggestive of Neuroblastoma, it is important to consider the possibility of alternative explanations. Further investigation is warranted to confirm the diagnosis.\"\n    }\n  }\n}\n```\n```json\n{\n  \"clinical_impression\": \"Stage III Neuroblastoma\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": [\n      \"large heterogeneous suprarenal mass with calcifications\",\n      \"MIBG avidity\",\n      \"elevated urinary catecholamines\",\n      \"Stage III disease\"\n    ],\n    \"malignancy_assessment\": {\n      \"potential_malignancy\": true,\n      \"alternative_explanations\": [\n        \"Calcifications could be due to benign processes, although less likely in this context.\",\n        \"MIBG avidity is highly suggestive of Neuroblastoma, but could be present in other rare conditions.\",\n        \"Elevated urinary catecholamines are a classic finding in Neuroblastoma, but could be elevated in other conditions.\",\n        \"Stage III disease is a serious finding, but could be a misdiagnosis or a misinterpretation of the imaging.\"\n      ],\n      \"conclusion\": \"The findings are highly suggestive of Neuroblastoma, but further investigation is needed to confirm the diagnosis.\"\n    }\n  }\n}\n```\n```json\n{\n  \"clinical_impression\": \"Stage III Neuroblastoma\",\n  \"skeptical_assessment\": {\n    \"abnormal_",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T19:00:55.883256"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a high-grade medulloblastoma in the posterior fossa, along with hydrocephalus. This strongly suggests malignancy. The restricted diffusion and enhancement on ultrasound are also consistent with a malignant process. The recommendation for MDT discussion and treatment planning further supports the diagnosis of a brain tumor.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion. These findings are suggestive of a malignant process, specifically a high-grade medulloblastoma. The recommendation for MDT discussion and treatment planning reinforces the suspicion of malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a posterior fossa mass with enhancement and hydrocephalus. The presence of restricted diffusion on ultrasound is a concerning finding that is often associated with malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor. The recommendation for MDT discussion and treatment planning further supports the diagnosis of a brain tumor. Given these findings, it is likely that the mass is malignant.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a posterior fossa mass with enhancement and hydrocephalus. The presence of restricted diffusion on ultrasound is a concerning finding that is often associated with malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor. The recommendation for MDT discussion and treatment planning further supports the diagnosis of a brain tumor. Given these findings, it is likely that the mass is malignant.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion. These findings are suggestive of a malignant process, specifically a high-grade medulloblastoma. The recommendation for MDT discussion and treatment planning reinforces the suspicion of malignancy. The report also mentions that the mass is high-grade medulloblastoma on histology, which is a type of brain tumor. Given these findings, it is likely that the mass is malignant.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a posterior fossa mass with enhancement and hydrocephalus, along with restricted diffusion. These findings are suggestive of a malignant process, specifically a high",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T19:00:55.883267"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a normal chest radiograph with no evidence of malignancy.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy. The findings are reassuring and suggest no need for further investigation.\",\n  \"malignancy_probability\": \"0\",\n  \"alternative_explanations\": [\n    \"The patient may have a benign condition that is not visible on the radiograph.\"\n  ],\n  \"final_conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal chest radiograph with no evidence of malignancy.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T19:00:55.883279"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"sacrococcygeal mass with mixed solid and cystic components, Elevated AFP and beta-hCG, Yolk sac tumor elements present\",\n  \"malignancy_assessment\": \"The findings suggest a possible germ cell tumor, specifically a yolk sac tumor, given the elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. However, it's important to consider that these findings could be reactive or benign, particularly in the context of a known germ cell tumor.\",\n  \"skeptical_reasoning\": \"While the report points towards a germ cell tumor, it's crucial to consider alternative explanations for the elevated AFP and beta-hCG. These could be due to reactive processes, other malignancies, or even medication side effects. The presence of yolk sac tumor elements is highly suggestive, but it's essential to rule out any possibility of a benign cause. The sacrococcygeal mass itself could be a reactive response to the elevated tumor markers, or it could be a benign lesion. Further investigation and a multidisciplinary team (MDT) discussion are warranted to confirm the diagnosis and treatment plan.\",\n  \"conclusion\": \"Based on the report, the findings are suggestive of a germ cell tumor, specifically a yolk sac tumor, but further investigation and MDT discussion are necessary to confirm the diagnosis and rule out alternative explanations.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated AFP and beta-hCG\",\n  \"malignancy_assessment\": \"Elevated AFP and beta-hCG can be indicative of germ cell tumors, but they can also be elevated in benign conditions such as pregnancy, liver disease, or certain infections.\",\n  \"skeptical_reasoning\": \"While elevated AFP and beta-hCG raise suspicion for germ cell tumors, it's important to consider other potential causes. These could include pregnancy, liver disease, or certain infections. The clinical context and further investigations are crucial to differentiate between malignancy and benign causes.\",\n  \"conclusion\": \"Elevated AFP and beta-hCG warrant further investigation to rule out non-malignant causes.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Yolk sac tumor elements present\",\n  \"malignancy_assessment\": \"The presence of yolk sac tumor elements is highly suggestive of a germ cell tumor, particularly a yolk sac tumor. However, it",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T19:00:55.883306"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report describes a mediastinal mass with FDG-avid nodes, consistent with classical Hodgkin lymphoma. While the findings are suggestive of malignancy, it is important to consider alternative explanations, such as reactive lymphadenopathy, although the PET-CT findings make this less likely. Further investigation, including MDT discussion and treatment planning, is warranted.\",\n  \"abnormal_findings\": [\n    \"mediastinal lymphadenopathy\",\n    \"bulky anterior mediastinal mass\",\n    \"FDG-avid nodes\"\n  ],\n  \"malignancy_assessment\": \"The report indicates FDG-avid nodes, which are highly suggestive of malignancy. The description of the mass as 'bulky' also raises concern. However, reactive lymphadenopathy can also show FDG uptake, and the 'bulky' nature of the mass could be due to reactive inflammation.\",\n  \"alternative_explanations\": [\n    \"reactive lymphadenopathy\",\n    \"reactive inflammation\"\n  ],\n  \"benign_findings\": [\n    \"None explicitly mentioned\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a mediastinal mass with FDG-avid nodes, which is highly suggestive of malignancy. While the report mentions that the findings could be due to reactive lymphadenopathy, the presence of FDG-avid nodes makes this less likely. Further investigation, including MDT discussion and treatment planning, is warranted.\",\n  \"abnormal_findings\": [\n    \"mediastinal lymphadenopathy\",\n    \"bulky anterior mediastinal mass\",\n    \"FDG-avid nodes\"\n  ],\n  \"malignancy_assessment\": \"The report indicates FDG-avid nodes, which are highly suggestive of malignancy. The description of the mass as 'bulky' also raises concern. However, reactive lymphadenopathy can also show FDG uptake, and the 'bulky' nature of the mass could be due to reactive inflammation.\",\n  \"alternative_explanations\": [\n    \"reactive lymphadenopathy\",\n    \"reactive inflammation\"\n  ],\n  \"benign_findings\": [\n    \"None explicitly mentioned\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a mediast",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T19:00:55.883330"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates that the bone marrow biopsy was normal, with no blast cells and no evidence of malignancy. The CBC results are within normal limits. The patient received reassurance. Therefore, there is no evidence of malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient is a young child with a normal bone marrow. Blast cells are not always present in malignant conditions.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report shows a normal CBC and no blast cells, ruling out acute leukemia. While the report mentions a bone marrow biopsy, the description of the findings is reassuring and does not suggest malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient's age might be a factor in the bone marrow composition, and normal values are expected.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal bone marrow biopsy with no evidence of malignancy. The CBC results are within normal limits, further supporting the absence of malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient may be undergoing routine surveillance, and the bone marrow biopsy was performed to rule out any potential issues.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the bone marrow biopsy was normal, with no blast cells and no evidence of malignancy. The CBC results are within normal limits. The patient received reassurance. Therefore, there is no evidence of malignancy.\",\n  \"malignancy_likelihood\": \"0\",\n  \"benign_likelihood\": \"1\",\n  \"alternative_explanations\": [\n    \"The patient is a young child with a normal bone marrow. Blast cells are not always present in malignant conditions.\"\n  ],\n  \"final_judgment\": \"No malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a normal bone",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T19:00:55.883344"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"benign\",\n  \"reason\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. The mass has no enhancement and no",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T19:00:55.883352"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"No malignancy identified.\",\n  \"malignancy_assessment\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass. The heart size is normal. Therefore, based on the provided information, there is no evidence of malignancy.\",\n  \"alternative_explanations\": \"The findings are consistent with a normal bone marrow and overall health. The screening was performed as a precaution, and the normal results provide reassurance.\",\n  \"conclusion\": \"The report indicates no evidence of malignancy. The findings are consistent with a normal bone marrow and overall health.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass. The heart size is normal.\",\n  \"malignancy_assessment\": \"The report indicates no malignancy. The chest radiograph is normal, showing clear lung fields and no mediastinal mass. The heart size is normal. Therefore, the report does not suggest malignancy.\",\n  \"alternative_explanations\": \"The report is a screening result. Normal findings do not necessarily rule out the possibility of future malignancy, but they do not indicate any current malignancy.\",\n  \"conclusion\": \"The report indicates no evidence of malignancy. The findings are consistent with a normal bone marrow and overall health.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass. The heart size is normal.\",\n  \"malignancy_assessment\": \"The report indicates no malignancy. The chest radiograph is normal, showing clear lung fields and no mediastinal mass. The heart size is normal. Therefore, the report does not suggest malignancy.\",\n  \"alternative_explanations\": \"The report is a screening result. Normal findings do not necessarily rule out the possibility of future malignancy, but they do not indicate any current malignancy.\",\n  \"conclusion\": \"The report indicates no evidence of malignancy. The findings are consistent with a normal bone marrow and overall health.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"The report states that no malignancy was identified. The chest radiograph and lung fields are clear, and there is no mediastinal mass.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T19:00:55.883368"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of suspected osteosarcoma further strengthens the likelihood of malignancy. Therefore, the report is highly suggestive of osteosarcoma.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are highly suggestive of osteosarcoma. The elevated alkaline phosphatase further supports this diagnosis. The recommendation for MDT discussion and treatment planning is also consistent with this suspicion. The report does not mention any benign findings, and the clinical history of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T19:00:55.883381"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. Elevated alkaline phosphatase is also noted. These findings are highly suggestive of osteosarcoma, a primary bone cancer. The recommendation for MDT discussion and treatment planning further supports this suspicion. However, it's important to consider that other conditions, such as aggressive infections or rare bone tumors, could potentially mimic these findings. Further investigation, including biopsy, is necessary to confirm the diagnosis and rule out alternative possibilities.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": [\n    \"Aggressive infection (e.g., osteomyelitis)\",\n    \"Rare bone tumor (e.g., giant cell tumor, chondrosarcoma)\",\n    \"Benign bone lesion with aggressive features\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, along with elevated alkaline phosphatase. These findings are highly suggestive of osteosarcoma. The recommendation for MDT discussion and treatment planning further supports this suspicion. However, it's important to consider that other conditions, such as aggressive infections or rare bone tumors, could potentially mimic these findings. Further investigation, including biopsy, is necessary to confirm the diagnosis and rule out alternative possibilities.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": [\n    \"Aggressive infection (e.g., osteomyelitis)\",\n    \"Rare bone tumor (e.g., giant cell tumor, chondrosarcoma)\",\n    \"Benign bone lesion with aggressive features\"\n  ],\n  \"further_investigation_needed\": true\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. Elevated alkaline phosphatase is also noted. These findings are highly suggestive of osteosarcoma, a primary bone cancer. The recommendation for MDT discussion and treatment planning further supports this suspicion. However, it's important to consider that other conditions, such as aggressive infections or rare bone tumors, could potentially mimic these findings. Further investigation, including biopsy, is necessary to confirm the diagnosis and rule out alternative possibilities.\",\n  \"malignancy_",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T19:00:55.883402"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_reasoning\": \"The report explicitly states that no malignancy was identified and provides reassurance. The findings are consistent with a post-viral infection, specifically mononucleosis, confirmed by EBV serology. Therefore, the presence of atypical lymphocytes resolving is a normal reaction to the viral infection, and not a sign of malignancy.\",\n  \"final_conclusion\": \"No malignancy\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated PSA. Possible prostate cancer. Further investigation required.\",\n  \"malignancy_assessment\": \"Possible prostate cancer. Further investigation required.\",\n  \"skeptical_reasoning\": \"Elevated PSA can be caused by a variety of factors, including benign prostatic hyperplasia (BPH), prostatitis, urinary tract infections, and even recent ejaculation. While prostate cancer is a possibility, it is not the only explanation. The report recommends further investigation, which is a prudent approach to rule out other potential causes.\",\n  \"final_conclusion\": \"Further investigation required\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Microscopic hematuria. Possible renal cell carcinoma. Further investigation required.\",\n  \"malignancy_assessment\": \"Possible renal cell carcinoma. Further investigation required.\",\n  \"skeptical_reasoning\": \"Microscopic hematuria can be caused by a variety of benign conditions, such as benign prostatic hyperplasia, kidney stones, or urinary tract infections. While renal cell carcinoma is a possibility, it is not the only explanation. The report recommends further investigation to determine the cause of the hematuria.\",\n  \"final_conclusion\": \"Further investigation required\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated CEA. Possible colorectal cancer. Further investigation required.\",\n  \"malignancy_assessment\": \"Possible colorectal cancer. Further investigation required.\",\n  \"skeptical_reasoning\": \"Elevated CEA can be caused by a variety of factors, including benign conditions such as inflammatory bowel disease, smoking, and certain medications. While colorectal cancer is a possibility, it is not the only explanation. The report recommends further investigation to determine the cause of the elevated",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T19:00:55.883417"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"no vascular invasion\",\n    \"favorable histology on biopsy\",\n    \"stage II\"\n  ],\n  \"malignancy_assessment\": \"The report describes a left renal mass with favorable histology and no vascular invasion. The stage is II. While this indicates malignancy, the favorable histology suggests a less aggressive type of Wilms tumor. The absence of vascular invasion is also a positive finding.\",\n  \"alternative_explanations\": [\n    \"The large renal mass could be a benign tumor, such as a simple cyst or angiomyolipoma, although the description suggests it is a Wilms tumor.\",\n    \"The stage II designation could be misleading, and the tumor might be less aggressive than initially suspected.\",\n    \"The report might be an error, and the patient actually has a benign condition.\"\n  ],\n  \"conclusion\": \"While the report suggests a stage II Wilms tumor with favorable histology, the presence of a large renal mass warrants further investigation to rule out benign possibilities. The report should be reviewed to confirm the diagnosis and stage.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"pancytopenia\"\n  ],\n  \"malignancy_assessment\": \"Pancytopenia can be caused by various conditions, including bone marrow disorders, infections, medications, and autoimmune diseases. It is not specific to malignancy.\",\n  \"alternative_explanations\": [\n    \"The pancytopenia could be due to a medication side effect.\",\n    \"The pancytopenia could be caused by an underlying autoimmune disorder.\",\n    \"The pancytopenia could be due to a viral infection.\"\n  ],\n  \"conclusion\": \"Pancytopenia requires further investigation to determine the underlying cause. It is not sufficient to conclude that the patient has a malignancy based solely on pancytopenia.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"no vascular invasion\",\n    \"favorable histology on biopsy\",\n    \"stage II\"\n  ],\n  \"malignancy_assessment\": \"The report describes a left renal mass with favorable histology and no vascular invasion. The stage is II. While this indicates malignancy, the favorable histology suggests a less aggressive type of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T19:00:55.883441"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n  \"malignancy_assessment\": \"The report indicates mediastinal lymphadenopathy with a bulky anterior mediastinal mass, FDG-avid nodes, and a diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type). These findings are highly suggestive of malignancy. The report also recommends MDT discussion and treatment planning, further supporting the suspicion of malignancy.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Hodgkin Lymphoma, it's important to consider alternative explanations, such as: 1) Reactive lymphadenopathy: Inflammatory conditions can mimic malignant lymphadenopathy. 2) Other malignancies: Although less likely given the specific description of Classical Hodgkin Lymphoma, other lymphomas or metastatic cancers could present with similar findings. 3) Benign conditions: Certain benign conditions can cause mediastinal masses and lymph node enlargement. However, the presence of FDG-avid nodes strongly suggests malignancy.\",\n  \"final_conclusion\": \"Based on the report, the findings are highly suggestive of Classical Hodgkin Lymphoma. Further investigation, including MDT discussion and treatment planning, is recommended. However, it's crucial to consider alternative explanations, such as reactive lymphadenopathy or other malignancies, before definitively concluding that the patient has Hodgkin Lymphoma.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass and FDG-avid nodes. These findings are suggestive of malignancy.\",\n  \"alternative_explanations\": \"1) Reactive lymphadenopathy: Inflammatory processes can cause similar findings. 2) Metastatic disease: Cancer from another site can spread to the mediastinum. 3) Lymphoma: Other types of lymphoma can present with similar findings. 4) Benign conditions: Certain benign conditions can cause mediastinal masses.\",\n  \"final_conclusion\": \"The findings are suggestive of malignancy. Further investigation is warranted to determine the underlying cause.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass and FDG-avid nodes. These findings are suggestive of malignancy.\",\n  \"alternative_explanations\": \"1) Reactive lymphadenopathy: Inflammatory processes can cause similar findings. 2) Metastatic disease: Cancer from another site can spread to the mediastinum. 3) Lymphoma: Other types of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T19:00:55.883468"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that no malignancy was identified. It also describes post-viral lymphocytosis and atypical lymphocytes resolving, with a positive Monospot and EBV serology confirming the diagnosis. Therefore, the report provides reassurance that there is no malignancy present.\",\n  \"alternative_explanations\": \"The findings could be due to a viral infection, such as mononucleosis (Epstein-Barr virus). The atypical lymphocytes and positive Monospot/EBV serology support this diagnosis. Other less common viral infections could also present with similar findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report states that no malignancy was identified. The findings suggest post-viral lymphocytosis, with atypical lymphocytes resolving and a positive Monospot and EBV serology. This confirms the diagnosis of a viral infection, such as mononucleosis, which is not malignant. Therefore, the report provides reassurance that there is no malignancy present.\",\n  \"alternative_explanations\": \"The findings could be due to a viral infection, such as mononucleosis (Epstein-Barr virus). The atypical lymphocytes and positive Monospot/EBV serology support this diagnosis. Other less common viral infections could also present with similar findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report clearly states that no malignancy was found. The presence of post-viral lymphocytosis, resolving atypical lymphocytes, and positive Monospot/EBV serology confirms a viral infection, specifically mononucleosis. This is not a malignancy. Therefore, the report provides reassurance.\",\n  \"alternative_explanations\": \"The findings could be due to a viral infection, such as mononucleosis (Epstein-Barr virus). The atypical lymphocytes and positive Monospot/EBV serology support this diagnosis. Other less common viral infections could also present with similar findings.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that no malignancy was identified. The presence of post-viral lymphocytosis, resolving atypical lymphocytes, and positive Monospot/EBV serology confirms a viral infection, specifically mon",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T19:00:55.883483"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are attributed to migraine. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy. The brain MRI is normal, and no mass lesion or abnormal enhancement is identified. Headaches are",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T19:00:55.883491"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report describes a case of Ewing Sarcoma. Based on the findings of permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and EWSR1 fusion positivity, the report strongly suggests the presence of Ewing Sarcoma. The clinical context of suspected Ewing Sarcoma further supports this conclusion. The report recommends MDT discussion and treatment planning, indicating the need for further investigation and management.\",\n  \"alternative_explanations\": \"While the report strongly suggests Ewing Sarcoma, it's important to consider alternative explanations for the observed findings. For example, other bone tumors, such as osteosarcoma or chondrosarcoma, could present with similar features. Additionally, metastatic disease from another primary site could potentially cause bone destruction and soft tissue masses. However, the EWSR1 fusion positivity is highly suggestive of Ewing Sarcoma and makes these alternative diagnoses less likely.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a case of Ewing Sarcoma. Based on the findings of permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and EWSR1 fusion positivity, the report strongly suggests the presence of Ewing Sarcoma. The clinical context of suspected Ewing Sarcoma further supports this conclusion. The report recommends MDT discussion and treatment planning, indicating the need for further investigation and management.\",\n  \"alternative_explanations\": \"While the report strongly suggests Ewing Sarcoma, it's important to consider alternative explanations for the observed findings. For example, other bone tumors, such as osteosarcoma or chondrosarcoma, could present with similar features. Additionally, metastatic disease from another primary site could potentially cause bone destruction and soft tissue masses. However, the EWSR1 fusion positivity is highly suggestive of Ewing Sarcoma and makes these alternative diagnoses less likely.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a case of Ewing Sarcoma. Based on the findings of permeative bone destruction, a large soft tissue mass, onion-skin periosteal reaction, and EWSR1 fusion positivity, the report strongly suggests the presence of Ewing Sarcoma. The clinical context of suspected Ewing Sarcoma further supports this conclusion. The report recommends MDT discussion and treatment planning, indicating the need for further investigation and management.\",\n  \"alternative_explanations\": \"While the report strongly suggests Ewing Sarcoma, it's important to consider alternative",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T19:00:55.883511"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n  \"analysis\": \"The report indicates that the MRI of the brain was normal for the patient's age. No mass lesions or abnormal enhancement were observed. Headaches are attributed to migraine, and no malignancy was identified. The report provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report mentions follow-up post-treatment. No previous oncology history is stated. The MRI shows normal brain findings, including no mass lesions or abnormal enhancement. Headaches are attributed to migraine. The report concludes that no malignancy was identified and provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report describes a follow-up MRI of the brain post-treatment. No previous oncology history is mentioned. The MRI findings are normal, with no mass lesions or abnormal enhancement. The report attributes headaches to migraine and states that no malignancy was identified. It provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report indicates a follow-up MRI of the brain after treatment. No prior oncology history is stated. The MRI shows normal brain structures, with no mass lesions or abnormal enhancement. Headaches are attributed to migraine, and no malignancy is identified. The report provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report describes a follow-up MRI of the brain after treatment. No prior oncology history is mentioned. The MRI shows normal brain findings, including no mass lesions or abnormal enhancement. The report attributes headaches to migraine and states that no malignancy was identified. It provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report mentions a follow-up MRI of the brain post-treatment. No previous oncology history is stated. The MRI shows normal brain structures, with no mass lesions or abnormal enhancement. Headaches are attributed to migraine, and no malignancy is identified. The report provides reassurance.\",\n  \"conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"analysis\": \"The report describes a follow-up MRI of the brain after treatment. No prior oncology history is mentioned. The MRI findings are normal, with no mass lesions or abnormal enhancement. The report attributes headaches",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T19:00:55.883521"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Physiological splenomegaly\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Physiological splenomegaly for age.\",\n  \"conclusion\": \"The report indicates physiological splenomegaly, which is a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Normal echo texture.\",\n  \"conclusion\": \"The report indicates no focal lesions and normal echo texture. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"No focal lesions. Normal echo texture. Benign finding.\",\n  \"malignancy_assessment\": \"No malignancy identified. Reassurance provided.\",\n  \"alternative_explanations\": \"Benign finding.\",\n  \"conclusion\": \"The report indicates no focal lesions, normal echo texture, and a benign finding. Therefore, no malignancy is identified.\"\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T19:00:55.883530"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy secondary to a viral infection. There are no atypical features and no malignancy identified. The node size is decreasing on follow-up. The report provides reassurance. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report states that there is no malignancy identified and that the findings are reactive lymphadenopathy secondary to a viral infection. The report also mentions that the node size is decreasing on follow-up. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a non-malignant condition. The report further states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up, which is a positive sign. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes reactive lymphadenopathy, which is a benign condition. The report also states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a non-malignant condition. The report further states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up, which is a positive sign. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a benign condition. The report also states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a non-malignant condition. The report further states that there are no atypical features and no malignancy identified. The node size is decreasing on follow-up, which is a positive sign. Therefore, the findings are benign and do not indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates reactive lymphadenopathy, which is a benign condition.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T19:00:55.883539"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, along with elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer. Further investigation and discussion with the MDT (Multi-Disciplinary Team) are recommended to determine the appropriate treatment plan.\",\n  \"reasoning\": \"The report explicitly mentions osteosarcoma, a malignant bone tumor, as the suspected diagnosis. The findings of a destructive lesion, soft tissue component, and sunburst periosteal reaction are all characteristic of osteosarcoma. Elevated alkaline phosphatase is also a common finding in bone tumors. The recommendation for MDT discussion and treatment planning further supports the suspicion of malignancy. However, it is important to note that the report is based on a preliminary assessment, and further investigations, such as biopsy and imaging studies, are needed to confirm the diagnosis and stage the cancer. While osteosarcoma is a malignant condition, it is possible that the findings could be due to a benign process. The report does not provide enough information to rule out other possibilities, such as infection or inflammatory conditions. Therefore, a definitive diagnosis requires further evaluation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report suggests osteosarcoma, but the findings could potentially be explained by a benign process. Further investigation is needed to confirm the diagnosis.\",\n  \"reasoning\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. These findings are highly suggestive of osteosarcoma, a malignant bone tumor. The elevated alkaline phosphatase is also consistent with bone tumors. However, it is important to consider that some benign conditions can also cause similar findings. For example, infection or inflammatory conditions can lead to bone destruction and periosteal reaction. Therefore, it is essential to rule out these possibilities before concluding that the findings represent osteosarcoma. A biopsy is needed to confirm the diagnosis and determine the nature of the lesion.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction, along with elevated alkaline phosphatase. These findings are suggestive of osteosarcoma, a type of bone cancer. Further investigation and discussion with the MDT (Multi-Disciplinary Team) are recommended to determine the appropriate treatment plan.\",\n  \"reasoning\": \"The report explicitly mentions oste",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T19:00:55.883565"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T19:00:55.883570"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",\n  \"justification\": \"The report explicitly states that a chest radiograph was normal, and no malignancy was identified. The findings are reassuring and suggest a benign presentation.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that no malignancy was identified. The findings are reassuring and suggest a benign presentation.\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T19:00:55.883580"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report explicitly states that a benign soft tissue mass (lipoma) was confirmed. There is no mention of any malignant cells or suspicious features. The report also provides reassurance that no intervention is required.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report indicates that a benign soft tissue mass, specifically a lipoma, was identified. The mass is described as well-circumscribed and not enhancing, which are characteristics associated with benign lesions. The report also states that no malignancy was identified. Therefore, the findings are consistent with a benign process.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report clearly states that a benign soft tissue mass (lipoma) was found. The description of the mass as well-circumscribed and non-enhancing further supports the benign nature of the findings. The report also explicitly mentions that no malignancy was identified, which is a key indicator of a benign diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report indicates the presence of a benign soft tissue mass, identified as a lipoma. The mass is described as well-circumscribed and not enhancing, which are typical characteristics of benign lipomas. Furthermore, the report explicitly states that no malignancy was identified. Therefore, the findings are consistent with a benign diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report clearly states that a benign soft tissue mass, specifically a lipoma, was identified. The mass is described as well-circumscribed and not enhancing, which are characteristics associated with benign lesions. The report also provides reassurance that no intervention is required. Therefore, the findings are consistent with a benign process.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"reasoning\": \"The report indicates that a benign soft tissue mass, a lipoma, was found. The description of the mass as well-circumscribed and non-enhancing supports the benign nature of the findings. The report explicitly states that no malignancy was identified. Therefore, the findings are consistent with a benign diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"Benign\",\n  \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T19:00:55.883588"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n  \"clinical_impression\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II. Recommend MDT discussion and treatment planning.\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II.\",\n    \"malignancy_assessment\": \"The report indicates a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. Stage II. The presence of a mass and the stage are concerning for malignancy. However, the report also mentions favorable histology, which suggests a more benign or less aggressive tumor. The absence of vascular invasion is also a positive finding. The report recommends MDT discussion and treatment planning. This suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"clinical_impression\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II. Recommend MDT discussion and treatment planning.\",\n  \"skeptical_assessment\": {\n    \"abnormal_findings\": \"Large heterogeneous left renal mass with pseudocapsule, no vascular invasion, favorable histology on biopsy, Stage II.\",\n    \"malignancy_assessment\": \"The report indicates a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology on biopsy. Stage II. The presence of a mass and the stage are concerning for malignancy. However, the report also mentions favorable histology, which suggests a more benign or less aggressive tumor. The absence of vascular invasion is also a positive finding. The report recommends MDT discussion and treatment planning. This suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's age and overall health. The recommendation for MDT discussion and treatment planning suggests that the findings are being taken seriously, but it also indicates that the diagnosis is not yet definitive. It is possible that the mass is a benign tumor, such as a cyst, or that it is a malignant tumor that is not yet aggressive. The stage II is not a definitive indicator of malignancy, as it can be influenced by factors such as the patient's",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T19:00:55.883688"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to a viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",\n  \"reasoning\": \"The report explicitly states that the findings are reactive lymphadenopathy secondary to viral infection, with decreasing node size and no atypical features. The report also states that no malignancy was identified. Therefore, the diagnosis is no malignancy identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T19:00:55.883698"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report describes a large heterogeneous hepatic mass with elevated AFP in a patient with a history of hepatoblastoma. The staging is PRETEXT stage II, and the recommendation is for MDT discussion and treatment planning. The report does not explicitly state whether the mass is malignant or benign. The presence of a hepatic mass with elevated AFP in a patient with a history of hepatoblastoma raises concern for malignancy. However, it is important to consider that the mass could be a recurrence of the original hepatoblastoma, or it could be a different type of liver cancer. Further investigation, such as a biopsy, is needed to determine the nature of the mass. The PRETEXT stage II suggests that the disease is locally advanced, but it does not necessarily mean that the disease is metastatic. Therefore, the report does not provide enough information to definitively conclude whether the mass is malignant or benign. It is important to consider all possible explanations before making a final diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP in a patient with a history of hepatoblastoma, staged as PRETEXT stage II. While the presence of a mass and elevated AFP are concerning, the report does not definitively state that the mass is malignant. The patient's history of hepatoblastoma suggests the possibility of recurrence, but other etiologies for the mass and elevated AFP should be considered. Further investigation, such as a biopsy, is necessary to determine the nature of the mass. The PRETEXT staging indicates that the disease is locally advanced, but it does not necessarily mean that the disease is metastatic. Therefore, the report does not provide enough information to definitively conclude whether the mass is malignant or benign. It is important to consider all possible explanations before making a final diagnosis.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes a large heterogeneous hepatic mass with elevated AFP in a patient with a history of hepatoblastoma, staged as PRETEXT stage II. While the presence of a mass and elevated AFP are concerning, the report does not definitively state that the mass is malignant. The patient's history of hepatoblastoma suggests the possibility of recurrence, but other etiologies for the mass and elevated AFP should be considered. Further investigation, such as a biopsy, is necessary to determine the nature of the mass. The PRETEXT staging indicates that the disease is locally advanced, but it does not necessarily mean that the disease is metastatic. Therefore",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T19:00:55.883720"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion that the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no malignancy present. The chest radiograph is normal, and no mass is identified. The patient has no prior history of oncology, and the doctor has provided reassurance.\",\n  \"justification\": \"The report explicitly states that there is no malignancy identified. The findings are normal, and there are no abnormal masses or other concerning features. The doctor's reassurance further supports the conclusion",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T19:00:55.883732"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size on follow-up\"\n  ],\n  \"further_investigation_needed\": false\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Reactive lymphadenopathy secondary to viral infection\",\n    \"Decreasing node size",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T19:00:55.883741"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Germ Cell Tumor\",\n  \"suspicion\": \"Yolk sac tumor\",\n  \"alternative_explanations\": [\n    \"Benign cystic mass\",\n    \"Inflammatory process\",\n    \"Other non-cancerous conditions\"\n  ],\n  \"justification\": \"The report mentions a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. While these findings are suggestive of a Germ Cell Tumor, particularly a Yolk Sac Tumor, it's crucial to consider that these markers can be elevated in benign conditions. The report also notes that the mass is in the sacrococcygeal region, which is a common location for benign cysts and masses. Furthermore, the report indicates the patient is a child, which could point towards a benign etiology. The report does not explicitly rule out benign explanations, so it's essential to consider them before concluding that the findings are indicative of malignancy. The report also recommends an MDT discussion and treatment planning, which suggests that the possibility of malignancy is being taken seriously, but it doesn't automatically confirm it. Therefore, while the findings are concerning, it's important to consider alternative explanations before reaching a definitive conclusion. It is important to note that the presence of yolk sac tumor elements is highly suggestive of malignancy. However, the report does not provide sufficient information to rule out the possibility of a benign condition.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Germ Cell Tumor\",\n  \"suspicion\": \"Yolk sac tumor\",\n  \"alternative_explanations\": [\n    \"Benign cystic mass\",\n    \"Inflammatory process\",\n    \"Other non-cancerous conditions\"\n  ],\n  \"justification\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. While these findings are suggestive of a Germ Cell Tumor, particularly a Yolk Sac Tumor, it's crucial to consider that these markers can be elevated in benign conditions. The report also notes that the mass is in the sacrococcygeal region, which is a common location for benign cysts and masses. Furthermore, the report indicates the patient is a child, which could point towards a benign etiology. The report does not explicitly rule out benign explanations,",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T19:00:55.883770"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n  \"malignancy_assessment\": \"The report suggests a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements. These findings are highly suggestive of a Germ Cell Tumor, specifically a Yolk Sac Tumor. Given the patient's history of suspected Germ Cell Tumor and the presence of these specific tumor markers, the suspicion of malignancy is high.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of malignancy, it is important to consider the possibility of a reactive process or a benign condition that mimics a germ cell tumor. For example, a benign cystic mass could be mistaken for a yolk sac tumor, or elevated tumor markers could be due to an inflammatory process. However, the presence of yolk sac tumor elements and the clinical context of a suspected germ cell tumor make these alternative explanations less likely.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report indicates a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. This constellation of findings strongly suggests a germ cell tumor, specifically a yolk sac tumor. The elevated tumor markers further support this diagnosis. Therefore, the suspicion of malignancy is high.\",\n  \"alternative_explanations\": \"Although the findings are highly suggestive of malignancy, it's crucial to consider that a reactive process or a benign condition could mimic a germ cell tumor. For example, a benign cystic mass could be misdiagnosed as a yolk sac tumor, or elevated tumor markers could be due to an inflammatory response. However, the presence of yolk sac tumor elements and the clinical context of a suspected germ cell tumor make these alternative explanations less probable.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes a sacrococcygeal mass with mixed solid and cystic components, elevated AFP and beta-hCG, and the presence of yolk sac tumor elements. These findings are highly suggestive of a germ cell tumor, specifically a yolk sac tumor. The elevated tumor markers further support this diagnosis. Therefore, the suspicion of malignancy is high.\",\n  \"alternative_explanations\": \"While the findings strongly suggest malignancy, it is important to consider that a reactive process or a benign condition could potentially mimic a germ cell tumor. For instance, a benign cystic mass could be misdiagnosed as a yolk sac tumor",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T19:00:55.883790"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"severity\": \"Malignant\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'. The clinical history also indicates 'Rhabdomyosarcoma'. The presence of a 'parameningeal mass with intracranial extension' further supports the diagnosis of a malignant tumor. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy.\",\n  \"alternative_explanations\": \"While the report strongly suggests malignancy, it's important to consider that the clinical context (paediatric oncology assessment) and the presence of a mass with intracranial extension are highly suggestive. However, it's crucial to rule out any other potential causes for the findings, such as a rare benign tumor or a reactive process. Further investigation and specialist consultation are warranted to confirm the diagnosis and rule out alternative possibilities.\",\n  \"further_investigation\": \"Further investigations may include imaging studies (MRI, CT scan) to assess the extent of the tumor and to rule out other potential causes. A multidisciplinary team (MDT) discussion is recommended to determine the best course of treatment.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"severity\": \"Benign\",\n  \"justification\": \"The report indicates that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy. However, the report also states that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy. However, the report also states that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the need for MDT discussion and treatment planning, which is typical for a confirmed malignancy. However, the report also states that the findings are 'Embryonal rhabdomyosarcoma on biopsy'. The report also mentions that 'PAX-FOXO1 fusion negative'. The report also mentions the",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T19:00:55.883815"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. The brain MRI was normal, and no mass lesions or abnormal enhancement were found. Headaches are attributed to migraine, which is not a malignancy. Therefore, there is no evidence to suggest malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to other causes unrelated to malignancy.\",\n    \"The absence of a mass lesion on the brain MRI does not definitively rule out malignancy, as some cancers may not present as mass lesions.\"\n  ],\n  \"conclusion\": \"No malignancy identified. The patient is reassured.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. The brain MRI was normal, and no mass lesions or abnormal enhancement were found. Headaches are attributed to migraine, which is not a malignancy. Therefore, there is no evidence to suggest malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to other causes unrelated to malignancy.\",\n    \"The absence of a mass lesion on the brain MRI does not definitively rule out malignancy, as some cancers may not present as mass lesions.\"\n  ],\n  \"conclusion\": \"No malignancy identified. The patient is reassured.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. The brain MRI was normal, and no mass lesions or abnormal enhancement were found. Headaches are attributed to migraine, which is not a malignancy. Therefore, there is no evidence to suggest malignancy.\",\n  \"alternative_explanations\": [\n    \"The patient's headaches could be due to other causes unrelated to malignancy.\",\n    \"The absence of a mass lesion on the brain MRI does not definitively rule out malignancy, as some cancers may not present as mass lesions.\"\n  ],\n  \"conclusion\": \"No malignancy identified. The patient is reassured.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No malignancy identified\"\n  ],\n  \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T19:00:55.883832"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report describes post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No malignancy identified. The report indicates post-viral lymphocytosis with resolving atypical lymphocytes and a positive Monospot test confirming EBV infection. The presence of a viral infection and resolution of atypical lymphocytes are strong indicators that the findings are not malignant.\"\n}\n```\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T19:00:55.883841"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow biopsy. The findings are consistent with reactive lymphadenopathy secondary to a viral infection, which is decreasing in size. The report also provides reassurance to the patient.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that there is no evidence of malignancy in the bone marrow",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T19:00:55.883850"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood counts have normalized. There is no evidence of organomegaly, and the patient has clinically improved. The report explicitly states that no malignancy was identified. Therefore, the most likely conclusion is that the patient is not currently experiencing any malignancy. The resolved febrile illness and normalization of blood counts support this conclusion.\",\n  \"malignancy_assessment\": \"No malignancy identified. Clinical improvement and normalization of blood counts suggest resolution of a previous illness.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that the patient's previous febrile illness has resolved, and their blood",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T19:00:55.883876"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection. No malignancy is identified. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that reactive lymphadenopathy is present, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy, and no malignancy is identified. The nodes are decreasing in size, and there are no atypical features. Therefore, the patient does not have cancer.\"\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T19:00:55.883884"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report describes a patient with a history of retinoblastoma, confirmed by imaging and genetic testing. The presence of an intraocular mass with calcifications and bilateral disease, along with a positive family history and a detected RB1 germline mutation, strongly suggests retinoblastoma. While the report does not explicitly state the stage or extent of the disease, the description of the mass and bilateral involvement indicates a significant and potentially aggressive form of the disease. Given the patient's age (paediatric oncology assessment) and the presence of a germline mutation, the diagnosis is highly likely. The report also recommends MDT discussion and treatment planning, further supporting the diagnosis of retinoblastoma. While benign explanations are possible, the combination of findings makes malignancy the most probable diagnosis.\",\n  \"malignancy_likelihood\": \"High\",\n  \"benign_explanation_possible\": \"No\",\n  \"alternative_diagnosis_possible\": \"No\",\n  \"stage_and_extent\": \"Unknown\",\n  \"conclusion\": \"The report strongly suggests retinoblastoma, likely a significant and aggressive form given the patient's age, bilateral involvement, and presence of a germline mutation. Further evaluation and treatment planning are warranted.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a patient with a history of retinoblastoma, confirmed by imaging and genetic testing. The presence of an intraocular mass with calcifications and bilateral disease, along with a positive family history and a detected RB1 germline mutation, strongly suggests retinoblastoma. While the report does not explicitly state the stage or extent of the disease, the description of the mass and bilateral involvement indicates a significant and potentially aggressive form of the disease. Given the patient's age (paediatric oncology assessment) and the presence of a germline mutation, the diagnosis is highly likely. The report also recommends MDT discussion and treatment planning, further supporting the diagnosis of retinoblastoma. While benign explanations are possible, the combination of findings makes malignancy the most probable diagnosis.\",\n  \"malignancy_likelihood\": \"High\",\n  \"benign_explanation_possible\": \"No\",\n  \"alternative_diagnosis_possible\": \"No\",\n  \"stage_and_extent\": \"Unknown\",\n  \"conclusion\": \"The report strongly suggests retinoblastoma, likely a significant and aggressive form given the patient's age, bilateral involvement, and presence of a germline mutation",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T19:00:55.883910"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": \"The report suggests Stage III Neuroblastoma, which is a malignant tumor. The presence of a heterogeneous mass, calcifications, MIBG avidity, and elevated urinary catecholamines are all concerning for malignancy. The report recommends MDT discussion and treatment planning, further supporting the diagnosis of malignancy.\",\n  \"alternative_explanations\": [\n    \"The heterogeneous mass could be a benign tumor with calcifications. While calcifications are more common in malignant tumors, they can also occur in benign ones.\",\n    \"MIBG avidity is a marker for neuroendocrine tumors, which can be both benign and malignant. It is not specific to neuroblastoma.\",\n    \"Elevated urinary catecholamines can be caused by various factors, including benign conditions such as pheochromocytoma. While neuroblastoma is a common cause, other causes should be considered.\",\n    \"Stage III disease is a serious finding, but it can be associated with both benign and malignant conditions. The staging criteria may not be fully understood.\"\n  ],\n  \"final_judgement\": \"The report strongly suggests malignancy, specifically Stage III Neuroblastoma, due to the combination of the heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. However, further investigation is needed to confirm the diagnosis and rule out alternative explanations. The alternative explanations should be considered before making a final judgement.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous suprarenal mass with calcifications\",\n    \"MIBG avidity present\",\n    \"Elevated urinary catecholamines\",\n    \"Stage III disease\"\n  ],\n  \"malignancy_assessment\": \"The report suggests Stage III Neuroblastoma, which is a malignant tumor. The presence of a heterogeneous mass, calcifications, MIBG avidity, and elevated urinary catecholamines are all concerning for malignancy. The report recommends MDT discussion and treatment planning, further supporting the diagnosis of malignancy.\",\n  \"alternative_explanations\": [\n    \"The heterogeneous mass could be a benign tumor with calcifications. While calcifications are more common in malignant tumors, they can also occur in benign ones.\",\n",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T19:00:55.883944"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is normal, and there are no blast cells present. The findings are reassuring and provide no indication of malignancy. Therefore, no further action is required at this time.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates no malignancy was identified. The patient's CBC is",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T19:00:55.883952"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, a type of cancer, in the bone marrow. The presence of a parameningeal mass with intracranial extension is also mentioned. However, the report also states that the PAX-FOXO1 fusion is negative, which is important information. The clinical context suggests a possible rhabdomyosarcoma, and the biopsy confirms the diagnosis. The recommendation for MDT discussion and treatment planning is also important. The report mentions the bone pain and the suspicion of rhabdomyosarcoma, which are relevant clinical factors. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of",
      "predicted": null,
      "ground_truth": true,
      "correct": null,
      "reasoning": "```json\n{\n  \"assessment\": \"The report indicates the presence of embryonal rhabdomyosarcoma, a type of cancer, in the bone marrow. The presence of a parameningeal mass with intracranial extension is also mentioned. However, the report also states that the PAX-FOXO1 fusion is negative, which is important information. The clinical context suggests a possible rhabdomyosarcoma, and the biopsy confirms the diagnosis. The recommendation for MDT discussion and treatment planning is also important. The report mentions the bone pain and the suspicion of rhabdomyosarcoma, which are relevant clinical factors. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of cancer. The negative PAX-FOXO1 fusion result is important for treatment planning. The clinical context of bone pain and suspicion of rhabdomyosarcoma is also relevant. The report recommends MDT discussion and treatment planning, which is also important. The report does not mention any benign findings. Therefore, based on the information provided, the most likely diagnosis is embryonal rhabdomyosarcoma, which is a type of",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T19:00:55.884047"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates that a bone marrow biopsy was performed to rule out malignancy. However, the findings are normal, and no malignancy is identified. The chest radiograph is also clear, and there is no evidence of a mediastinal mass. The heart size is normal. Therefore, the report provides reassurance that no malignancy is present. The patient has no previous oncology history.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"The bone marrow biopsy was performed due to a concern about malignancy, but the biopsy itself was normal.\",\n    \"The patient's symptoms, if any, are not related to malignancy.\"\n  ],\n  \"final_conclusion\": \"No malignancy is identified in the bone marrow biopsy or chest radiograph. The patient is reassured.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that a bone marrow biopsy was performed to rule out malignancy. The findings are normal, and no malignancy is identified. The chest radiograph is also clear, and there is no evidence of a mediastinal mass. The heart size is normal. Therefore, the report provides reassurance that no malignancy is present. The patient has no previous oncology history.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"The bone marrow biopsy was performed due to a concern about malignancy, but the biopsy itself was normal.\",\n    \"The patient's symptoms, if any, are not related to malignancy.\"\n  ],\n  \"final_conclusion\": \"No malignancy is identified in the bone marrow biopsy or chest radiograph. The patient is reassured.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates that a bone marrow biopsy was performed to rule out malignancy. The findings are normal, and no malignancy is identified. The chest radiograph is also clear, and there is no evidence of a mediastinal mass. The heart size is normal. Therefore, the report provides reassurance that no malignancy is present. The patient has no previous oncology history.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"The bone marrow biopsy was performed due to a concern about malignancy, but the biopsy itself was normal.\",\n    \"The patient's symptoms, if any, are not related to malignancy.\"\n  ],\n  \"final_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T19:00:55.884065"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"intraocular mass with calcifications\",\n    \"bilateral disease\",\n    \"family history positive\",\n    \"RB1 germline mutation detected\"\n  ],\n  \"malignancy_assessment\": \"The report indicates a possible retinoblastoma, which is a type of eye cancer. The presence of an intraocular mass with calcifications, bilateral disease, positive family history, and an RB1 germline mutation are all concerning findings that support a diagnosis of retinoblastoma. The recommendation for MDT discussion and treatment planning further reinforces the suspicion of malignancy.\",\n  \"skeptical_reasoning\": \"While the findings are concerning, it is important to consider alternative explanations. The intraocular mass could be a benign tumor, such as a hamartoma or a tumor of non-malignant origin. Bilateral disease could be due to a non-malignant condition affecting both eyes. A positive family history does not automatically indicate malignancy, as it could be due to a genetic predisposition to a non-malignant condition. The RB1 germline mutation is associated with retinoblastoma, but it could also be associated with other conditions. It is important to gather more information about the patient's symptoms and perform further investigations to confirm the diagnosis of retinoblastoma and rule out other possibilities.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"intraocular mass with calcifications\",\n    \"bilateral disease\",\n    \"family history positive\",\n    \"RB1 germline mutation detected\"\n  ],\n  \"malignancy_assessment\": \"The report indicates a possible retinoblastoma, which is a type of eye cancer. The presence of an intraocular mass with calcifications, bilateral disease, positive family history, and an RB1 germline mutation are all concerning findings that support a diagnosis of retinoblastoma. The recommendation for MDT discussion and treatment planning further reinforces the suspicion of malignancy.\",\n  \"skeptical_reasoning\": \"The report suggests a possible retinoblastoma. However, it is important to consider whether the findings are truly indicative of malignancy. The intraocular mass could be a benign tumor, such as a hamartoma. Bilateral disease could be due to a non-malignant condition affecting both eyes. A positive family history does not automatically indicate malignancy, as it could be due to a genetic predisposition to a non-malignant condition. The",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T19:00:55.884092"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report suggests a diagnosis of Classical Hodgkin Lymphoma. However, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment planning, rather than a definitive diagnosis. Further investigation is required to confirm the diagnosis and determine the optimal treatment strategy. It is possible that the findings could be due to a benign condition, although the report states that the findings are consistent with Classical Hodgkin Lymphoma. Therefore, it is important to consider the possibility that the findings are not malignant.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a diagnosis of Classical Hodgkin Lymphoma. While the findings are concerning, it is important to consider that the report is a recommendation for further discussion and treatment",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T19:00:55.884106"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Embryonal rhabdomyosarcoma\",\n  \"justification\": \"The report explicitly states 'Embryonal rhabdomyosarcoma on biopsy'.\",\n  \"alternative_explanations\": [\n    \"The mass could be a benign tumor with similar imaging characteristics.\",\n    \"The biopsy result might be inaccurate.\"\n  ],\n  \"conclusion\": \"The report indicates the presence of embryonal rhabdomyosarcoma, which is a malignant tumor. Further investigation is needed to confirm the diagnosis and treatment plan.\"\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T19:00:55.884119"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"Physiological splenomegaly\",\n    \"Benign findings\"\n  ],\n  \"final_conclusion\": \"No malignancy identified.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates no malignancy was identified. Physiological splenomegaly is a common finding in children and does not raise suspicion for malignancy. The normal echo texture further supports this conclusion. The reassurance provided is appropriate.\",\n  \"malignancy_likelihood\": \"Very low\",\n  \"alternative_explanations\": [\n    \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T19:00:55.884131"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive.\",\n  \"malignancy_assessment\": \"The report explicitly mentions 'Ewing Sarcoma' and 'EWSR1 fusion positive'. These findings strongly suggest malignancy. The presence of 'permeative bone destruction' and 'onion-skin periosteal reaction' are also indicative of a malignant process.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Ewing Sarcoma, it is important to consider that other rare bone tumors or metastatic disease could present with similar features. However, the combination of findings and the patient's history (Ewing Sarcoma) makes this less likely.\",\n  \"final_judgment\": \"The report strongly suggests the presence of Ewing Sarcoma. Further investigation and confirmation are necessary, but the current evidence is highly concerning for malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive.\",\n  \"malignancy_assessment\": \"The report explicitly mentions 'Ewing Sarcoma' and 'EWSR1 fusion positive'. These findings strongly suggest malignancy. The presence of 'permeative bone destruction' and 'onion-skin periosteal reaction' are also indicative of a malignant process.\",\n  \"alternative_explanations\": \"While the findings are highly suggestive of Ewing Sarcoma, it is important to consider that other rare bone tumors or metastatic disease could present with similar features. However, the combination of findings and the patient's history (Ewing Sarcoma) makes this less likely.\",\n  \"final_judgment\": \"The report strongly suggests the presence of Ewing Sarcoma. Further investigation and confirmation are necessary, but the current evidence is highly concerning for malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive.\",\n  \"malignancy_assessment\": \"The report explicitly mentions 'Ewing Sarcoma' and 'EWSR1 fusion positive'. These findings strongly suggest malignancy. The presence of 'permeative bone destruction' and 'onion-skin periosteal reaction' are also indicative",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T19:00:55.884151"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates reactive lymphadenopathy secondary to a viral infection, with no evidence of malignancy. The node size is decreasing on follow-up, and there are no atypical features. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that reactive lymphadenopathy secondary to a viral infection was found. No atypical features were noted, and no malignancy was identified. The node size is decreasing on follow-up. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, likely due to a viral infection, with no evidence of malignancy. The node size is decreasing, and there are no atypical features. The report provides reassurance. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that reactive lymphadenopathy is present, which is a common finding and not necessarily indicative of malignancy. No atypical features are mentioned, and the node size is decreasing. The report provides reassurance. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the presence of reactive lymphadenopathy, which is a benign condition. No atypical features are observed, and the node size is decreasing. The report provides reassurance, and the findings do not suggest malignancy. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes reactive lymphadenopathy, likely caused by a viral infection. No atypical features are identified, and the node size is decreasing on follow-up. The report provides reassurance, and the findings do not suggest malignancy. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that reactive lymphadenopathy is present, which is a common finding and does not necessarily indicate malignancy. No atypical features are mentioned, and the node size is decreasing on follow-up. The report provides reassurance. Therefore, the findings are reassuring and do not suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the presence of reactive lymphadenopathy, which is a benign condition. No atypical features are observed, and the node",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T19:00:55.884160"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n  \"patient_history\": \"Benign presentation. No previous oncology history.\",\n  \"lab_results\": {\n    \"cbc\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits.\",\n    \"malignancy\": \"No malignancy identified.\"\n  },\n  \"imaging_findings\": \"No malignancy identified.\",\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_assessment\": {\n    \"is_malignancy_likely\": false,\n    \"reason\": \"The report explicitly states that no malignancy is identified. The CBC is normal, and there are no blast cells. Therefore, it is highly unlikely that the patient has cancer.\"\n  }\n}\n```\n```json\n{\n  \"patient_history\": \"Benign presentation. No previous oncology history.\",\n  \"lab_results\": {\n    \"cbc\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits.\",\n    \"malignancy\": \"No malignancy identified.\"\n  },\n  \"imaging_findings\": \"No malignancy identified.\",\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_assessment\": {\n    \"is_malignancy_likely\": false,\n    \"reason\": \"The report explicitly states that no malignancy is identified. The CBC is normal, and there are no blast cells. Therefore, it is highly unlikely that the patient has cancer.\"\n  }\n}\n```\n```json\n{\n  \"patient_history\": \"Benign presentation. No previous oncology history.\",\n  \"lab_results\": {\n    \"cbc\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits.\",\n    \"malignancy\": \"No malignancy identified.\"\n  },\n  \"imaging_findings\": \"No malignancy identified.\",\n  \"diagnosis\": \"No malignancy identified. Reassurance provided.\",\n  \"skeptical_assessment\": {\n    \"is_malignancy_likely\": false,\n    \"reason\": \"The report explicitly states that no malignancy is identified. The CBC is normal, and there are no blast cells. Therefore, it is highly unlikely that the patient has cancer.\"\n  }\n}\n```\n```json\n{\n  \"patient_history\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T19:00:55.884177"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified. The report explicitly states that there are no pathological features and no malignancy was identified. The healing fracture is described as a normal process.\",\n  \"alternative_explanations\": [\n    \"The fracture is healing normally, and there are no pathological features that indicate malignancy.\",\n    \"The bone density is normal, and there is no evidence of metastatic disease.\"\n  ],\n  \"final_conclusion\": \"The report indicates that the healing fracture is normal and there is no evidence of malignancy. The bone density is normal. Therefore, malignancy is ruled out.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"no pathological features\",\n  \"malignancy_assessment\": \"The report states that there are no pathological features, which is a key indicator that malignancy is not present.\",\n  \"alternative_explanations\": [\n    \"The absence of pathological features could be due to the healing process of the fracture.\",\n    \"The bone density is normal, and there is no evidence of metastatic disease.\"\n  ],\n  \"final_conclusion\": \"Given that the report explicitly states there are no pathological features and no malignancy is identified, the conclusion is that malignancy is ruled out.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"no malignancy identified\",\n  \"malignancy_assessment\": \"The report explicitly states that no malignancy was identified. This is the most important piece of information.\",\n  \"alternative_explanations\": [\n    \"The absence of malignancy could be due to the healing process of the fracture.\",\n    \"The bone density is normal, and there is no evidence of metastatic disease.\"\n  ],\n  \"final_conclusion\": \"The report indicates that no malignancy was identified. Therefore, the conclusion is that malignancy is ruled out.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"bone density normal\",\n  \"malignancy_assessment\": \"A normal bone density makes the presence of malignancy less likely.\",\n  \"alternative_explanations\": [\n    \"The normal bone density could be due to the healing process of the fracture.\",\n    \"The absence of malignancy could be due to the healing process of the fracture.\"\n  ],\n  \"final_conclusion\": \"The normal bone density makes malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T19:00:55.884193"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n  \"malignancy_assessment\": \"The report describes bone marrow infiltration with lymphoblasts, consistent with Acute Lymphoblastic Leukemia (ALL). The immunophenotyping is also consistent with B-cell ALL. CNS involvement is negative.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a reactive process, although this is less likely given the high percentage of lymphoblasts.\",\n    \"The bone marrow infiltration could be due to a different hematologic malignancy, although ALL is the most likely diagnosis based on the information provided.\",\n    \"The CNS involvement could be negative due to early stage disease or the presence of a treatment that has effectively suppressed the disease in the CNS.\"\n  ],\n  \"conclusion\": \"Based on the report, the findings are highly suggestive of Acute Lymphoblastic Leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a reactive process, although this is less likely given the high percentage of lymphoblasts.\",\n    \"The bone marrow infiltration could be due to a different hematologic malignancy, although ALL is the most likely diagnosis based on the information provided.\",\n    \"The CNS involvement could be negative due to early stage disease or the presence of a treatment that has effectively suppressed the disease in the CNS.\"\n  ],\n  \"conclusion\": \"Based on the report, the findings are highly suggestive of Acute Lymphoblastic Leukemia (ALL). Further investigation and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"malignancy_assessment\": \"The report describes bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a reactive process, although this is less likely given the high percentage of lymphoblasts.\",\n    \"The bone marrow infiltration could be due to a different hematologic malignancy, although ALL is the most likely diagnosis based on the information provided.\",\n    \"The CNS involvement could be negative due to early stage disease or the",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T19:00:55.884213"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates post-viral lymphocytosis with atypical lymphocytes resolving, confirmed by a positive monospot and EBV serology. No malignancy is identified. The report provides reassurance.\"\n}\n```\n```json",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T19:00:55.884221"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"Physiological splenomegaly for age\",\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"Physiological splenomegaly for age\",\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",\n    \"Normal echo texture\"\n  ],\n  \"malignancy_assessment\": {\n    \"assessment\": \"No malignancy identified\",\n    \"alternative_explanations\": [\n      \"No focal lesions\",\n      \"Normal echo texture\"\n    ],\n    \"conclusion\": \"Benign finding\"\n  }\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"No focal lesions\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T19:00:55.884232"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Lipoma\",\n  \"justification\": \"The report explicitly states that a benign soft tissue mass, confirmed as a lipoma, was found. The lipoma is well-circumscribed, shows no enhancement, and no intervention is required. Malignancy is explicitly ruled out.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report indicates a benign soft tissue mass, specifically a lipoma. The description of the lipoma (well-circumscribed, no enhancement) further supports a benign diagnosis. The report explicitly states that no malignancy was identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report explicitly states that a benign soft tissue mass, confirmed as a lipoma, was found. The lipoma is well-circumscribed, shows no enhancement, and no intervention is required. Malignancy is explicitly ruled out. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report describes a benign soft tissue mass, confirmed as a lipoma. The lipoma is well-circumscribed and shows no enhancement. The report explicitly states that no malignancy was identified. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report states that a benign soft tissue mass, confirmed as a lipoma, was found. The lipoma is described as well-circumscribed and showing no enhancement. The report explicitly states that no malignancy was identified. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report indicates a benign soft tissue mass, confirmed as a lipoma. The description of the lipoma (well-circumscribed, no enhancement) further supports a benign diagnosis. The report explicitly states that no malignancy was identified.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Benign\",\n  \"justification\": \"The report describes a benign soft tissue mass, confirmed as a lipoma. The lipoma is well-circumscribed and shows no enhancement. The report explicitly states that no malignancy was identified. Therefore, the diagnosis is benign.\"\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T19:00:55.884241"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"No vascular invasion\",\n    \"Favorable histology on biopsy\",\n    \"Stage II\"\n  ],\n  \"malignancy_assessment\": \"The report indicates a large heterogeneous left renal mass with a pseudocapsule, no vascular invasion, and favorable histology. The stage is II. The report recommends MDT discussion and treatment planning.  The presence of a mass and the recommendation for treatment planning suggest a potential malignancy, but the 'favorable histology' and 'no vascular invasion' are reassuring. The stage II is also important.  Given the 'favorable histology', it is less likely to be a high-grade malignancy. The absence of vascular invasion is a positive prognostic factor.  The stage II suggests a localized disease, which is also a positive prognostic factor.\",\n  \"skeptical_reasoning\": \"While the report describes a renal mass with features suggestive of malignancy, the 'favorable histology' and 'no vascular invasion' are crucial pieces of information. These findings suggest a less aggressive tumor. The stage II also suggests a localized disease, which is a positive prognostic factor. Further investigation, such as immunohistochemistry, might be needed to confirm the diagnosis and grade of the tumor.  It is important to consider the patient's clinical context and other imaging findings to fully assess the risk. The recommendation for MDT discussion and treatment planning is standard practice in this scenario, but it does not automatically confirm malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": [\n    \"large heterogeneous left renal mass with pseudocapsule\",\n    \"No vascular invasion\",\n    \"Favorable histology on biopsy\",\n    \"Stage II\"\n  ],\n  \"malignancy_assessment\": \"The report describes a large, heterogeneous left renal mass with a pseudocapsule. The absence of vascular invasion and favorable histology on biopsy are important findings. The stage is II. The report recommends MDT discussion and treatment planning.  The presence of a mass and the recommendation for treatment planning suggest a potential malignancy, but the 'favorable histology' and 'no vascular invasion' are reassuring. The stage II is also important.  Given the 'favorable histology', it is less likely to be a high-grade malignancy. The absence of vascular invasion is a positive prognostic factor. The stage II suggests a localized disease, which is also a",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T19:00:55.884272"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Osteosarcoma\",\n  \"justification\": \"The report mentions a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are characteristic findings of osteosarcoma. Elevated alkaline phosphatase also supports this diagnosis.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to other bone tumors, such as Ewing sarcoma or chondrosarcoma, although these are less likely given the presence of sunburst periosteal reaction.\",\n    \"The findings could be due to a benign condition, such as a bone infection or a reactive process.\",\n    \"The findings could be due to a metastatic lesion from another primary cancer.\"\n  ],\n  \"conclusion\": \"While the findings are suggestive of osteosarcoma, further investigation is needed to confirm the diagnosis. An MDT discussion and treatment planning are recommended.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Osteosarcoma\",\n  \"justification\": \"The report indicates a destructive lesion in the distal femur with soft tissue component and sunburst periosteal reaction, which are classic features of osteosarcoma. The elevated alkaline phosphatase also points towards bone turnover, consistent with tumor activity.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign process, such as a reactive bone lesion or a non-neoplastic inflammatory condition. However, the presence of a soft tissue component and sunburst periosteal reaction makes this less likely.\",\n    \"It is possible that the findings represent a metastatic lesion from another primary cancer, but this is less likely given the location in the distal femur.\"\n  ],\n  \"conclusion\": \"The findings are highly suggestive of osteosarcoma. Further investigation, including imaging studies and potentially a biopsy, is necessary to confirm the diagnosis and rule out other possibilities.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Osteosarcoma\",\n  \"justification\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and sunburst periosteal reaction. Elevated alkaline phosphatase is also noted. These findings are highly suggestive of osteosarcoma.\",\n  \"alternative_explanations\": [\n    \"The findings could be due to a benign condition, such as a reactive bone lesion or a non-neoplastic inflammatory process. However, the presence of a soft tissue component and sunburst periosteal reaction makes",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T19:00:55.884291"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report explicitly states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report explicitly states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The healing fracture is described as normal, and bone density is normal. The trauma history is consistent with the findings. Therefore, there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"No malignancy identified.\",\n  \"reasoning\": \"The report states that the MRI was performed for a benign presentation, and no pathological features were identified. The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T19:00:55.884301"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence of malignancy. Routine surveillance is appropriate.\"\n}\n```\n```json\n{\n  \"conclusion\": \"No evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T19:00:55.884306"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, consistent with a fetal histology subtype of hepatoblastoma. The stage is II, and the report recommends MDT discussion and treatment planning. The findings are suggestive of malignancy.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": \"While the findings are suggestive of hepatoblastoma, it's important to consider alternative explanations. Elevated AFP can be seen in other conditions, and the heterogeneous appearance could be due to other liver diseases. The stage II classification suggests a localized disease, but metastasis cannot be completely ruled out without further investigation.\",\n  \"final_judgement\": \"The report is highly suggestive of hepatoblastoma. Further investigation, including biopsy and MDT discussion, is recommended to confirm the diagnosis and plan treatment. However, the possibility of alternative explanations should be considered.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, consistent with a fetal histology subtype of hepatoblastoma. The stage is II, and the report recommends MDT discussion and treatment planning. The findings are suggestive of malignancy.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": \"While the findings are suggestive of hepatoblastoma, it's important to consider alternative explanations. Elevated AFP can be seen in other conditions, and the heterogeneous appearance could be due to other liver diseases. The stage II classification suggests a localized disease, but metastasis cannot be completely ruled out without further investigation.\",\n  \"final_judgement\": \"The report is highly suggestive of hepatoblastoma. Further investigation, including biopsy and MDT discussion, is recommended to confirm the diagnosis and plan treatment. However, the possibility of alternative explanations should be considered.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a large heterogeneous hepatic mass with elevated AFP, consistent with a fetal histology subtype of hepatoblastoma. The stage is II, and the report recommends MDT discussion and treatment planning. The findings are suggestive of malignancy.\",\n  \"malignancy_likelihood\": \"High\",\n  \"alternative_explanations\": \"While the findings are suggestive of hepatoblastoma, it's important to consider alternative explanations. Elevated AFP can be seen in other conditions, and the heterogeneous appearance could be due to other liver diseases. The stage II classification suggests a localized disease, but metastasis",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T19:00:55.884327"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates the presence of myeloblasts, a cytogenetic translocation t(8;21), and a favorable risk category. These findings are suggestive of Acute Myeloid Leukemia (AML). However, the report also mentions that the myeloblasts account for 70% of marrow cellularity and the patient is a child. While the presence of myeloblasts and a translocation are concerning, the relatively low percentage of myeloblasts and the favorable risk category suggest that the disease might be indolent or potentially curable with appropriate treatment. Further investigation and discussion with the Multidisciplinary Team (MDT) are warranted to confirm the diagnosis and determine the optimal treatment plan. It's crucial to consider that the report is a preliminary assessment, and a definitive diagnosis requires further investigations and analysis. Therefore, while the findings are concerning, they do not automatically confirm malignancy. A more detailed evaluation is needed to rule out any possibility of benign explanations for the abnormal findings.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates the presence of myeloblasts, a cytogenetic translocation t(8;21), and a favorable risk category. These findings are suggestive of Acute Myeloid Leukemia (AML). However, the report also mentions that the myeloblasts account for 70% of marrow cellularity and the patient is a child. While the presence of myeloblasts and a translocation are concerning, the relatively low percentage of myeloblasts and the favorable risk category suggest that the disease might be indolent or potentially curable with appropriate treatment. Further investigation and discussion with the Multidisciplinary Team (MDT) are warranted to confirm the diagnosis and determine the optimal treatment plan. It's crucial to consider that the report is a preliminary assessment, and a definitive diagnosis requires further investigations and analysis. Therefore, while the findings are concerning, they do not automatically confirm malignancy. A more detailed evaluation is needed to rule out any possibility of benign explanations for the abnormal findings.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates the presence of myeloblasts, a cytogenetic translocation t(8;21), and a favorable risk category. These findings are suggestive of Acute Myeloid Leukemia (AML). However, the report also mentions that the myeloblasts account for 70% of marrow cellularity and the patient is a child. While the presence of myeloblasts and a translocation are concerning, the relatively low percentage of myeloblasts and the favorable risk category",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T19:00:55.884349"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report indicates a left renal mass with favorable histology and Stage II. While the report mentions Wilms Tumor, the biopsy shows favorable histology and no vascular invasion. Given the favorable histology and the absence of vascular invasion, it's likely that the patient is responding well to treatment. Therefore, the report does not provide enough evidence to suggest malignancy. The report recommends MDT discussion and treatment planning, which is a standard approach for Wilms Tumor.\",\n  \"conclusion\": \"The report suggests a favorable response to treatment and does not provide enough evidence to indicate malignancy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report mentions pancytopenia and a suspected Wilms Tumor. The bone marrow biopsy reveals a large heterogeneous left renal mass with pseudocapsule, but no vascular invasion. The histology is described as favorable. Given the favorable histology and the absence of vascular invasion, it is less likely that the renal mass is malignant. Pancytopenia could be related to the tumor itself or to treatment.\",\n  \"conclusion\": \"The renal mass is likely not malignant, based on the favorable histology and absence of vascular invasion. Pancytopenia may be related to the tumor or treatment.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a large heterogeneous left renal mass with pseudocapsule. The biopsy shows favorable histology and no vascular invasion. The report mentions pancytopenia, which could be related to the tumor or treatment. The report concludes that the patient should be discussed in MDT and treatment planning should be done. The report suggests a favorable response to treatment and does not provide enough evidence to indicate malignancy.\",\n  \"conclusion\": \"The renal mass is likely not malignant, based on the favorable histology and absence of vascular invasion. Pancytopenia may be related to the tumor or treatment.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report describes a left renal mass with favorable histology and no vascular invasion. The report mentions pancytopenia, which could be related to the tumor or treatment. The report concludes that the patient should be discussed in MDT and treatment planning should be done. The report suggests a favorable response to treatment and does not provide enough evidence to indicate malignancy.\",\n  \"conclusion\": \"The renal mass is likely not malignant, based on the favorable histology and absence of vascular invasion. Pancytopenia may be related to the tumor or treatment.\"\n}\n```\n```json\n{",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T19:00:55.884364"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy shows infiltration with lymphoblasts comprising 85% of nucleated cells, which is consistent with Acute Lymphoblastic Leukemia (ALL). The immunophenotyping is also consistent with B-cell ALL. CNS involvement is negative. The report recommends MDT discussion and treatment planning.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy reveals a high percentage of lymphoblasts (85%), which is a hallmark of Acute Lymphoblastic Leukemia (ALL). The immunophenotyping further confirms this diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy shows infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping is consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The bone marrow biopsy shows infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping is consistent with B-cell ALL. CNS involvement is negative. Recommend MDT discussion and treatment planning.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Acute Lymphoblastic Leukemia\",\n  \"justification\": \"The report indicates a high percentage of lymphoblasts in the bone marrow, suggesting a leukemia diagnosis. The immunophenotyping confirms the type of leukemia.\"\n}\n```\n",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T19:00:55.884374"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report describes an intraocular mass with calcifications in both eyes, a positive family history for retinoblastoma, and the presence of an RB1 germline mutation. These findings are highly suggestive of retinoblastoma. However, it's important to consider the possibility of a benign explanation for the mass, such as a tumor other than retinoblastoma. Further evaluation is needed to confirm the diagnosis and rule out other possibilities.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of intraocular mass, calcifications, positive family history, and RB1 mutation. These findings strongly support the diagnosis.\"\n}\n```\n```json\n{\n  \"diagnosis\": \"Retinoblastoma\",\n  \"reasoning\": \"The report clearly indicates retinoblastoma with a description of",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T19:00:55.884387"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified. The report explicitly states that no pathological features or malignancy were found. The healing fracture is considered a normal process.\",\n  \"alternative_explanations\": \"Healing fracture. Trauma history consistent.\",\n  \"conclusion\": \"The report indicates a healing fracture with no pathological features or malignancy. The trauma history is consistent with the findings. Therefore, the report does not suggest malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated PSA\",\n  \"malignancy_assessment\": \"The report mentions an elevated PSA, but it does not provide sufficient information to definitively conclude malignancy. Further investigation, such as a repeat PSA, free PSA, and/or prostate biopsy, is needed to determine the cause of the elevated PSA.\",\n  \"alternative_explanations\": \"Benign prostatic hyperplasia (BPH), prostatitis, or other non-cancerous conditions can cause elevated PSA levels.\",\n  \"conclusion\": \"While the elevated PSA raises suspicion, it is not conclusive evidence of malignancy. Further investigation is required to determine the cause of the elevated PSA.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Presence of cancer cells\",\n  \"malignancy_assessment\": \"The presence of cancer cells is a significant finding that suggests malignancy. However, it is important to consider the context of the findings. The report should provide information about the type of cancer cells, their location, and their stage. Further investigation is needed to determine the extent of the disease.\",\n  \"alternative_explanations\": \"The cancer cells could be a result of a benign condition or a misdiagnosis. Further investigation is needed to determine the cause of the cancer cells.\",\n  \"conclusion\": \"The presence of cancer cells is a concerning finding that suggests malignancy. However, further investigation is needed to determine the extent of the disease and to rule out other possible explanations.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated LDH\",\n  \"malignancy_assessment\": \"An elevated LDH level can be associated with various conditions, including malignancy. However, it is not a specific marker for cancer. Other causes of elevated LDH include hemolysis, liver disease, and certain infections. Further investigation is needed to determine the cause of the elevated LDH.\",\n  \"alternative_explanations\":",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T19:00:55.884400"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features, normal bone density, and no recurrence on imaging. Malignancy is not identified. Therefore, the findings are reassuring and do not suggest malignancy.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the diagnosis of malignancy.\",\n  \"benign_findings_ignored\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the diagnosis of malignancy.\",\n  \"benign_findings_ignored\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the diagnosis of malignancy.\",\n  \"benign_findings_ignored\": true\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates a benign bone cyst that has resolved. There are no aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\",\n  \"reasoning\": \"The report explicitly states that the bone cyst is benign and has resolved. It also mentions that there are no aggressive features, normal bone density, and no recurrence on imaging. Finally, the report confirms that no malignancy is identified. These findings are all consistent with a benign condition and do not support the",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T19:00:55.884415"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"Healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Healing fracture - normal process.\"\n  ],\n  \"final_judgment\": \"The report indicates a healing fracture with no pathological features. Therefore, no malignancy is identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Abnormal lymph nodes\",\n  \"malignancy_assessment\": \"Abnormal lymph nodes are noted. Further investigation is warranted to determine the cause.\",\n  \"alternative_explanations\": [\n    \"The abnormal lymph nodes could be reactive to a recent infection or inflammation.\",\n    \"The abnormal lymph nodes could be due to a benign condition such as lymphoma or metastatic disease.\"\n  ],\n  \"final_judgment\": \"The abnormal lymph nodes warrant further investigation to determine the underlying cause. While malignancy is a possibility, benign explanations should be considered first. The report suggests that further investigation is warranted.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Elevated PSA\",\n  \"malignancy_assessment\": \"The patient's PSA level is elevated. This could be due to prostate cancer, but it could also be due to a benign condition such as prostatitis or benign prostatic hyperplasia.\",\n  \"alternative_explanations\": [\n    \"Prostatitis\",\n    \"Benign prostatic hyperplasia (BPH)\",\n    \"Other benign causes of elevated PSA\"\n  ],\n  \"final_judgment\": \"The elevated PSA level warrants further investigation to determine the underlying cause. While prostate cancer is a concern, benign conditions such as prostatitis or BPH are also possible. Further evaluation is needed to differentiate between these possibilities.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"Abnormal liver function tests\",\n  \"malignancy_assessment\": \"Abnormal liver function tests are noted. This could be due to a variety of causes, including liver cancer, but it could also be due to a benign condition such as hepatitis or cirrhosis.\",\n  \"alternative_explanations\": [\n    \"Hepatitis\",\n    \"Cirrhosis\",\n    \"Medications\",\n    \"Other benign causes of abnormal liver function tests\"\n  ],\n  \"final_judgment\": \"Abnormal liver function tests warrant further investigation to determine the underlying",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T19:00:55.884425"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report confirms the absence of malignancy. The MRI is normal, and no mass lesions or abnormal enhancement are present. The patient's headaches are attributed to migraines. Therefore, there is no evidence to suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the brain MRI is normal, and no mass lesions or abnormal enhancement were found. The patient's headaches are attributed to migraines, and no malignancy is identified. Therefore, the report suggests the absence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The patient's headaches are attributed to migraines, and no malignancy is identified. This suggests that there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the absence of malignancy. The brain MRI is normal, and no mass lesions or abnormal enhancement are present. The patient's headaches are attributed to migraines. Therefore, there is no evidence to suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the brain MRI is normal, and no mass lesions or abnormal enhancement were found. The patient's headaches are attributed to migraines, and no malignancy is identified. Therefore, the report suggests the absence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The patient's headaches are attributed to migraines, and no malignancy is identified. This suggests that there is no evidence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report confirms the absence of malignancy. The brain MRI is normal, and no mass lesions or abnormal enhancement are present. The patient's headaches are attributed to migraines. Therefore, there is no evidence to suggest malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report indicates that the brain MRI is normal, and no mass lesions or abnormal enhancement were found. The patient's headaches are attributed to migraines, and no malignancy is identified. Therefore, the report suggests the absence of malignancy.\"\n}\n```\n```json\n{\n  \"conclusion\": \"The report states that the brain MRI is normal, and there are no mass lesions or abnormal enhancement. The",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T19:00:55.884434"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n  \"abnormal_findings\": \"healing fracture\",\n  \"malignancy_assessment\": \"No malignancy identified.\",\n  \"alternative_explanations\": [\n    \"Healing fracture - normal process\",\n    \"No pathological features\",\n    \"Bone density normal\",\n    \"Trauma history consistent\"\n  ],\n  \"conclusion\": \"The report indicates a healing fracture with no pathological features, normal bone density, and a consistent trauma history. Therefore, malignancy is not identified.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"a few small nodules in the right lung\",\n  \"malignancy_assessment\": \"The report mentions a few small nodules in the right lung, but it does not explicitly state that these are malignant. It only mentions that the findings are being followed up.\",\n  \"alternative_explanations\": [\n    \"The nodules could be benign, such as granulomas or hamartomas.\",\n    \"The nodules could be due to a benign process, such as inflammation or infection.\",\n    \"The nodules could be related to a prior infection or exposure.\"\n  ],\n  \"conclusion\": \"The report suggests the presence of nodules in the lung, but without further information, it is difficult to determine whether they are malignant. Further investigation is needed to rule out malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"a few small nodules in the right lung\",\n  \"malignancy_assessment\": \"The report mentions a few small nodules in the right lung, but it does not explicitly state that these are malignant. It only mentions that the findings are being followed up.\",\n  \"alternative_explanations\": [\n    \"The nodules could be benign, such as granulomas or hamartomas.\",\n    \"The nodules could be due to a benign process, such as inflammation or infection.\",\n    \"The nodules could be related to a prior infection or exposure.\"\n  ],\n  \"conclusion\": \"The report suggests the presence of nodules in the lung, but without further information, it is difficult to determine whether they are malignant. Further investigation is needed to rule out malignancy.\"\n}\n```\n```json\n{\n  \"abnormal_findings\": \"a few small nodules in the right lung\",\n  \"malignancy_assessment\": \"The report mentions a few small nodules in the right lung, but it does not explicitly",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T19:00:55.884446"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n  \"patient_history\": \"Hodgkin Lymphoma\",\n  \"imaging_findings\": \"Mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type.\",\n  \"differential_diagnosis\": \"Hodgkin Lymphoma\",\n  \"conclusion\": \"The report indicates a diagnosis of Hodgkin Lymphoma with mediastinal involvement and FDG-avid nodes on PET-CT. The imaging characteristics are consistent with the nodular sclerosing type. Further investigation and treatment planning are recommended. While the report strongly suggests Hodgkin Lymphoma, it's important to consider that other conditions can mimic this presentation, such as lymphoma variants or reactive lymphadenopathy. However, the report's description of the PET-CT findings and the clinical context of Hodgkin Lymphoma make this diagnosis the most likely.\"\n}\n```\n```json\n{\n  \"patient_history\": \"Hodgkin Lymphoma\",\n  \"imaging_findings\": \"Mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type.\",\n  \"differential_diagnosis\": \"Hodgkin Lymphoma\",\n  \"conclusion\": \"The report suggests a diagnosis of Hodgkin Lymphoma, with mediastinal involvement and FDG-avid nodes on PET-CT. The imaging characteristics are consistent with the nodular sclerosing type. Further investigation and treatment planning are recommended. While the report strongly suggests Hodgkin Lymphoma, it's important to consider that other conditions can mimic this presentation, such as lymphoma variants or reactive lymphadenopathy. However, the report's description of the PET-CT findings and the clinical context of Hodgkin Lymphoma make this diagnosis the most likely.\"\n}\n```\n```json\n{\n  \"patient_history\": \"Hodgkin Lymphoma\",\n  \"imaging_findings\": \"Mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type.\",\n  \"differential_diagnosis\": \"Hodgkin Lymphoma\",\n  \"conclusion\": \"The report indicates a diagnosis of Hodgkin Lymphoma with mediastinal involvement and FDG-avid nodes on PET-CT. The imaging characteristics are consistent with the nodular sclerosing type. Recommend MDT discussion and treatment planning. While the report strongly suggests Hod",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T19:00:55.884464"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n  \"assessment\": \"The report confirms a diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. This is a type of brain tumor. Given the patient is a child, the grade II classification is relevant. The report also recommends MDT discussion and treatment planning. The findings indicate a mass with mass effect, which is consistent with a brain tumor. The biopsy confirms the diagnosis. While a Grade II astrocytoma is not typically considered a high-grade malignancy, it is still a tumor and requires treatment. The MDT discussion and treatment planning are important steps in managing the patient's condition.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report indicates a diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. The presence of a mass with mass effect suggests a tumor. The biopsy confirms the diagnosis. While a Grade II astrocytoma is not considered a high-grade malignancy, it is still a tumor and requires treatment. The recommendation for MDT discussion and treatment planning is standard practice for brain tumors. The patient's age is relevant to the overall management plan. The report does not explicitly state that the tumor is cancerous, but it is a confirmed diagnosis of a brain tumor. Further investigation may be needed to determine the extent of the tumor and the patient's prognosis.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report confirms a diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. The presence of a mass with mass effect is consistent with a brain tumor. The biopsy confirms the diagnosis. While a Grade II astrocytoma is not a high-grade malignancy, it is still a tumor and requires treatment. The recommendation for MDT discussion and treatment planning is standard practice. The report does not provide any information about the tumor's aggressiveness or potential for metastasis. Further investigation may be needed to assess the tumor's extent and the patient's prognosis. The patient's age is relevant to the overall management plan. The report does not explicitly state that the tumor is cancerous, but it is a confirmed diagnosis of a brain tumor. The recommendation for MDT discussion and treatment planning is important to determine the appropriate treatment strategy.\"\n}\n```\n```json\n{\n  \"assessment\": \"The report confirms the diagnosis of Diffuse Astrocytoma WHO Grade II in the left temporal lobe. The presence of a mass with mass",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T19:00:55.884478"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified. Reassurance provided.\"\n}\n```\n```json\n{\n  \"report_type\": \"MRI Brain\",\n  \"date\": \"29/06/2025\",\n  \"findings\": \"Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\",\n  \"conclusion\": \"No malignancy identified",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T19:00:55.884487"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n  \"conclusion\": \"The report suggests the presence of mediastinal lymphadenopathy with a bulky anterior mediastinal mass, confirmed by PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. The report recommends MDT discussion and treatment planning. Based on the description, it is highly likely that the findings represent a malignancy, specifically Hodgkin Lymphoma. The patient is a child, which is a common age for Hodgkin Lymphoma. The presence of FDG-avid nodes on PET-CT is a strong indicator of malignancy. Therefore, the report is consistent with a diagnosis of Hodgkin Lymphoma.\",\n  \"supporting_evidence\": [\n    \"Mediastinal lymphadenopathy\",\n    \"Bulky anterior mediastinal mass\",\n    \"FDG-avid nodes on PET-CT\",\n    \"Nodular sclerosing type Hodgkin Lymphoma\",\n    \"Paediatric oncology assessment\"\n  ],\n  \"alternative_explanations\": [\n    \"The mediastinal lymphadenopathy could be due to a reactive process, although this is less likely given the presence of FDG-avid nodes.\",\n    \"The PET-CT findings could be due to a non-Hodgkin lymphoma, although the nodular sclerosing type is less common.\"\n  ],\n  \"uncertainties\": [\n    \"The exact extent of the disease is not fully defined, and further imaging may be required.\",\n    \"The specific subtype of Hodgkin Lymphoma is not fully characterized.\",\n    \"The patient's response to treatment is unknown.\"\n  ]\n}\n```\n```json\n{\n  \"conclusion\": \"The report describes mediastinal lymphadenopathy with a bulky anterior mediastinal mass, confirmed by PET-CT showing FDG-avid nodes. The type of Hodgkin lymphoma is nodular sclerosing. The report recommends MDT discussion and treatment planning. Based on the description, it is highly likely that the findings represent a malignancy, specifically Hodgkin Lymphoma. The patient is a child, which is a common age for Hodgkin Lymphoma. The presence of FDG-avid nodes on PET-CT is a strong indicator of malignancy. Therefore, the report is consistent with a diagnosis of Hodgkin Lymphoma.\",\n  \"supporting_evidence\": [\n    \"Mediastinal lymphadenopathy\",\n    \"Bulky anterior mediastinal mass\",\n    \"FDG-avid nodes",
      "predicted": false,
      "ground_truth": true,
      "correct": false,
      "reasoning": "",
      "findings": [],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T19:00:55.884515"
    }
  ],
  "end_time": "2026-01-10T19:00:55.884978",
  "duration_seconds": 61.004084
}